gene_symbol,hgnc_id,type,locus_type,JAX,MSK,NWU,UCSF,JAX_MorPhiC_Code,MSK_category,one2one_ortholog_hgnc,mgi_id,impc_viability,impc_phenotypes_homozygote,impc_phenotypes_heterozygote,impc_phenotypes_hemizygote,percentage_essential_all,mean_score_all,cellular_essential,omim,omim_name,dd,dd_name,dd_confidence_category,dd_allelic_requirement
ADGRG6,HGNC:13841,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE006,-,y,MGI:1916151,-,-,-,-,NA,NA,-,omim_disease,LETHAL CONGENITAL CONTRACTURE SYNDROME 9,dd,LETHAL CONGENITAL CONTRACTURE SYNDROME 9,definitive,biallelic_autosomal
ASCL1,HGNC:738,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE003,-,y,MGI:96919,-,-,-,-,176.252.319.109.462,-103.811.859.429.361,n,-,-,dd,AUTOSOMAL RECESSIVE INTELLECTUAL DEVELOPMENTAL DISORDER,limited,biallelic_autosomal
ATP10D,HGNC:13549,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE022,-,y,MGI:2450125,-,-,-,-,0,130.117.947.605.767,n,-,-,-,-,-,-
C2orf72,HGNC:27418,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE020,-,y,MGI:1920042,-,-,-,-,0,856.532.398.780.552,n,-,-,-,-,-,-
C4orf19,HGNC:25618,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE018,-,y,MGI:1923511,viable,enlarged heart|abnormal spleen morphology|abnormal heart morphology|small spleen|increased circulating HDL cholesterol level,-,-,0,-230.075.235.774.335,n,-,-,-,-,-,-
CCKBR,HGNC:1571,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE012,-,y,MGI:99479,viable,abnormal autopod morphology,-,-,927.643.784.786.642,-15.647.052.243.676,n,-,-,-,-,-,-
CSF3R,HGNC:2439,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE014,-,y,MGI:1339755,subviable,"preweaning lethality, incomplete penetrance",hydrometra|small superior vagus ganglion|abnormal heart morphology|small testis|abnormal testis morphology|enlarged heart,-,185.528.756.957.328,-947.295.768.640.827,n,omim_disease,"NEUTROPHILIA, HEREDITARY|NEUTROPENIA, SEVERE CONGENITAL, 7, AUTOSOMAL RECESSIVE",-,-,-,-
CYP2C18,HGNC:2620,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE007,-,-,-,-,-,-,-,371.057.513.914.657,-189.062.811.670.222,n,omim_disease,"DRUG METABOLISM, POOR, CYP2C19-RELATED",-,-,-,-
DLX3,HGNC:2916,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE038,-,y,MGI:94903,lethal,"preweaning lethality, complete penetrance",edema|hemorrhage|embryonic growth retardation|abnormal heart morphology|small heart|increased circulating alkaline phosphatase level,-,111.317.254.174.397,-170.398.889.040.138,n,omim_disease,"AMELOGENESIS IMPERFECTA, TYPE IV|TRICHODENTOOSSEOUS SYNDROME",-,-,-,-
DLX4,HGNC:2917,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE039,-,y,MGI:94904,viable,-,-,-,0,-14.789.437.933.064,n,omim_disease,OROFACIAL CLEFT 15,-,-,-,-
DLX5,HGNC:2918,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE040,-,y,MGI:101926,-,-,-,-,12.987.012.987.013,-970.594.092.748.928,n,omim_disease,"SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL RECESSIVE|SPLIT-HAND/FOOT MALFORMATION 1",dd,SPLIT HAND AND FOOT MALFORMATION,limited,biallelic_autosomal
DLX6,HGNC:2919,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE041,-,y,MGI:101927,-,-,-,-,371.057.513.914.657,-432.987.902.895.998,n,-,-,-,-,-,-
DMRTA1,HGNC:13826,approved_symbol,gene_with_protein_product,JAX,-,-,-,NE007,-,y,MGI:2653627,-,-,-,-,0,-100.847.613.979.892,n,-,-,-,-,-,-
EMX2,HGNC:3341,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,NE023,-,y,MGI:95388,-,-,-,-,0,-353.183.817.646.568,n,omim_disease,SCHIZENCEPHALY,dd,"FAMILIAL SCHIZENCEPHALY, EMX2-RELATED",limited,monoallelic_autosomal
EN2,HGNC:3343,approved_symbol,gene_with_protein_product,JAX,-,-,-,NE016,-,y,MGI:95390,-,-,-,-,0,325.924.363.760.421,n,-,-,-,-,-,-
EPAS1,HGNC:3374,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,ExE045,-,y,MGI:109169,lethal,"preweaning lethality, complete penetrance|increased total body fat amount",abnormal heart morphology|decreased hemoglobin content,-,834.879.406.307.978,-439.193.871.695.406,n,omim_disease,"ERYTHROCYTOSIS, FAMILIAL, 4",-,-,-,-
ESRRG,HGNC:3474,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE048,-,y,MGI:1347056,-,-,-,-,371.057.513.914.657,-305.285.053.558.671,n,-,-,-,-,-,-
FDX1,HGNC:3638,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE010,-,y,MGI:103224,lethal,"preweaning lethality, complete penetrance",abnormal lens morphology|increased grip strength|abnormal retina morphology,-,13.821.892.393.321,-270.721.885.703.395,n,-,-,-,-,-,-
FEZF1,HGNC:22788,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,NE014,-,y,MGI:1920441,-,-,-,-,0,804.584.680.308.855,n,omim_disease,HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA,dd,HYPOGONADOTROPIC HYPOGONADISM WITH OR WITHOUT ANOSMIA,strong,biallelic_autosomal
FEZF2,HGNC:13506,approved_symbol,gene_with_protein_product,JAX,-,-,-,NE015,-,y,MGI:1859823,-,-,-,-,0,159.491.195.226.367,n,-,-,-,-,-,-
FOSB,HGNC:3797,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE035,-,y,MGI:95575,viable,enlarged heart|abnormal heart morphology|abnormal skin morphology|abnormal kidney morphology|enlarged kidney,-,-,0,-839.069.688.526.628,n,-,-,-,-,-,-
FOXG1,HGNC:3811,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE002,-,y,MGI:1347464,-,-,-,-,371.057.513.914.657,-396.620.417.079.757,n,omim_disease,"RETT SYNDROME, CONGENITAL VARIANT",dd,CONGENITAL VARIANT OF RETT SYNDROME,definitive,monoallelic_autosomal
GBX2,HGNC:4186,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE025,-,y,MGI:95668,-,-,-,-,927.643.784.786.642,-110.840.532.047.163,n,-,-,-,-,-,-
GPR32,HGNC:4487,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE001,-,-,-,-,-,-,-,0,-206.301.137.373.176,n,-,-,-,-,-,-
GPR78,HGNC:4528,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE005,-,-,-,-,-,-,-,0,418.455.272.530.096,n,-,-,-,-,-,-
GPR87,HGNC:4538,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE026,-,y,MGI:1934133,viable,-,-,-,927.643.784.786.642,-492.850.894.908.662,n,-,-,-,-,-,-
GPR157,HGNC:23687,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE011,-,y,MGI:2442046,viable,-,-,-,0,193.823.733.121.234,n,-,-,-,-,-,-
GRHL1,HGNC:17923,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE037,-,y,MGI:2182540,-,-,-,-,927.643.784.786.642,887.765.006.727.434,n,-,-,-,-,-,-
HES5,HGNC:19764,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,NE006,-,y,MGI:104876,-,-,-,-,649.350.649.350.649,-629.393.112.567.603,n,-,-,-,-,-,-
HEY1,HGNC:4880,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE050,-,y,MGI:1341800,-,-,-,-,278.293.135.435.993,-404.732.813.236.021,n,-,-,-,-,-,-
HMGCS2,HGNC:5008,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE008,-,y,MGI:101939,viable,-,-,-,0,174.632.470.340.369,n,omim_disease,3-HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE-2 DEFICIENCY,dd,3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2 DEFICIENCY,definitive,biallelic_autosomal
HOPX,HGNC:24961,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE030,-,y,MGI:1916782,-,-,-,-,0,-475.236.268.032.894,n,-,-,-,-,-,-
ISL1,HGNC:6132,approved_symbol,gene_with_protein_product,JAX,MSK,NWU,-,ExE033,Xianming (DH),y,MGI:101791,-,-,-,-,222.634.508.348.794,-642.485.837.015.435,n,-,-,-,-,-,-
LHX5,HGNC:14216,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE018,-,y,MGI:107792,lethal,"preweaning lethality, complete penetrance|no spontaneous movement",enlarged thymus|increased leukocyte cell number|abnormal thymus morphology|enlarged spleen|abnormal heart morphology|abnormal seminal vesicle morphology|small seminal vesicle|abnormal spleen morphology|enlarged heart|abnormal tooth morphology,-,463.821.892.393.321,-100.005.258.685.011,n,-,-,-,-,-,-
LHX9,HGNC:14222,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,NE011,-,y,MGI:1316721,-,-,-,-,0,-301.349.028.078.908,n,-,-,-,-,-,-
LMO2,HGNC:6642,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE004,-,y,MGI:102811,-,-,-,-,222.634.508.348.794,743.358.069.487.366,n,-,-,-,-,-,-
MAFF,HGNC:6780,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE042,-,y,MGI:96910,-,-,-,-,371.057.513.914.657,-190.961.862.982.297,n,-,-,-,-,-,-
MEIS1,HGNC:7000,approved_symbol,gene_with_protein_product,JAX,MSK,NWU,UCSF,ExE044,"FUSIL ""developmental lethal""",y,MGI:104717,lethal,"preweaning lethality, complete penetrance",hyperactivity|increased bone mineral content|decreased prepulse inhibition|increased startle reflex,-,556.586.270.871.985,-605.711.524.552.647,n,-,-,-,-,-,-
MRGPRX1,HGNC:17962,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE003,-,-,-,-,-,-,-,556.586.270.871.985,-108.239.271.848.281,n,-,-,-,-,-,-
MSX2,HGNC:7392,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE052,-,y,MGI:97169,-,-,-,-,278.293.135.435.993,430.185.215.472.037,n,omim_disease,CRANIOSYNOSTOSIS 2|PARIETAL FORAMINA 1|PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA,dd,"ENLARGED PARIETAL FORAMINA/CRANIUM BIFIDUM|CRANIOSYNOSTOSIS, TYPE 2",definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
MXD1,HGNC:6761,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE043,-,y,MGI:96908,-,-,-,-,0,488.433.258.393.044,n,-,-,-,-,-,-
NEURL1,HGNC:7761,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE013,-,y,MGI:1334263,-,-,-,-,278.293.135.435.993,-248.310.951.772.165,n,-,-,-,-,-,-
NEUROD4,HGNC:13802,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE009,-,y,MGI:108055,-,-,-,-,0,688.512.621.757.756,n,-,-,-,-,-,-
NKX6-2,HGNC:19321,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,NE021,-,y,MGI:1352738,-,-,-,-,0,225.995.200.122.717,n,omim_disease,"SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY",dd,Progressive Spastic Ataxia and Hypomyelination,strong,biallelic_autosomal
NR2F1,HGNC:7975,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,NE012,-,y,MGI:1352451,lethal,"embryonic growth retardation|preweaning lethality, complete penetrance",abnormal auditory brainstem response,-,278.293.135.435.993,-164.063.960.013.373,n,omim_disease,BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME,dd,BOSCH-BOONSTRA OPTIC ATROPHY SYNDROME,definitive,monoallelic_autosomal
NR2F2,HGNC:7976,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,ExE036,-,y,MGI:1352452,-,-,-,-,649.350.649.350.649,469.845.224.896.728,n,omim_disease,"46,XX SEX REVERSAL 5|CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4",dd,CONGENITAL HEART DEFECTS and XX sex reversal,definitive,monoallelic_autosomal
OTX1,HGNC:8521,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE005,-,y,MGI:97450,-,-,-,-,102.040.816.326.531,-195.746.496.565.601,n,-,-,-,-,-,-
OVOL1,HGNC:8525,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,ExE027,-,y,MGI:1330290,viable,-,decreased erythrocyte cell number|abnormal coat/hair pigmentation|abnormal vibrissa morphology|decreased hematocrit|thrombocytopenia|decreased hemoglobin content,-,463.821.892.393.321,-791.049.819.651.488,n,-,-,-,-,-,-
PAX6,HGNC:8620,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE001,-,y,MGI:97490,lethal,"abnormal placenta morphology|abnormal placenta vasculature|preweaning lethality, complete penetrance|abnormal craniofacial morphology|facial cleft|anophthalmia|cleft palate",hyperactivity|corneal vascularization|abnormal eye morphology|small liver|increased monocyte cell number|microphthalmia|anophthalmia|corneal opacity|abnormal brain morphology|cataract|developmental dysplasia|abnormal liver morphology|abnormal placenta morphology,-,0,351.945.609.005.453,n,omim_disease,"COLOBOMA OF OPTIC NERVE|COLOBOMA, OCULAR, AUTOSOMAL DOMINANT|ANIRIDIA 1|ANTERIOR SEGMENT DYSGENESIS 5|FOVEAL HYPOPLASIA 1|KERATITIS, HEREDITARY|OPTIC NERVE HYPOPLASIA, BILATERAL",dd,PETERS ANOMALY|ANIRIDIA,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
PHOSPHO1,HGNC:16815,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE016,-,y,MGI:2447348,-,-,-,-,0,-709.677.906.213.173,n,-,-,-,-,-,-
PITX1,HGNC:9004,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE047,-,y,MGI:107374,lethal,"preweaning lethality, complete penetrance",polysyndactyly|abnormal joint morphology|abnormal nail morphology|abnormal autopod morphology|abnormal cornea morphology|vertebral transformation|abnormal digit morphology|abnormal tibia morphology|abnormal femur morphology|fused phalanges,-,463.821.892.393.321,-785.075.066.225.832,n,omim_disease,"CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR MIRROR-IMAGE POLYDACTYLY|LIEBENBERG SYNDROME",dd,HOMEOTIC ARM-TO-LEG TRANSFORMATION ASSOCIATED WITH GENOMIC REARRANGEMENTS AT THE PITX1 LOCUS|CONGENITAL CLUBFOOT,strong|strong,monoallelic_autosomal|monoallelic_autosomal
POU2F3,HGNC:19864,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE028,-,y,MGI:102565,viable,enlarged heart,-,-,463.821.892.393.321,508.586.560.249.858,n,-,-,-,-,-,-
POU3F1,HGNC:9214,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE019,-,y,MGI:101896,-,-,-,-,185.528.756.957.328,151.461.026.529.295,n,-,-,-,-,-,-
POU3F2,HGNC:9215,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE022,-,y,MGI:101895,-,-,-,-,371.057.513.914.657,583.410.569.050.597,n,-,-,-,-,-,-
POU3F3,HGNC:9216,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE013,-,y,MGI:102564,-,-,-,-,371.057.513.914.657,-854.608.483.704.436,n,omim_disease,SNIJDERS BLOK-FISHER SYNDROME,dd,INTELLECTUAL DISABILITY,definitive,monoallelic_autosomal
RFX4,HGNC:9985,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE017,-,y,MGI:1918387,-,-,-,-,927.643.784.786.642,-942.439.355.403.784,n,-,-,-,-,-,-
RLBP1,HGNC:10024,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE024,-,y,MGI:97930,viable,increased lean body mass|abnormal tooth morphology,-,-,927.643.784.786.642,269.334.725.334.488,n,omim_disease,BOTHNIA RETINAL DYSTROPHY|FUNDUS ALBIPUNCTATUS|NEWFOUNDLAND ROD-CONE DYSTROPHY,-,-,-,-
RUNX1,HGNC:10471,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE032,-,y,MGI:99852,-,-,-,-,36.178.107.606.679,-214.051.988.151.786,n,omim_disease,"LEUKEMIA, ACUTE MYELOID|PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY",-,-,-,-
SIX3,HGNC:10889,approved_symbol,gene_with_protein_product,JAX,MSK,NWU,UCSF,NE004,T2D (DH),y,MGI:102764,-,-,-,-,185.528.756.957.328,-199.888.361.207.198,n,omim_disease,HOLOPROSENCEPHALY 2|SCHIZENCEPHALY,dd,HOLOPROSENCEPHALY,definitive,monoallelic_autosomal
SLC52A1,HGNC:30225,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE021,-,-,-,-,-,-,-,0,-303.535.377.207.908,n,omim_disease,RIBOFLAVIN DEFICIENCY,-,-,-,-
SMAD7,HGNC:6773,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE046,-,y,MGI:1100518,-,-,-,-,36.178.107.606.679,-101.862.568.220.147,n,omim_disease,"COLORECTAL CANCER, SUSCEPTIBILITY TO, 3",-,-,-,-
SNAI2,HGNC:11094,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE002,-,y,MGI:1096393,subviable,"preweaning lethality, incomplete penetrance",enlarged heart,-,519.480.519.480.519,-102.529.393.616.731,n,omim_disease,"PIEBALD TRAIT|WAARDENBURG SYNDROME, TYPE 2D",-,-,-,-
SOX1,HGNC:11189,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,NE024,-,y,MGI:98357,-,-,-,-,463.821.892.393.321,564.444.263.342.061,n,-,-,-,-,-,-
SOX7,HGNC:18196,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE031,-,y,MGI:98369,-,-,-,-,371.057.513.914.657,-188.953.043.031.389,n,-,-,-,-,-,-
SOX21,HGNC:11197,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,NE020,-,y,MGI:2654070,viable,abnormal skin morphology|cataract|increased monocyte cell number|increased neutrophil cell number|hydrocephaly|inflammation|abnormal heart morphology|corneal opacity|abnormal lymph node morphology|enlarged lymph nodes|abnormal kidney morphology|enlarged kidney|abnormal brain morphology|abnormal eyelid morphology|eye hemorrhage|small liver|abnormal vitreous body morphology|increased mean corpuscular volume|decreased lymphocyte cell number|enlarged heart|abnormal liver morphology,-,-,0,622.936.296.839.672,n,-,-,-,-,-,-
SP8,HGNC:19196,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,NE008,-,y,MGI:2443471,-,-,-,-,185.528.756.957.328,-494.346.006.517.262,n,-,-,-,-,-,-
STS,HGNC:11425,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE023,-,y,MGI:98438,-,-,-,-,0,175.429.970.138.932,n,omim_disease,"ICHTHYOSIS, X-LINKED",dd,"ICHTHYOSIS, X-LINKED",definitive,monoallelic_X_hem
TBR1,HGNC:11590,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,NE026,-,y,MGI:107404,subviable,"preweaning lethality, incomplete penetrance",decreased circulating glucose level|decreased circulating creatinine level|increased erythrocyte cell number,-,278.293.135.435.993,-120.928.170.279.848,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY,dd,AUTISM,definitive,monoallelic_autosomal
TNFRSF1B,HGNC:11917,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE025,-,y,MGI:1314883,-,decreased locomotor activity|increased circulating total protein level|decreased prepulse inhibition|decreased T cell number|increased B cell number,-,-,0,-121.569.289.191.396,n,-,-,-,-,-,-
TREML2,HGNC:21092,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE009,-,y,MGI:2147038,-,-,-,-,584.415.584.415.584,-205.512.276.502.054,n,-,-,-,-,-,-
TWIST2,HGNC:20670,approved_symbol,gene_with_protein_product,JAX,-,NWU,UCSF,ExE029,-,y,MGI:104685,subviable,"preweaning lethality, incomplete penetrance",abnormal lung morphology|abnormal testis morphology|abnormal heart morphology|small testis|enlarged heart|enlarged lung,-,278.293.135.435.993,461.880.307.687.165,n,omim_disease,"ABLEPHARON-MACROSTOMIA SYNDROME|BARBER-SAY SYNDROME|FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE",dd,ABLEPHARON MACROSTOMIA SYNDROME|SETLEIS SYNDROME,definitive|strong,monoallelic_autosomal|biallelic_autosomal
VSIR,HGNC:30085,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE017,-,y,MGI:1921298,viable,-,-,-,0,737.232.738.210.774,n,-,-,-,-,-,-
VTCN1,HGNC:28873,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE015,-,y,MGI:3039619,-,-,-,-,909.090.909.090.909,-295.299.213.379.035,n,-,-,-,-,-,-
ZBTB7C,HGNC:31700,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE049,-,y,MGI:2443302,-,-,-,-,927.643.784.786.642,62.434.212.856.139,n,-,-,-,-,-,-
ZFHX3,HGNC:777,approved_symbol,gene_with_protein_product,JAX,-,-,UCSF,ExE051,-,y,MGI:99948,-,-,-,-,927.643.784.786.642,201.110.213.473.724,n,omim_disease,PROSTATE CANCER,dd,ZFHX3-related developmental disorder (monoallelic),limited,monoallelic_autosomal
ZIC4,HGNC:20393,approved_symbol,gene_with_protein_product,JAX,-,NWU,-,NE027,-,y,MGI:107201,-,-,-,-,0,693.523.859.842.076,n,-,-,-,-,-,-
ZNF488,HGNC:23535,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE034,-,y,MGI:2686052,subviable,"abnormal spleen morphology|preweaning lethality, incomplete penetrance",-,-,0,-86.531.777.847.931,n,-,-,-,-,-,-
ZNF521,HGNC:24605,approved_symbol,gene_with_protein_product,JAX,-,-,-,NE010,-,y,MGI:95459,-,-,-,-,371.057.513.914.657,-160.667.952.315.819,n,-,-,-,-,-,-
ZNF703,HGNC:25883,approved_symbol,gene_with_protein_product,JAX,-,-,-,ExE019,-,y,MGI:2662729,-,-,-,-,278.293.135.435.993,922.092.942.913.581,n,-,-,-,-,-,-
ABCC8,HGNC:59,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:1352629,viable,impaired glucose tolerance|increased lean body mass,-,-,0,272.814.648.519.358,n,omim_disease,"TYPE 2 DIABETES MELLITUS|DIABETES MELLITUS, PERMANENT NEONATAL, 3|DIABETES MELLITUS, TRANSIENT NEONATAL, 2|HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1|HYPOGLYCEMIA, LEUCINE-INDUCED",-,-,-,-
ACVR1B,HGNC:172,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1338944,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",abnormal uterus morphology|small adrenal glands|abnormal coat/ hair morphology|enlarged lymph nodes|small testis,-,120.593.692.022.263,-999.506.636.519.203,n,-,-,-,-,-,-
AP1G1,HGNC:555,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:101919,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",decreased lean body mass|abnormal retina morphology|hyperactivity|cataract|decreased bone mineral content|increased total body fat amount|increased vertical activity,-,435.992.578.849.722,-151.832.322.121.287,n,omim_disease,"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT|USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE",dd,"AP1G1-related intellectual disability, biallelic|AP1G1-related intellectual disability and epilepsy, monoallelic",limited|strong,biallelic_autosomal|monoallelic_autosomal
AP2B1,HGNC:563,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919020,lethal,"abnormal embryo size|cleft palate|preweaning lethality, complete penetrance",decreased grip strength,-,185.528.756.957.328,-122.259.493.031.917,n,-,-,-,-,-,-
APH1A,HGNC:29509,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2385110,lethal,"pale yolk sac|pallor|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance|abnormal embryo size",abnormal skin coloration|hyperactivity|abnormal coat appearance|abnormal retina outer nuclear layer morphology|decreased total retina thickness|increased bone mineral content,-,583.487.940.630.798,-54.004.540.252.905,y,-,-,-,-,-,-
ARHGEF7,HGNC:15607,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1860493,lethal,"preweaning lethality, complete penetrance",-,-,241.187.384.044.527,-308.613.207.890.737,n,-,-,-,-,-,-
ARID1A,HGNC:11110,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,TV genes,y,MGI:1935147,-,-,-,-,116.883.116.883.117,-21.981.583.787.963,n,omim_disease,COFFIN-SIRIS SYNDROME 2,dd,COFFIN-SIRIS SYNDROME,definitive,monoallelic_autosomal
ARID1B,HGNC:18040,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,TV genes,y,MGI:1926129,lethal|subviable,"male infertility|preweaning lethality, complete penetrance|edema|preweaning lethality, incomplete penetrance",increased circulating creatinine level|decreased prepulse inhibition|decreased locomotor activity|decreased fasting circulating glucose level|decreased exploration in new environment|abnormal freezing behavior|impaired cued conditioning behavior|increased freezing behavior|abnormal spleen morphology,-,352.504.638.218.924,-912.127.521.916.803,n,omim_disease,COFFIN-SIRIS SYNDROME 1,dd,COFFIN SIRIS SYNDROME,definitive,monoallelic_autosomal
ARID3A,HGNC:3031,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:1328360,lethal,"abnormal limb bud morphology|hemorrhage|abnormal embryo size|preweaning lethality, complete penetrance|abnormal placenta morphology",increased circulating triglyceride level|decreased hemoglobin content|increased mean corpuscular hemoglobin|decreased erythrocyte cell number|abnormal lens morphology|decreased hematocrit|increased circulating insulin level,-,463.821.892.393.321,-138.058.052.944.899,n,-,-,-,-,-,-
ARIH2,HGNC:690,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1344361,lethal,"embryonic growth retardation|abnormal embryo size|preweaning lethality, complete penetrance",polycystic kidney|abnormal embryo size|cystolithiasis|abnormal heart morphology|abnormal kidney morphology|enlarged heart|abnormal skin morphology|embryonic growth retardation|abnormal urinary bladder morphology,-,371.057.513.914.657,181.427.601.656.615,n,-,-,-,-,-,-
ARL15,HGNC:25945,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2442308,lethal,"preweaning lethality, complete penetrance",increased circulating creatinine level|short tibia,-,185.528.756.957.328,453.778.264.816.528,n,-,-,-,-,-,-
ARMH3,HGNC:25788,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1918867,-,-,increased grip strength,-,148.423.005.565.863,-903.962.318.217.649,n,-,-,-,-,-,-
ARPC2,HGNC:705,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1923959,lethal,"preweaning lethality, complete penetrance",decreased body weight|decreased total body fat amount|abnormal coat/hair pigmentation|increased mean corpuscular hemoglobin|increased leukocyte cell number|increased mean corpuscular volume|vertebral fusion,-,404.452.690.166.976,-459.822.680.181.396,n,-,-,-,-,-,-
ASF1A,HGNC:20995,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1913653,lethal,"embryonic lethality prior to tooth bud stage|abnormal neural tube closure|embryonic growth retardation|preweaning lethality, complete penetrance|abnormal embryo size|abnormal neural tube morphology",embryonic growth retardation|abnormal embryo size|abnormal embryo turning|increased circulating alkaline phosphatase level|decreased thigmotaxis|increased circulating insulin level,-,556.586.270.871.985,-157.815.078.711.215,n,-,-,-,-,-,-
ASH2L,HGNC:744,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1344416,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",abnormal skin coloration|abnormal coat appearance,-,255.102.040.816.327,-355.187.146.694.728,n,-,-,-,-,-,-
ATG13,HGNC:29091,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1196429,lethal,"preweaning lethality, complete penetrance",short tibia,-,185.528.756.957.328,-269.841.151.199.666,n,-,-,-,-,-,-
ATP6V0A1,HGNC:865,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:103286,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage",increased bone mineral content|increased circulating potassium level|decreased total body fat amount,-,278.293.135.435.993,-178.264.213.857.482,n,omim_disease,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 104|NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND BRAIN ATROPHY,dd,ATP6V0A1-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
ATP6V0D1,HGNC:13724,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1201778,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage",abnormal kidney morphology|increased neutrophil cell number|dysplasia|increased startle reflex|spermatogenesis defect|abnormal seminal vesicle morphology|short tibia|decreased lymphocyte cell number|decreased mean corpuscular hemoglobin concentration,-,942.486.085.343.228,-101.083.289.267.255,y,-,-,-,-,-,-
ATXN7L3,HGNC:25416,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:3036270,lethal,"preweaning lethality, complete penetrance",abnormal vocalization|abnormal retina vasculature morphology|short tibia|abnormal retina blood vessel morphology|decreased total retina thickness|abnormal coat/hair pigmentation,-,193.877.551.020.408,-288.017.171.306.894,n,-,-,-,-,-,-
BECN1,HGNC:1034,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1891828,lethal,"preweaning lethality, complete penetrance",increased leukocyte cell number|decreased lean body mass|increased circulating bilirubin level|increased startle reflex|increased total body fat amount|decreased circulating HDL cholesterol level,-,49.165.120.593.692,-203.573.074.331.345,n,-,-,-,-,-,-
BEND3,HGNC:23040,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2677212,lethal,"preweaning lethality, complete penetrance",abnormal coat/hair pigmentation,-,463.821.892.393.321,-104.609.031.275.608,n,-,-,-,-,-,-
BRD2,HGNC:1103,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:99495,lethal,"preweaning lethality, complete penetrance","decreased CD8-positive, alpha-beta T cell number|abnormal auditory brainstem response|abnormal vertebral arch morphology|increased mean corpuscular hemoglobin|increased CD4-positive, alpha beta T cell number",-,307.977.736.549.165,-368.915.581.436.223,n,-,-,-,-,-,-
CAMTA2,HGNC:18807,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2135957,-,-,-,-,0,-450.687.874.537.418,n,-,-,-,-,-,-
CARM1,HGNC:23393,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1913208,lethal,"preweaning lethality, complete penetrance",decreased lymphocyte cell number,-,249.536.178.107.607,-367.135.226.348.041,n,-,-,-,-,-,-
CASZ1,HGNC:26002,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1196251,lethal,"preweaning lethality, complete penetrance",persistence of hyaloid vascular system,-,556.586.270.871.985,-127.187.762.648.014,n,-,-,-,-,-,-
CBX1,HGNC:1551,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:105369,lethal,"preweaning lethality, complete penetrance",-,-,589.981.447.124.304,-571.564.475.362.178,y,-,-,-,-,-,-
CBX4,HGNC:1554,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1195985,lethal,"preweaning lethality, complete penetrance|abnormal embryo size",hyperactivity|abnormal embryo size|increased total body fat amount|decreased lean body mass,-,463.821.892.393.321,-103.752.700.684.083,n,-,-,-,-,-,-
CDK8,HGNC:1779,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1196224,lethal,"abnormal neural tube closure|abnormal embryo size|abnormal embryo turning|abnormal heart morphology|preweaning lethality, complete penetrance",decreased exploration in new environment|abnormal freezing behavior,-,315.398.886.827.458,-232.310.883.623.868,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPOTONIA AND BEHAVIORAL ABNORMALITIES,dd,SYNDROMIC INTELLECTUAL DISABILITY,definitive,monoallelic_autosomal
CDK12,HGNC:24224,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1098802,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",decreased exploration in new environment|decreased circulating HDL cholesterol level|enlarged urinary bladder|decreased hematocrit|abnormal liver morphology|increased red blood cell distribution width|decreased erythrocyte cell number|increased spleen weight|decreased hemoglobin content|increased heart weight|enlarged spleen|abnormal urinary bladder morphology,-,4.860.853.432.282,-49.800.054.092.565,n,-,-,-,-,-,-
CELF4,HGNC:14015,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1932407,lethal,"preweaning lethality, complete penetrance",increased circulating insulin level|decreased circulating calcium level|decreased circulating cholesterol level|impaired glucose tolerance,-,0,-77.351.848.308.501,n,-,-,-,-,-,-
CHTOP,HGNC:24511,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1913761,lethal,"preweaning lethality, complete penetrance",abnormal joint morphology,-,148.423.005.565.863,-333.404.316.226.162,n,-,-,-,-,-,-
CMIP,HGNC:24319,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1921690,lethal,"preweaning lethality, complete penetrance",-,-,173.469.387.755.102,-299.944.954.463.012,n,-,-,-,-,-,-
CNOT4,HGNC:7880,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1859026,lethal,"preweaning lethality, complete penetrance",decreased lean body mass|decreased circulating alkaline phosphatase level|increased total body fat amount|decreased body length|decreased bone mineral content|decreased KLRG1-positive NK cell number|abnormal bone structure|abnormal epidermal immune compartment,-,157.699.443.413.729,-477.083.888.353.397,n,-,-,-,-,-,-
CNOT10,HGNC:23817,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926143,lethal,"embryonic growth retardation|preweaning lethality, complete penetrance",hyperactivity|increased grip strength,-,278.293.135.435.993,-655.281.281.408.697,n,-,-,-,-,-,-
CNTFR,HGNC:2170,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:99605,lethal,"preweaning lethality, complete penetrance",increased circulating serum albumin level|increased circulating aspartate transaminase level|abnormal behavior|decreased leukocyte cell number|increased lactate dehydrogenase level|increased circulating cholesterol level,-,0,-842.365.734.216.202,n,-,-,-,-,-,-
CS,HGNC:2422,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:88529,lethal,"preweaning lethality, complete penetrance",decreased grip strength|impaired glucose tolerance|abnormal digit morphology|decreased prepulse inhibition,-,517.625.231.910.946,-531.547.888.987.898,y,-,-,-,-,-,-
CSK,HGNC:2444,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:88537,lethal,"abnormal embryo size|preweaning lethality, complete penetrance|embryonic growth retardation|abnormal embryo development|abnormal neural tube closure|abnormal embryo turning|embryonic lethality prior to tooth bud stage",decreased total retina thickness|abnormal retina inner nuclear layer morphology|abnormal retina vasculature morphology,-,417.439.703.153.989,-934.415.030.920.626,n,-,-,-,-,-,-
CUL5,HGNC:2556,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1922967,lethal,"abnormal embryo size|pallor|abnormal pericardium morphology|embryonic lethality prior to tooth bud stage|abnormal neural tube morphology|embryonic growth retardation|preweaning lethality, complete penetrance",enlarged spleen|enlarged heart|abnormal spleen morphology|abnormal heart morphology|increased spleen weight,-,927.643.784.786.642,14.506.305.530.984,n,-,-,-,-,-,-
DAAM1,HGNC:18142,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1914596,lethal,"preweaning lethality, complete penetrance",increased blood urea nitrogen level|increased circulating amylase level,-,0,573.192.225.923.813,n,-,-,-,-,-,-
DACH1,HGNC:2663,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:1277991,lethal,"preweaning lethality, complete penetrance",increased circulating chloride level|increased circulating alanine transaminase level|increased startle reflex,-,927.643.784.786.642,-138.322.445.867.824,n,-,-,-,-,-,-
DDX1,HGNC:2734,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2144727,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage",-,-,173.469.387.755.102,-332.407.448.159.827,n,-,-,-,-,-,-
DERL2,HGNC:17943,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2151483,lethal,"preweaning lethality, complete penetrance",-,-,155.844.155.844.156,-284.838.833.673.602,n,-,-,-,-,-,-
DLG5,HGNC:2904,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1918478,lethal,"preweaning lethality, complete penetrance",abnormal brain morphology|hydrocephaly,-,445.269.016.697.588,-189.084.068.869.834,n,-,-,dd,DLG5-associated developmental disorder (monoallelic)|DLG5-associated developmental disorder (biallelic),limited|limited,monoallelic_autosomal|biallelic_autosomal
DPY30,HGNC:24590,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1913560,lethal,"preweaning lethality, complete penetrance",increased circulating sodium level,-,333.024.118.738.404,-413.627.114.818.959,n,-,-,-,-,-,-
DSTN,HGNC:15750,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1929270,-,embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage,abnormal heart morphology|enlarged heart,-,142.857.142.857.143,-3.279.814.182.775,n,-,-,-,-,-,-
ELAVL1,HGNC:3312,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1100851,lethal,"anophthalmia|preweaning lethality, complete penetrance|embryonic growth retardation|abnormal embryo size|abnormal limb morphology|edema",increased circulating alanine transaminase level|decreased mean corpuscular hemoglobin|impaired pupillary reflex,-,136.363.636.363.636,-264.479.396.104.707,n,-,-,-,-,-,-
EOMES,HGNC:3372,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Positive Control (DH),y,MGI:1201683,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage|embryonic lethality prior to organogenesis",increased total body fat amount|decreased bone mineral content|decreased lean body mass|decreased circulating creatinine level,-,185.528.756.957.328,554.522.108.907.484,n,-,-,dd,POLYMICROGYRIA AND CORPUS CALLOSUM AGENESIS,limited,biallelic_autosomal
EPC2,HGNC:24543,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1278321,lethal,"abnormal retina pigmentation|preweaning lethality, complete penetrance|increased circulating alkaline phosphatase level|decreased lactate dehydrogenase level|thrombocytopenia|abnormal eye morphology",increased respiratory quotient|abnormal retina blood vessel morphology|increased pulmonary respiratory rate|abnormal behavior|abnormal retina morphology|abnormal lens morphology|increased thigmotaxis|decreased total retina thickness|abnormal vertebral arch morphology|increased mean corpuscular volume|decreased locomotor activity|cataract|decreased body weight|increased mean corpuscular hemoglobin concentration,-,139.146.567.717.996,-249.560.092.112.837,n,-,-,-,-,-,-
EXOC8,HGNC:24659,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2142527,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",-,-,471.243.042.671.614,-497.303.122.954.158,n,omim_disease,"NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND BRAIN ATROPHY",-,-,-,-
FCHO2,HGNC:25180,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:3505790,lethal,"preweaning lethality, complete penetrance",decreased mean corpuscular hemoglobin|increased red blood cell distribution width|decreased circulating serum albumin level|decreased circulating fructosamine level,-,667.903.525.046.382,-143.073.590.451.298,n,-,-,-,-,-,-
FNDC3B,HGNC:24670,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919257,lethal,"preweaning lethality, complete penetrance",abnormal coat/hair pigmentation|urinary bladder obstruction|abnormal heart morphology|enlarged heart|abnormal eye morphology,-,102.040.816.326.531,-525.610.290.708.301,n,-,-,-,-,-,-
FOXA2,HGNC:5022,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Xianming (DH),y,MGI:1347476,-,-,-,-,287.569.573.283.859,-977.988.632.990.747,n,-,-,-,-,-,-
FRS2,HGNC:16971,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1100860,lethal,"preweaning lethality, complete penetrance",abnormal auditory brainstem response,-,371.057.513.914.657,-138.495.966.466.752,n,-,-,-,-,-,-
FURIN,HGNC:8568,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:97513,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",brachydactyly|abnormal vibrissa morphology,-,136.363.636.363.636,-199.886.044.166.343,n,-,-,-,-,-,-
FYN,HGNC:4037,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:95602,lethal,"preweaning lethality, complete penetrance",-,-,0,243.212.174.114.171,n,-,-,-,-,-,-
FZR1,HGNC:24824,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926790,lethal,"abnormal embryo size|abnormal placenta size|preweaning lethality, complete penetrance",abnormal heart morphology|enlarged heart,-,140.074.211.502.783,-222.972.834.187.154,n,omim_disease,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 109,dd,FZR1-related intellectual disability and epilepsy,strong,monoallelic_autosomal
G3BP2,HGNC:30291,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2442040,lethal,"preweaning lethality, complete penetrance",-,-,12.987.012.987.013,-810.242.258.593.574,n,-,-,-,-,-,-
GABARAPL2,HGNC:13291,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1890602,lethal,"preweaning lethality, complete penetrance",decreased circulating serum albumin level|decreased lymphocyte cell number|increased monocyte cell number|decreased hemoglobin content|increased heart weight|increased neutrophil cell number,-,0,360.331.494.536.558,n,-,-,-,-,-,-
GABPA,HGNC:4071,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:95610,lethal,"abnormal ear morphology|abnormal facial morphology|anophthalmia|preweaning lethality, complete penetrance|abnormal cranium morphology",increased circulating bilirubin level,-,73.191.094.619.666,-636.725.044.140.167,y,-,-,-,-,-,-
GART,HGNC:4163,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:95654,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",-,-,333.024.118.738.404,-399.753.694.353.319,n,-,-,-,-,-,-
GATA6,HGNC:4174,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Positive Control (DH),y,MGI:107516,-,-,-,-,102.040.816.326.531,-113.417.609.792.184,n,omim_disease,"ATRIAL SEPTAL DEFECT 9|ATRIOVENTRICULAR SEPTAL DEFECT 5|HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES|CONOTRUNCAL HEART MALFORMATIONS|TETRALOGY OF FALLOT",dd,"ATRIOVENTRICULAR SEPTAL DEFECT 5|PANCREATIC AGENESIS, DIAPHRAGMATIC HERNIA AND CONGENITAL HEART DEFECTS|ATRIAL SEPTAL DEFECT 9",definitive|definitive|definitive,monoallelic_autosomal|monoallelic_autosomal|monoallelic_autosomal
GDF11,HGNC:4216,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1338027,lethal,"abnormal tail morphology|abnormal facial morphology|cleft palate|preweaning lethality, complete penetrance|abnormal craniofacial morphology",increased cardiac stroke volume,-,742.115.027.829.314,-792.292.877.501.675,n,omim_disease,VERTEBRAL HYPERSEGMENTATION AND OROFACIAL ANOMALIES,dd,"GDF11-related vertebral hypersegmentation, orofacial anomalies and neurodevelopmental disorder.",strong,monoallelic_autosomal
GLIS3,HGNC:28510,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:2444289,-,-,-,-,0,843.383.729.186.153,n,omim_disease,"DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM",dd,DIABETES MELLITUS NEONATAL WITH CONGENITAL HYPOTHYROIDISM,definitive,biallelic_autosomal
GNAZ,HGNC:4395,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:95780,-,-,decreased body length|abnormal skin morphology|increased total body fat amount,-,278.293.135.435.993,106.035.349.468.092,n,-,-,-,-,-,-
HDAC1,HGNC:4852,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:108086,lethal,"preweaning lethality, complete penetrance",cardiovascular system phenotype|increased circulating HDL cholesterol level|decreased heart rate variability|decreased mean corpuscular hemoglobin|decreased exploration in new environment|increased circulating cholesterol level,-,315.398.886.827.458,-146.963.547.419.056,n,-,-,-,-,-,-
HES1,HGNC:5192,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:104853,-,-,-,-,834.879.406.307.978,-228.262.514.820.653,n,-,-,-,-,-,-
HMGA1,HGNC:5010,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,T2D (DH),y,MGI:96160,subviable,"unresponsive to tactile stimuli|preweaning lethality, incomplete penetrance",unresponsive to tactile stimuli,-,956.400.742.115.028,-893.115.297.559.368,y,omim_disease,TYPE 2 DIABETES MELLITUS,-,-,-,-
HNF1A,HGNC:11621,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:98504,-,-,-,-,371.057.513.914.657,-121.313.531.910.704,n,omim_disease,"TYPE 1 DIABETES MELLITUS 20|HEPATIC ADENOMAS, FAMILIAL|MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3|RENAL CELL CARCINOMA, NONPAPILLARY|TYPE 2 DIABETES MELLITUS",-,-,-,-
HNF1B,HGNC:11630,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:98505,-,-,-,-,101.113.172.541.744,-254.421.941.407.753,n,omim_disease,"RENAL CYSTS AND DIABETES SYNDROME|TYPE 2 DIABETES MELLITUS|RENAL CELL CARCINOMA, NONPAPILLARY",dd,RENAL CYSTS AND DIABETES SYNDROME,definitive,monoallelic_autosomal
HNF4A,HGNC:5024,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:109128,-,-,abnormal lens morphology|abnormal retina vasculature morphology|abnormal retina blood vessel morphology|decreased body weight|cataract|enlarged thyroid gland|abnormal retina morphology|increased circulating cholesterol level|persistence of hyaloid vascular system|increased circulating bilirubin level|increased total retina thickness|increased circulating HDL cholesterol level,-,278.293.135.435.993,297.558.644.713.338,n,omim_disease,"FANCONI RENOTUBULAR SYNDROME 4 WITH MATURITY-ONSET DIABETES OF THE YOUNG|MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1|TYPE 2 DIABETES MELLITUS",dd,HNF4A-RELATED MATURITY-ONSET DIABETES OF THE YOUNG TYPE 1|ATYPICAL DOMINANT FANCONI SYNDROME WITH MODY,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
IAPP,HGNC:5329,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:96382,-,-,-,-,0,224.143.418.422.851,n,-,-,-,-,-,-
IL6ST,HGNC:6021,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:96560,lethal,"abnormal retina vasculature morphology|preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",increased mean corpuscular hemoglobin concentration,-,111.317.254.174.397,-985.857.605.821.411,n,omim_disease,"IMMUNODEFICIENCY 94 WITH AUTOINFLAMMATION AND DYSMORPHIC FACIES|HYPER-IgE RECURRENT INFECTION SYNDROME 4A, AUTOSOMAL DOMINANT|HYPER-IgE RECURRENT INFECTION SYNDROME 4B, AUTOSOMAL RECESSIVE|STUVE-WIEDEMANN SYNDROME 2",-,-,-,-
ILK,HGNC:6040,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1195267,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",hyperactivity|increased circulating phosphate level|abnormal lens morphology|abnormal embryo size|increased vertical activity,-,321.892.393.320.965,-36.139.897.665.037,n,-,-,-,-,-,-
INS,HGNC:6081,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:96573,-,-,-,-,103.896.103.896.104,-327.943.949.741.286,n,omim_disease,"TYPE 1 DIABETES MELLITUS 2|DIABETES MELLITUS, PERMANENT NEONATAL, 4|HYPERPROINSULINEMIA|MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10",-,-,-,-
INSM1,HGNC:6090,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,T2D (DH),y,MGI:1859980,-,-,-,-,463.821.892.393.321,412.037.413.410.297,n,-,-,-,-,-,-
INTS10,HGNC:25548,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1918135,lethal,"abnormal heart morphology|abnormal neural tube closure|abnormal embryo turning|embryonic lethality prior to tooth bud stage|embryonic growth retardation|abnormal embryo size|abnormal chorioallantoic fusion|preweaning lethality, complete penetrance",impaired pupillary reflex|decreased circulating creatinine level,-,396.103.896.103.896,-448.800.257.486.096,n,-,-,-,-,-,-
INTS12,HGNC:25067,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919043,lethal,"preweaning lethality, complete penetrance",increased circulating triglyceride level|decreased lean body mass|increased circulating creatine kinase level|increased circulating magnesium level|decreased red blood cell distribution width,-,547.309.833.024.119,-528.655.224.153.872,y,-,-,-,-,-,-
ITGB8,HGNC:6163,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1338035,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",abnormal retina outer nuclear layer morphology|abnormal skin coloration,-,927.643.784.786.642,-473.937.220.918.963,n,-,-,-,-,-,-
JAG2,HGNC:6189,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1098270,lethal,"preweaning lethality, complete penetrance",-,-,927.643.784.786.642,366.413.898.288.576,n,omim_disease,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 27",dd,JAG2-related muscular dystrophy,strong,biallelic_autosomal
JAZF1,HGNC:28917,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,T2D (DH),y,MGI:2141450,viable,-,small testis|abnormal testis morphology,-,87.012.987.012.987,-819.947.545.795.481,y,-,-,-,-,-,-
JMJD6,HGNC:19355,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1858910,lethal,"preweaning lethality, complete penetrance",abnormal retina morphology|abnormal motor coordination/balance|abnormal retina blood vessel morphology|abnormal retina vasculature morphology|increased startle reflex|increased total body fat amount|decreased mean platelet volume|increased NK cell number|abnormal lens morphology,-,319.109.461.966.605,-409.181.363.822.017,n,-,-,-,-,-,-
JUN,HGNC:6204,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Positive Control (DH),y,MGI:96646,lethal,"embryonic growth retardation|hemorrhage|preweaning lethality, complete penetrance|abnormal placenta morphology|abnormal blood vessel morphology|edema",abnormal placenta morphology|abnormal blood vessel morphology|enlarged lymph nodes|abnormal eye morphology|abnormal lymph node morphology|hyperactivity|edema|abnormal craniofacial morphology|anophthalmia|increased prepulse inhibition,-,141.929.499.072.356,-241.866.537.112.173,n,-,-,-,-,-,-
KIF3C,HGNC:6321,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:107979,lethal,"preweaning lethality, complete penetrance",increased circulating alkaline phosphatase level|hyperactivity|abnormal sleep behavior,-,927.643.784.786.642,120.521.767.336.212,n,-,-,-,-,-,-
KIF26B,HGNC:25484,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2447076,lethal,"preweaning lethality, complete penetrance",hyperactivity|decreased circulating free fatty acids level|increased heart weight,-,185.528.756.957.328,-416.343.883.584.089,n,-,-,-,-,-,-
KIFAP3,HGNC:17060,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:107566,lethal,"preweaning lethality, complete penetrance",impaired glucose tolerance,-,927.643.784.786.642,900.129.663.926.521,n,-,-,-,-,-,-
KLF7,HGNC:6350,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:1935151,lethal,"preweaning lethality, complete penetrance",hyperactivity|abnormal vertebrae morphology|impaired righting response|persistence of hyaloid vascular system|decreased circulating serum albumin level|increased mean platelet volume|increased circulating aspartate transaminase level,-,49.165.120.593.692,-208.028.211.443.135,n,-,-,dd,KLF7-related developmental disorder,definitive,monoallelic_autosomal
L3MBTL3,HGNC:23035,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:2143628,lethal,"abnormal embryo size|edema|preweaning lethality, complete penetrance|polydactyly|abnormal craniofacial morphology",increased circulating triglyceride level|edema|abnormal skin morphology,-,278.293.135.435.993,35.775.396.955.641,n,-,-,-,-,-,-
LAMA5,HGNC:6485,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:105382,lethal,"preweaning lethality, complete penetrance",enlarged heart,-,0,-106.528.441.839.329,n,omim_disease,"BENT BONE DYSPLASIA SYNDROME 2|NEPHROTIC SYNDROME, TYPE 26",-,-,-,-
LCP2,HGNC:6529,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1321402,lethal,"preweaning lethality, complete penetrance",abnormal lens morphology|cataract,-,0,170.193.991.999.715,n,omim_disease,IMMUNODEFICIENCY 81,-,-,-,-
LEF1,HGNC:6551,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:96770,lethal,"abnormal craniofacial morphology|preweaning lethality, complete penetrance",enlarged heart|abnormal heart morphology|increased monocyte cell number|decreased prepulse inhibition,-,742.115.027.829.314,-107.410.961.926.183,n,-,-,-,-,-,-
MAEA,HGNC:13731,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1891748,lethal,"preweaning lethality, complete penetrance",abnormal coat appearance,-,23.469.387.755.102,-329.233.960.912.317,n,-,-,-,-,-,-
MAFA,HGNC:23145,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,T2D (DH),y,MGI:2673307,-,-,-,-,185.528.756.957.328,-237.416.903.063.708,n,omim_disease,INSULINOMATOSIS AND DIABETES MELLITUS,-,-,-,-
MAFB,HGNC:6408,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Xianming (DH),y,MGI:104555,-,-,-,-,185.528.756.957.328,654.748.202.910.602,n,omim_disease,DUANE RETRACTION SYNDROME 3 WITH OR WITHOUT DEAFNESS|MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME,dd,"MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME|Duane Syndrome, Aberrant Extraocular Muscle Innervation, and Inner-Ear Defects",definitive|strong,monoallelic_autosomal|monoallelic_autosomal
MAP2K7,HGNC:6847,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1346871,lethal,"preweaning lethality, complete penetrance",-,-,380.333.951.762.523,-162.849.144.372.544,n,-,-,-,-,-,-
MAP3K12,HGNC:6851,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1346881,lethal,"preweaning lethality, complete penetrance",increased heart left ventricle size|thick ventricular wall,-,185.528.756.957.328,-115.277.484.539.789,n,-,-,-,-,-,-
MAPKAP1,HGNC:18752,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2444554,lethal,"abnormal embryo size|preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation",increased cardiac stroke volume|increased cornea thickness|dilated heart left ventricle|decreased total retina thickness,-,136.363.636.363.636,-279.335.567.791.515,n,-,-,-,-,-,-
MBD6,HGNC:20445,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:106378,lethal,"preweaning lethality, complete penetrance",decreased body length|enlarged heart|abnormal heart morphology|increased fasting circulating glucose level|increased kidney weight,-,139.146.567.717.996,-144.017.962.844.647,n,-,-,-,-,-,-
MEIS2,HGNC:7001,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,T2D (DH),y,MGI:108564,-,-,-,-,463.821.892.393.321,541.369.951.200.614,n,omim_disease,"CLEFT PALATE, CARDIAC DEFECTS, AND IMPAIRED INTELLECTUAL DEVELOPMENT",dd,MEIS2-related developmental disorder (monoallelic),strong,monoallelic_autosomal
MEMO1,HGNC:14014,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1924140,lethal,"unresponsive to tactile stimuli|edema|preweaning lethality, complete penetrance|hemorrhage|abnormal pericardium morphology|abnormal embryo size",thick ventricular wall|trunk curl|unresponsive to tactile stimuli,-,153.061.224.489.796,-302.645.822.050.317,n,-,-,-,-,-,-
MNX1,HGNC:4979,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,T2D (DH),y,MGI:109160,-,-,-,-,927.643.784.786.642,-177.552.086.243.183,n,omim_disease,CURRARINO SYNDROME,dd,CURRARINO SYNDROME,definitive,monoallelic_autosomal
MORC3,HGNC:23572,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2136841,lethal,"preweaning lethality, complete penetrance",decreased hemoglobin content|increased neutrophil cell number|decreased hematocrit|decreased lymphocyte cell number|increased monocyte cell number|increased circulating alanine transaminase level|decreased erythrocyte cell number|increased circulating aspartate transaminase level|increased large unstained cell number|decreased exploration in new environment,-,0,-765.534.354.329.305,n,-,-,-,-,-,-
MYO18A,HGNC:31104,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2667185,lethal,"abnormal limb bud morphology|abnormal placenta size|pale liver|pale yolk sac|preweaning lethality, complete penetrance|abnormal embryo size|pallor",-,-,445.269.016.697.588,-245.945.814.567.922,n,-,-,-,-,-,-
NABP2,HGNC:28412,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1917167,lethal,"abnormal limb morphology|abnormal embryo size|abnormal craniofacial morphology|edema|preweaning lethality, complete penetrance",-,-,213.358.070.500.928,-168.000.580.570.934,n,-,-,-,-,-,-
NAMPT,HGNC:30092,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1929865,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",abnormal brain morphology|hydrocephaly,-,348.794.063.079.777,-500.296.148.418.114,y,-,-,-,-,-,-
NCOA5,HGNC:15909,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2385165,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage",enlarged heart|abnormal heart morphology|hydrometra|increased heart weight|small superior vagus ganglion,-,315.398.886.827.458,-161.520.451.685.378,n,-,-,-,-,-,-
NDEL1,HGNC:17620,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1932915,lethal,"embryonic growth retardation|abnormal embryo size|abnormal tail morphology|preweaning lethality, complete penetrance|respiratory system phenotype",-,-,371.057.513.914.657,-481.056.528.963.314,n,-,-,-,-,-,-
NEUROD1,HGNC:7762,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:1339708,-,-,-,-,742.115.027.829.314,426.783.913.698.486,n,omim_disease,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6|TYPE 2 DIABETES MELLITUS",-,-,-,-
NEUROD2,HGNC:7763,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,Xianming (DH),y,MGI:107755,viable,abnormal coat appearance|abnormal locomotor behavior|hyperactivity|decreased locomotor activity|increased exploration in new environment|increased thigmotaxis|abnormal behavior|decreased circulating calcium level|decreased prepulse inhibition|short tibia|increased anxiety-related response|decreased food intake|increased total body fat amount|decreased startle reflex|increased grip strength|decreased vertical activity,abnormal coat appearance|hyperactivity|increased exploration in new environment,-,120.593.692.022.263,-130.027.988.942.644,n,omim_disease,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 72,-,-,-,-
NEUROG3,HGNC:13806,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:893591,-,-,-,-,463.821.892.393.321,-14.720.116.876.517,n,omim_disease,"DIARRHEA 4, MALABSORPTIVE, CONGENITAL",-,-,-,-
NFATC3,HGNC:7777,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:103296,lethal,"preweaning lethality, complete penetrance",increased startle reflex|abnormal lens morphology,-,463.821.892.393.321,-465.934.478.697.813,n,-,-,-,-,-,-
NGDN,HGNC:20271,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1916216,lethal,"preweaning lethality, complete penetrance",decreased circulating cholesterol level|abnormal lens morphology|decreased circulating HDL cholesterol level|hydrometra,-,568.645.640.074.212,-546.378.085.328.059,y,-,-,-,-,-,-
NKX2-2,HGNC:7835,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:97347,-,-,-,-,0,130.983.876.083.455,n,-,-,-,-,-,-
NKX6-1,HGNC:7839,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:1206039,-,-,-,-,0,90.086.547.733.474,n,-,-,-,-,-,-
NKX6-3,HGNC:26328,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,T2D (DH),y,MGI:1921811,-,-,-,-,927.643.784.786.642,-294.431.073.134.797,n,-,-,-,-,-,-
NLK,HGNC:29858,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1201387,lethal,"preweaning lethality, complete penetrance",increased circulating alkaline phosphatase level|abnormal auditory brainstem response|increased startle reflex,-,0,185.984.452.562.815,n,-,-,-,-,-,-
NOTCH1,HGNC:7881,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:97363,lethal,"preweaning lethality, complete penetrance",abnormal vertebrae morphology|increased grip strength|increased startle reflex,-,371.057.513.914.657,-442.740.632.620.826,n,omim_disease,ADAMS-OLIVER SYNDROME 5|AORTIC VALVE DISEASE 1,dd,LEFT VENTRICULAR OUTFLOW TRACT OBSTRUCTION,strong,monoallelic_autosomal
NR6A1,HGNC:7985,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:1352459,lethal,"abnormal pharyngeal arch morphology|pale yolk sac|preweaning lethality, complete penetrance|abnormal heart looping|abnormal neural tube morphology|abnormal forebrain development|abnormal midbrain development|abnormal hindbrain development|abnormal embryo turning|abnormal neural tube closure|abnormal allantois morphology|abnormal chorioallantoic fusion|abnormal heart morphology|abnormal embryo development|abnormal pericardium morphology|abnormal somite shape|embryonic growth retardation|abnormal visceral yolk sac morphology|abnormal tail bud morphology|abnormal optic vesicle formation|embryonic lethality prior to tooth bud stage|abnormal embryo size",increased startle reflex|decreased body length,-,148.423.005.565.863,-51.331.123.834.979,n,-,-,-,-,-,-
NRP1,HGNC:8004,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:106206,lethal,"preweaning lethality, complete penetrance",decreased prepulse inhibition|abnormal auditory brainstem response,-,0,76.242.464.990.749,n,-,-,-,-,-,-
ONECUT1,HGNC:8138,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,T2D (DH),y,MGI:1196423,-,-,-,-,927.643.784.786.642,701.443.013.106.716,n,-,-,dd,ONECUT1-associated neonatal diabetes,strong,biallelic_autosomal
OSBPL11,HGNC:16397,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2146553,lethal,"preweaning lethality, complete penetrance",increased total body fat amount|improved glucose tolerance|decreased circulating triglyceride level,-,0,660.418.751.554.076,n,-,-,-,-,-,-
OTUB1,HGNC:23077,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2147616,lethal,"preweaning lethality, complete penetrance",decreased grip strength|abnormal cranium morphology|abnormal heart position or orientation|increased cornea thickness|decreased bone mineral content|abnormal lung morphology|decreased exploration in new environment,-,584.415.584.415.584,-210.663.601.111.536,n,-,-,-,-,-,-
PAICS,HGNC:8587,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1914304,lethal,"preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation",embryonic growth retardation,-,458.256.029.684.601,-542.988.433.921.788,y,omim_disease,PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASE DEFICIENCY,-,-,-,-
PARD3,HGNC:16051,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2135608,lethal,"preweaning lethality, complete penetrance",abnormal optic disk morphology|decreased spleen weight|abnormal retina morphology|decreased basophil cell number,-,593.692.022.263.451,-123.308.831.935.362,n,-,-,-,-,-,-
PATZ1,HGNC:13071,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:1891832,lethal,"preweaning lethality, complete penetrance",-,-,463.821.892.393.321,-990.421.474.882.419,n,-,-,-,-,-,-
PAX4,HGNC:8618,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:97488,lethal,"preweaning lethality, complete penetrance",increased circulating alkaline phosphatase level|increased circulating total protein level|tremors,-,0,364.305.317.015.642,n,omim_disease,"TYPE 2 DIABETES MELLITUS|MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9|DIABETES MELLITUS, KETOSIS-PRONE",-,-,-,-
PBX3,HGNC:8634,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:97496,lethal,"increased bone mineral density|increased bone mineral content|increased lean body mass|increased total body fat amount|preweaning lethality, complete penetrance|abnormal bone mineralization",absent ovary|decreased total body fat amount|decreased blood urea nitrogen level|abnormal tooth morphology|abnormal response to new environment|increased circulating bilirubin level,-,927.643.784.786.642,257.492.924.679.038,n,-,-,-,-,-,-
PCGF1,HGNC:17615,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1917087,lethal,"abnormal embryo size|abnormal heart looping|embryonic growth retardation|abnormal neural tube closure|preweaning lethality, complete penetrance|abnormal heart morphology|embryonic lethality prior to tooth bud stage|abnormal midbrain development|abnormal embryo turning|abnormal forebrain development|abnormal pharyngeal arch morphology",abnormal lens morphology|increased fasting circulating glucose level|hyperactivity,-,204.081.632.653.061,-100.337.544.433.592,n,-,-,-,-,-,-
PDX1,HGNC:6107,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,T2D (DH),y,MGI:102851,lethal,"preweaning lethality, complete penetrance",impaired glucose tolerance,-,0,-411.972.791.917.159,n,omim_disease,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4|PANCREATIC AGENESIS 1|TYPE 2 DIABETES MELLITUS",-,-,-,-
PIK3C2A,HGNC:8971,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1203729,lethal,"preweaning lethality, complete penetrance|embryonic growth retardation|abnormal embryo size|embryonic lethality prior to tooth bud stage",enlarged lymph nodes|increased neutrophil cell number|decreased lymphocyte cell number|decreased locomotor activity,-,0,334.848.449.883.141,n,omim_disease,OCULOSKELETODENTAL SYNDROME,-,-,-,-
PKN2,HGNC:9406,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:109211,lethal,"preweaning lethality, complete penetrance",decreased circulating HDL cholesterol level|increased startle reflex|increased circulating bilirubin level|decreased circulating total protein level|decreased exploration in new environment|decreased circulating cholesterol level|decreased circulating unsaturated transferrin level,-,238.404.452.690.167,-332.237.760.531.369,n,-,-,-,-,-,-
PLPP3,HGNC:9229,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1915166,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",decreased mean corpuscular hemoglobin|increased circulating creatinine level,-,0,-129.542.186.525.642,n,-,-,-,-,-,-
PPARG,HGNC:9236,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,T2D (DH),y,MGI:97747,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",increased fasting circulating glucose level|increased total body fat amount|decreased lean body mass|abnormal gait,-,194.805.194.805.195,-264.823.070.825.403,n,omim_disease,"CAROTID INTIMAL MEDIAL THICKNESS 1|LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3|OBESITY|TYPE 2 DIABETES MELLITUS",-,-,-,-
PPP2R2A,HGNC:9304,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919228,lethal,"preweaning lethality, complete penetrance",decreased bone mineral content|abnormal bone structure|decreased body length|decreased lean body mass|decreased bone mineral density,-,154.916.512.059.369,-226.582.600.969.759,n,-,-,-,-,-,-
PRPF4B,HGNC:17346,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:109584,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",-,-,695.732.838.589.982,-596.001.585.338.301,y,-,-,-,-,-,-
PRRC2B,HGNC:28121,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1923304,lethal,"preweaning lethality, complete penetrance",-,-,0,212.812.558.834.535,n,-,-,-,-,-,-
PTK7,HGNC:9618,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1918711,lethal,"preweaning lethality, complete penetrance",abnormal response to new environment|increased total body fat amount,-,0,-116.432.417.059.289,n,-,-,-,-,-,-
PTPRS,HGNC:9681,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:97815,lethal,"preweaning lethality, complete penetrance",enlarged heart|increased mean platelet volume|hyperactivity|abnormal heart morphology|abnormal uterus morphology|hydrometra,-,0,719.504.198.093.792,n,-,-,-,-,-,-
PUM2,HGNC:14958,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1931751,-,-,-,-,185.528.756.957.328,-176.144.037.562.632,n,-,-,-,-,-,-
PYGO2,HGNC:30257,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1916161,lethal,"microphthalmia|edema|hemorrhage|anophthalmia|abnormal craniofacial morphology|abnormal limb morphology|abnormal midbrain morphology|abnormal eye morphology|abnormal hindbrain morphology|preweaning lethality, complete penetrance|abnormal neural tube closure",persistence of hyaloid vascular system|abnormal kidney morphology|hyperactivity|abnormal uterus morphology|hydrometra,-,102.040.816.326.531,-110.485.906.943.083,n,-,-,-,-,-,-
QSER1,HGNC:26154,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,T2D (DH),y,MGI:2138986,subviable,"preweaning lethality, incomplete penetrance",-,-,927.643.784.786.642,765.306.097.778.176,n,-,-,-,-,-,-
RAB2A,HGNC:9763,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1928750,lethal,"preweaning lethality, complete penetrance|abnormal embryo size",increased mean corpuscular volume|decreased erythrocyte cell number|abnormal skin morphology|increased red blood cell distribution width|increased mean corpuscular hemoglobin|increased spleen weight,-,278.293.135.435.993,-864.682.274.363.333,n,-,-,-,-,-,-
RAB5C,HGNC:9785,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:105306,lethal,"preweaning lethality, complete penetrance",increased circulating total protein level|increased circulating alkaline phosphatase level|decreased circulating cholesterol level|increased circulating fructosamine level,-,584.415.584.415.584,-229.387.383.993.045,n,-,-,-,-,-,-
RAB35,HGNC:9774,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1924657,lethal,"preweaning lethality, complete penetrance",abnormal lens morphology|cataract,-,705.009.276.437.848,-154.728.243.443.466,n,-,-,-,-,-,-
RALGAPB,HGNC:29221,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2444531,lethal,"preweaning lethality, complete penetrance",increased grip strength|decreased circulating potassium level,-,649.350.649.350.649,-466.910.811.758.545,n,-,-,-,-,-,-
RANBP1,HGNC:9847,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:96269,lethal,"abnormal neural tube closure|abnormal midbrain morphology|abnormal embryo size|edema|abnormal craniofacial morphology|abnormal forebrain morphology|abnormal hindbrain morphology|abnormal placenta size|preweaning lethality, complete penetrance",-,-,482.374.768.089.054,-509.779.480.889.926,y,-,-,-,-,-,-
RAPGEF1,HGNC:4568,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:104580,lethal,"preweaning lethality, complete penetrance",abnormal retina morphology,-,584.415.584.415.584,-190.892.364.079.129,n,-,-,-,-,-,-
RBFOX1,HGNC:18222,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926224,lethal,"preweaning lethality, complete penetrance",short tibia,-,927.643.784.786.642,-532.609.756.237.607,n,-,-,dd,RBFOX1-related neurodevelopmental disorder,limited,monoallelic_autosomal
RBM33,HGNC:27223,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919670,lethal,"preweaning lethality, complete penetrance",-,-,145.640.074.211.503,-275.019.489.850.411,n,-,-,-,-,-,-
RBMS1,HGNC:9907,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1861774,lethal,"preweaning lethality, complete penetrance",abnormal coat/ hair morphology|enlarged heart|increased circulating alkaline phosphatase level|decreased lean body mass|impaired glucose tolerance,-,371.057.513.914.657,-466.650.217.751.568,n,-,-,-,-,-,-
REXO2,HGNC:17851,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1888981,lethal,"preweaning lethality, complete penetrance",decreased neutrophil cell number|decreased fasting circulating glucose level|increased lymphocyte cell number|increased circulating cholesterol level|increased circulating serum albumin level|increased circulating HDL cholesterol level,-,140.074.211.502.783,-259.383.460.057.094,n,-,-,-,-,-,-
RHOT1,HGNC:21168,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926078,lethal,"preweaning lethality, complete penetrance",-,-,333.951.762.523.191,-201.791.823.149.282,n,-,-,-,-,-,-
RIC8B,HGNC:25555,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2682307,lethal,"preweaning lethality, complete penetrance",increased leukocyte cell number|increased basophil cell number|increased lymphocyte cell number|corneal opacity,-,0,105.767.439.108.217,n,-,-,-,-,-,-
RREB1,HGNC:10449,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,T2D (DH),y,MGI:2443664,-,-,decreased total body fat amount|decreased circulating calcium level|decreased circulating serum albumin level|increased lean body mass|increased leukocyte cell number|decreased erythrocyte cell number|increased red blood cell distribution width|decreased hemoglobin content|decreased hematocrit,-,204.081.632.653.061,-105.705.987.470.382,n,-,-,-,-,-,-
RSBN1,HGNC:25642,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2444993,lethal,"preweaning lethality, complete penetrance",abnormal locomotor behavior|abnormal bone structure|decreased lean body mass|increased circulating cholesterol level|increased total body fat amount|abnormal seminal vesicle morphology,-,927.643.784.786.642,-41.907.624.901.008,n,-,-,-,-,-,-
RSF1,HGNC:18118,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:2682305,lethal,"preweaning lethality, complete penetrance|abnormal embryo size",decreased prepulse inhibition|increased bone mineral density|dysplasia|spermatogenesis defect,-,927.643.784.786.642,-100.827.595.588.317,n,-,-,-,-,-,-
RUNX3,HGNC:10473,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:102672,lethal,"preweaning lethality, complete penetrance",abnormal locomotor behavior,-,834.879.406.307.978,-695.878.090.442.772,n,-,-,-,-,-,-
SEL1L,HGNC:10717,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1329016,lethal,"preweaning lethality, complete penetrance",vertebral fusion,-,222.634.508.348.794,-988.789.460.983.054,n,-,-,-,-,-,-
SIX2,HGNC:10888,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:102778,-,-,-,-,185.528.756.957.328,103.365.611.811.688,n,-,-,-,-,-,-
SLC17A6,HGNC:16703,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2156052,lethal,"preweaning lethality, complete penetrance",-,-,927.643.784.786.642,584.850.384.781.694,n,-,-,-,-,-,-
SMAD2,HGNC:6768,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Positive Control (DH),y,MGI:108051,-,-,-,-,0,178.021.325.824.604,n,omim_disease,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 8, WITH OR WITHOUT HETEROTAXY|LOEYS-DIETZ SYNDROME 6",dd,CONGENITAL HEART DISEASE,limited,monoallelic_autosomal
SMAD4,HGNC:6770,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,Positive Control (DH),y,MGI:894293,-,-,-,-,139.146.567.717.996,-78.532.127.034.689,n,omim_disease,JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME|MYHRE SYNDROME|PANCREATIC CANCER|JUVENILE POLYPOSIS SYNDROME,dd,MYHRE SYNDROME|Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
SMARCA2,HGNC:11098,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,TV genes,y,MGI:99603,viable,hyperactivity|increased circulating phosphate level|increased circulating aspartate transaminase level|increased circulating bilirubin level,-,-,352.504.638.218.924,994.889.665.989.858,n,omim_disease,BLEPHAROPHIMOSIS-IMPAIRED INTELLECTUAL DEVELOPMENT SYNDROME|NICOLAIDES-BARAITSER SYNDROME,dd,NICOLAIDES-BARAITSER SYNDROME,definitive,monoallelic_autosomal
SMARCC2,HGNC:11105,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,TV genes,y,MGI:1915344,lethal,"preweaning lethality, complete penetrance",decreased thigmotaxis|decreased heart rate|abnormal auditory brainstem response|prolonged RR interval,-,111.317.254.174.397,-140.215.741.682.094,n,omim_disease,COFFIN-SIRIS SYNDROME 8,dd,Syndromic Intellectual Disability and Developmental Delay,strong,monoallelic_autosomal
SMARCD3,HGNC:11108,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:1914243,lethal,"preweaning lethality, complete penetrance|prenatal lethality",decreased grip strength,-,0,671.748.062.192.452,n,-,-,-,-,-,-
SPI1,HGNC:11241,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:98282,lethal,"hemorrhage|preweaning lethality, complete penetrance",decreased erythrocyte cell number|increased mean corpuscular volume,-,25.974.025.974.026,-856.405.604.315.386,n,omim_disease,"AGAMMAGLOBULINEMIA 10, AUTOSOMAL DOMINANT",-,-,-,-
SPOP,HGNC:11254,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1343085,lethal,"preweaning lethality, complete penetrance",decreased respiratory quotient|enlarged lymph nodes|decreased food intake|increased circulating aspartate transaminase level|small thymus|small adrenal glands,-,371.057.513.914.657,-88.737.459.789.843,n,omim_disease,"NABAIS SA-DE VRIES SYNDROME, TYPE 1|NABAIS SA-DE VRIES SYNDROME, TYPE 2",dd,"SPOP-related Neurodevelopmental Disorder, gain of function|SPOP-related Neurodevelopmental Disorder, dominant negative",strong|strong,monoallelic_autosomal|monoallelic_autosomal
SPTBN1,HGNC:11275,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:98388,-,-,decreased body weight|decreased total body fat amount|decreased circulating serum albumin level,-,927.643.784.786.642,-394.458.991.298.176,n,omim_disease,"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES",dd,SPTBN1-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
SQLE,HGNC:11279,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:109296,lethal,"preweaning lethality, complete penetrance",-,-,38.961.038.961.039,-135.240.355.221.057,n,-,-,-,-,-,-
STRN3,HGNC:15720,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2151064,lethal,"hemorrhage|preweaning lethality, complete penetrance|edema",decreased circulating glucose level|abnormal behavior|decreased thigmotaxis|increased vertical activity|hyperactivity,-,12.987.012.987.013,-153.489.788.278.158,n,-,-,-,-,-,-
SUPT3H,HGNC:11466,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1923723,lethal,"preweaning lethality, complete penetrance",-,-,352.504.638.218.924,-120.157.206.192.324,n,-,-,-,-,-,-
SUPT4H1,HGNC:11467,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:107416,lethal,"embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",decreased mean corpuscular hemoglobin concentration,-,74.025.974.025.974,-696.958.574.511.207,y,-,-,-,-,-,-
SVEP1,HGNC:15985,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1928849,lethal,"preweaning lethality, complete penetrance|abnormal limb morphology|abnormal skin appearance|edema|abnormal tail morphology",increased hemoglobin content|increased erythrocyte cell number|abnormal iris pigmentation|eye hemorrhage|decreased circulating sodium level|narrow eye opening|decreased circulating phosphate level|abnormal iris transillumination|increased hematocrit|corneal deposits|impaired pupillary reflex|abnormal eyelid morphology|eyelids fail to open|prolonged QRS complex duration|exophthalmos|decreased circulating glucose level,-,0,-300.147.881.514.571,n,-,-,-,-,-,-
SYK,HGNC:11491,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:99515,lethal,"preweaning lethality, complete penetrance",increased total body fat amount|decreased grip strength|decreased exploration in new environment|decreased lean body mass,-,148.423.005.565.863,-286.610.253.836.851,n,omim_disease,IMMUNODEFICIENCY 82 WITH SYSTEMIC INFLAMMATION,-,-,-,-
SYNRG,HGNC:557,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1354742,lethal,"preweaning lethality, complete penetrance",increased heart rate,-,927.643.784.786.642,-346.145.404.673.833,n,-,-,-,-,-,-
SYT4,HGNC:11512,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:101759,viable,hyperactivity|increased blood urea nitrogen level|decreased circulating serum albumin level|abnormal gait|decreased circulating fructosamine level,-,-,0,700.691.735.782.682,n,-,-,-,-,-,-
TCERG1,HGNC:15630,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926421,lethal,"preweaning lethality, complete penetrance|embryonic growth retardation",-,-,510.204.081.632.653,-522.372.421.833.725,y,-,-,-,-,-,-
TCF4,HGNC:11634,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:98506,subviable,"preweaning lethality, incomplete penetrance",abnormal retina morphology,-,278.293.135.435.993,839.377.675.116.981,n,omim_disease,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3|PITT-HOPKINS SYNDROME",dd,PITT-HOPKINS SYNDROME,definitive,monoallelic_autosomal
TCF7L2,HGNC:11641,approved_symbol,gene_with_protein_product,-,MSK,NWU,UCSF,-,T2D (DH),y,MGI:1202879,lethal,"preweaning lethality, complete penetrance",increased bone mineral content|increased bone mineral density|increased red blood cell distribution width|increased lean body mass|increased mean platelet volume|decreased total body fat amount,-,658.627.087.198.516,-123.464.153.452.495,n,omim_disease,TYPE 2 DIABETES MELLITUS,dd,TCF7L2-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
TENT5C,HGNC:24712,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1921895,lethal,"preweaning lethality, complete penetrance",decreased mean corpuscular hemoglobin|increased grip strength,-,0,-200.701.729.193.224,n,-,-,-,-,-,-
TIPRL,HGNC:30231,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1915087,lethal,"embryonic growth retardation|abnormal forebrain development|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",decreased locomotor activity|decreased thigmotaxis|decreased grip strength|abnormal startle reflex,-,300.556.586.270.872,-388.384.806.461.631,n,-,-,-,-,-,-
TMEM63B,HGNC:17735,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2387609,lethal,"preweaning lethality, complete penetrance",short tibia|hyperactivity|abnormal cornea morphology|increased circulating bilirubin level|limb grasping|decreased vertical activity,-,0,-159.452.058.648.763,n,-,-,-,-,-,-
TMEM161B,HGNC:28483,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1919995,lethal,"preweaning lethality, complete penetrance",increased total body fat amount|decreased circulating total protein level|decreased circulating serum albumin level,-,148.423.005.565.863,-724.345.804.013.519,n,-,-,-,-,-,-
TOX4,HGNC:20161,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1915389,lethal,"preweaning lethality, complete penetrance|embryonic growth retardation",decreased circulating glucose level|increased circulating creatinine level,-,202.226.345.083.488,-368.192.944.902.921,n,-,-,-,-,-,-
TRIM71,HGNC:32669,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2685973,lethal,"preweaning lethality, complete penetrance",abnormal ileum morphology|abnormal jejunum morphology,-,742.115.027.829.314,-656.308.974.669.264,n,omim_disease,"HYDROCEPHALUS, CONGENITAL COMMUNICATING, 1",-,-,-,-
TSPAN14,HGNC:23303,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1196325,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",-,-,927.643.784.786.642,-606.728.143.049.322,n,-,-,-,-,-,-
UBE2F,HGNC:12480,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1915171,lethal,"abnormal limb bud morphology|abnormal embryo turning|abnormal pharyngeal arch morphology|abnormal pericardium morphology|abnormal neural tube morphology|abnormal optic vesicle formation|abnormal heart morphology|prenatal lethality prior to heart atrial septation|preweaning lethality, complete penetrance",abnormal liver morphology|abnormal skin morphology|small testis|abnormal eye morphology|abnormal spleen morphology|enlarged liver|enlarged spleen|abnormal testis morphology|abnormal heart shape|increased heart weight|enlarged heart|enlarged seminal vesicle|abnormal heart morphology|small liver,-,176.252.319.109.462,-263.802.848.445.968,n,-,-,-,-,-,-
UBP1,HGNC:12507,approved_symbol,gene_with_protein_product,-,MSK,NWU,-,-,"FUSIL ""developmental lethal""",y,MGI:104889,lethal,"embryonic lethality prior to tooth bud stage|pale yolk sac|preweaning lethality, complete penetrance|pallor|abnormal embryo size",decreased circulating calcium level|increased circulating creatinine level|decreased circulating serum albumin level|decreased circulating alkaline phosphatase level,-,371.057.513.914.657,-292.885.342.989.533,n,-,-,-,-,-,-
UBXN7,HGNC:29119,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2146388,lethal,"embryonic growth retardation|abnormal skin appearance|abnormal skin coloration|abnormal embryo size|preweaning lethality, complete penetrance|abnormal craniofacial morphology",increased grip strength,-,185.528.756.957.328,-364.634.328.403.315,n,-,-,-,-,-,-
UCHL5,HGNC:19678,approved_symbol,gene_with_protein_product,-,MSK,-,UCSF,-,"FUSIL ""developmental lethal""",y,MGI:1914848,lethal,"preweaning lethality, complete penetrance",decreased locomotor activity,-,24.582.560.296.846,-357.705.497.192.831,n,-,-,-,-,-,-
UCN3,HGNC:17781,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:1932970,viable,abnormal heart morphology|increased circulating creatinine level|enlarged heart,-,-,0,677.392.041.209.008,n,-,-,-,-,-,-
UNC5C,HGNC:12569,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1095412,lethal,"preweaning lethality, complete penetrance",decreased locomotor activity,-,0,-56.815.503.224.605,n,-,-,-,-,-,-
USP14,HGNC:12612,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1928898,lethal,"preweaning lethality, complete penetrance",-,-,445.269.016.697.588,-787.716.570.967.581,n,-,-,dd,DISTAL ARTHROGRYPOSIS,limited,biallelic_autosomal
USP32,HGNC:19143,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2144475,lethal,"preweaning lethality, complete penetrance",increased lymphocyte cell number|increased mean platelet volume|decreased mean corpuscular hemoglobin concentration|increased leukocyte cell number|thrombocytosis|decreased circulating serum albumin level|decreased neutrophil cell number|increased red blood cell distribution width|decreased circulating glucose level|increased mean corpuscular volume,-,36.178.107.606.679,-214.033.535.354.661,n,-,-,-,-,-,-
VPS4A,HGNC:13488,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1890520,lethal,"preweaning lethality, complete penetrance|abnormal body wall morphology|abnormal embryo size|unresponsive to tactile stimuli|protruding tongue",abnormal skin morphology|enlarged spleen|cataract|increased spleen weight|tremors|unresponsive to tactile stimuli|abnormal lens morphology,-,201.298.701.298.701,-380.980.392.476.067,n,omim_disease,CIMDAG SYNDROME,dd,"CIMDAG Syndrome, monoallelic|CIMDAG Syndrome, biallelic",definitive|limited,monoallelic_autosomal|biallelic_autosomal
VPS37D,HGNC:18287,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2159402,lethal,"preweaning lethality, complete penetrance|unresponsive to tactile stimuli|abnormal body wall morphology",unresponsive to tactile stimuli|decreased locomotor activity|decreased total retina thickness|abnormal retina inner nuclear layer morphology|decreased prepulse inhibition,-,927.643.784.786.642,-778.420.284.859.781,n,-,-,-,-,-,-
WASF2,HGNC:12733,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1098641,lethal,"preweaning lethality, complete penetrance",abnormal stomach morphology|abnormal behavior,-,408.163.265.306.122,-220.315.632.971.777,n,-,-,-,-,-,-
WNT4,HGNC:12783,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,Xianming (DH),y,MGI:98957,-,-,-,-,0,-185.708.716.934.388,n,omim_disease,"46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS|MULLERIAN APLASIA AND HYPERANDROGENISM",dd,SERKAL SYNDROME|MULLERIAN APLASIA AND HYPERANDROGENISM,strong|strong,biallelic_autosomal|monoallelic_autosomal
YIPF5,HGNC:24877,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1914430,lethal,"embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",increased prepulse inhibition|decreased erythrocyte cell number|abnormal retina outer nuclear layer morphology|decreased total retina thickness|thick ventricular wall,-,686.456.400.742.115,-201.501.544.494.815,n,omim_disease,"MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME 2",-,-,-,-
YLPM1,HGNC:17798,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926195,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",persistence of hyaloid vascular system|decreased bone mineral content|abnormal startle reflex|increased total body fat amount|increased fasting circulating glucose level,-,371.057.513.914.657,-106.636.895.706.084,n,-,-,-,-,-,-
ZC3H4,HGNC:17808,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2682314,lethal,"preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation|embryonic lethality prior to organogenesis",abnormal coat/hair pigmentation|increased circulating calcium level|abnormal epididymis morphology|increased circulating serum albumin level|enlarged epididymis|abnormal eye morphology|cataract; lens extrusion,-,352.504.638.218.924,-163.924.345.983.417,n,-,-,-,-,-,-
ZC3H11A,HGNC:29093,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",-,-,-,-,-,-,667.903.525.046.382,-206.086.530.600.938,n,-,-,-,-,-,-
ZMIZ2,HGNC:22229,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:106374,lethal,"embryonic lethality prior to organogenesis|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",decreased exploration in new environment,-,927.643.784.786.642,-396.832.886.206.732,n,-,-,-,-,-,-
ZNF496,HGNC:23713,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:2679270,lethal,"preweaning lethality, complete penetrance",thrombocytopenia|increased heart weight,-,0,141.424.456.056.362,n,-,-,-,-,-,-
ZNF536,HGNC:29025,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1926102,lethal,"preweaning lethality, complete penetrance|cyanosis|respiratory system phenotype",hyperactivity|increased mean corpuscular hemoglobin concentration|increased circulating chloride level|increased hemoglobin content,-,111.317.254.174.397,-110.491.610.818.195,n,-,-,-,-,-,-
ZNF771,HGNC:29653,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,T2D (DH),y,MGI:2442050,-,-,-,-,463.821.892.393.321,-156.005.938.575.059,n,-,-,-,-,-,-
ZRANB2,HGNC:13058,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1858211,-,-,decreased body weight|decreased circulating fructosamine level,-,23.469.387.755.102,-375.117.242.436.113,n,-,-,-,-,-,-
ZZZ3,HGNC:24523,approved_symbol,gene_with_protein_product,-,MSK,-,-,-,"FUSIL ""developmental lethal""",y,MGI:1920453,-,-,corneal opacity|decreased hemoglobin content|decreased hematocrit|abnormal cornea morphology,-,844.155.844.155.844,-293.946.044.166.379,n,-,-,-,-,-,-
MEG3,HGNC:14575,approved_symbol,RNA_long_non_coding,-,MSK,-,-,-,Xianming (DH),-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
ADNP,HGNC:15766,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1338758,-,-,-,-,49.165.120.593.692,-151.269.565.652.838,n,omim_disease,HELSMOORTEL-VAN DER AA SYNDROME,dd,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT, 28",definitive,monoallelic_autosomal
AEBP1,HGNC:303,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1197012,lethal,"abnormal tail morphology|preweaning lethality, complete penetrance",enlarged heart|abnormal heart morphology,-,463.821.892.393.321,-109.394.967.771.823,n,omim_disease,"EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2",-,-,-,-
AEBP2,HGNC:24051,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1338038,-,-,-,-,927.643.784.786.642,-115.585.084.808.386,n,-,-,-,-,-,-
AHCTF1,HGNC:24618,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1915033,lethal,"preweaning lethality, complete penetrance",abnormal vitreous body morphology,-,993.506.493.506.494,-126.072.188.450.369,y,-,-,-,-,-,-
AHR,HGNC:348,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:105043,-,-,-,-,343.228.200.371.058,-184.060.029.785.123,n,omim_disease,RETINITIS PIGMENTOSA 85,-,-,-,-
ALX1,HGNC:1494,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104621,-,-,-,-,0,237.754.669.436.459,n,omim_disease,FRONTONASAL DYSPLASIA 3,dd,FRONTONASAL DYSPLASIA TYPE 3,definitive,biallelic_autosomal
ALX4,HGNC:450,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:108359,-,-,-,-,0,-24.811.420.495.648,n,omim_disease,"FRONTONASAL DYSPLASIA 2|PARIETAL FORAMINA 2|CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO",dd,FRONTONASAL DYSPLASIA 2|PARIETAL FORAMINA 2,definitive|definitive,biallelic_autosomal|monoallelic_autosomal
ARHGAP35,HGNC:4591,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1929494,-,-,-,-,0,110.755.613.249.931,n,-,-,dd,ARHGAP35-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
ARID3B,HGNC:14350,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1930768,-,-,-,-,204.081.632.653.061,-16.622.197.875.784,n,-,-,-,-,-,-
ARID5B,HGNC:17362,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2175912,-,-,-,-,834.879.406.307.978,-722.165.375.334.515,n,-,-,-,-,-,-
ARNT,HGNC:700,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:88071,-,-,increased mean platelet volume,-,287.569.573.283.859,-592.646.139.737.584,n,-,-,-,-,-,-
ARNT2,HGNC:16876,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107188,-,-,-,-,0,19.030.418.621.723,n,omim_disease,WEBB-DATTANI SYNDROME,dd,"ARNT2-associated hypopituitarism, post-natal microcephaly, visual and renal anomalies",limited,biallelic_autosomal
ARX,HGNC:18060,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1097716,-,-,-,-,927.643.784.786.642,471.515.088.747.119,n,omim_disease,"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 1|LISSENCEPHALY, X-LINKED, 2|INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 29|PARTINGTON SYNDROME|CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA",dd,INTELLECTUAL DEVELOPMENTAL DISORDER X-LINKED ARX-RELATED|PARTINGTON SYNDROME,definitive|definitive,monoallelic_X_hem|monoallelic_X_hem
ASCL2,HGNC:739,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96920,-,-,-,-,649.350.649.350.649,-289.633.817.332.382,n,-,-,-,-,-,-
ATF2,HGNC:784,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109349,-,-,abnormal spleen morphology|decreased body weight|abnormal urinary bladder morphology|decreased circulating chloride level|abnormal skin morphology|increased blood urea nitrogen level|increased fasting circulating glucose level|small testis|decreased thigmotaxis|abnormal kidney morphology|enlarged heart|increased circulating potassium level|abnormal testis morphology|decreased mean platelet volume|abnormal heart morphology,-,0,713.843.135.291.603,n,-,-,-,-,-,-
ATF4,HGNC:786,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:88096,lethal,"preweaning lethality, complete penetrance",increased mean corpuscular volume|decreased monocyte cell number|abnormal heart morphology|enlarged heart|increased circulating aspartate transaminase level|increased circulating alanine transaminase level,-,567.717.996.289.425,-577.398.331.326.316,y,-,-,-,-,-,-
ATMIN,HGNC:29034,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2682328,-,-,-,-,955.473.098.330.241,-253.699.539.157.161,n,-,-,-,-,-,-
ATOH1,HGNC:797,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104654,-,-,-,-,371.057.513.914.657,-123.355.189.017.232,n,-,-,-,-,-,-
ATOH8,HGNC:24126,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1918343,-,-,-,-,834.879.406.307.978,-100.094.880.759.639,n,-,-,-,-,-,-
BARHL2,HGNC:954,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1859314,-,-,-,-,120.593.692.022.263,-193.926.163.178.417,n,-,-,-,-,-,-
BARX1,HGNC:955,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103124,-,-,-,-,0,-201.101.183.490.846,n,-,-,-,-,-,-
BCL6,HGNC:1001,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107187,-,-,-,-,306.122.448.979.592,-988.862.390.489.582,n,-,-,-,-,-,-
BCL11A,HGNC:13221,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106190,-,-,-,-,371.057.513.914.657,-149.990.616.644.144,n,-,-,dd,INTELLECTUAL DISABILITY,definitive,monoallelic_autosomal
BCL11B,HGNC:13222,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1929913,lethal,"abnormal eyelid fusion|abnormal facial morphology|preweaning lethality, complete penetrance",increased fasting circulating glucose level|increased bone mineral content|increased vertical activity|abnormal bone structure,-,927.643.784.786.642,-29.820.475.499.041,n,omim_disease,"IMMUNODEFICIENCY 49|INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES",dd,BCL11B-related developmental disorder (monoallelic),strong,monoallelic_autosomal
BNC2,HGNC:30988,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2443805,-,-,increased cornea thickness|decreased exploration in new environment|decreased fluid intake,-,278.293.135.435.993,462.092.363.018.803,n,omim_disease,"LOWER URINARY TRACT OBSTRUCTION, CONGENITAL",dd,Congenital Lower Urinary Tract Obstruction,definitive,monoallelic_autosomal
BPTF,HGNC:3581,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2444008,lethal,"preweaning lethality, complete penetrance",decreased body length|decreased prepulse inhibition|vertebral fusion|abnormal bone structure,-,850.649.350.649.351,-78.560.736.520.291,y,omim_disease,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES,dd,"Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features",strong,monoallelic_autosomal
CBX2,HGNC:1552,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:88289,lethal,"preweaning lethality, complete penetrance",increased grip strength|persistence of hyaloid vascular system,-,185.528.756.957.328,-140.450.486.635.519,n,omim_disease,"46,XY SEX REVERSAL 5",-,-,-,-
CC2D1A,HGNC:30237,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2384831,-,-,-,-,0,-18.043.993.224.943,n,omim_disease,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 3",dd,INTELLECTUAL DEVELOPMENTAL DISORDER AUTOSOMAL RECESSIVE TYPE 3,definitive,biallelic_autosomal
CDX2,HGNC:1806,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:88361,-,-,-,-,176.252.319.109.462,-114.018.590.140.685,n,-,-,-,-,-,-
CEBPA,HGNC:1833,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99480,-,-,-,-,426.716.141.001.855,-167.038.519.596.734,n,omim_disease,"LEUKEMIA, ACUTE MYELOID",-,-,-,-
CEBPB,HGNC:1834,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:88373,-,-,-,-,36.178.107.606.679,-13.534.452.623.704,n,-,-,-,-,-,-
CEBPG,HGNC:1837,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:104982,-,-,-,-,0,-488.754.410.352.225,n,-,-,-,-,-,-
CENPA,HGNC:1851,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:88375,-,-,-,-,86.734.693.877.551,-919.144.005.607.096,y,-,-,-,-,-,-
CHCHD3,HGNC:21906,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1913325,-,-,-,-,14.100.185.528.757,-330.114.516.553.294,n,-,-,-,-,-,-
CREB1,HGNC:2345,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:88494,-,-,-,-,166.975.881.261.596,-969.732.114.595.499,n,omim_disease,"HISTIOCYTOMA, ANGIOMATOID FIBROUS",-,-,-,-
CREB3L2,HGNC:23720,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2442695,-,-,-,-,0,426.204.652.192.095,n,-,-,-,-,-,-
CREB5,HGNC:16844,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2443973,-,-,-,-,0,113.563.895.560.337,n,-,-,-,-,-,-
CSRNP1,HGNC:14300,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2387989,-,-,-,-,0,684.877.166.725.665,n,-,-,-,-,-,-
CTCF,HGNC:13723,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109447,-,-,lipid deposition,-,999.072.356.215.213,-185.449.622.249.131,y,omim_disease,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 21",dd,INTELLECTUAL DISABILITY,definitive,monoallelic_autosomal
CUX1,HGNC:2557,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:88568,-,-,-,-,463.821.892.393.321,498.928.382.916.218,n,omim_disease,GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT,dd,GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT,limited,monoallelic_autosomal
CUX2,HGNC:19347,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107321,-,-,-,-,0,-515.001.959.955.874,n,omim_disease,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 67,dd,Developmental epileptic encephalopathy,strong,monoallelic_autosomal
CXXC1,HGNC:24343,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1921572,-,-,-,-,187.384.044.526.902,-324.492.935.805.086,n,-,-,-,-,-,-
DBX1,HGNC:33185,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:94867,-,-,-,-,NA,NA,-,-,-,-,-,-,-
DEAF1,HGNC:14677,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1858496,-,-,-,-,0,217.746.951.591.658,n,omim_disease,NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA AND IMPAIRED EXPRESSIVE LANGUAGE AND WITH OR WITHOUT SEIZURES|VULTO-VAN SILFHOUT-DE VRIES SYNDROME,dd,"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 24|Autism, intellectual disability, basal ganglia dysfunction and epilepsy",definitive|strong,monoallelic_autosomal|biallelic_autosomal
DLX1,HGNC:2914,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:94901,-,-,-,-,0,-870.804.715.718.347,n,-,-,-,-,-,-
DLX2,HGNC:2915,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:94902,-,-,-,-,0,-938.618.954.459.956,n,-,-,-,-,-,-
DMBX1,HGNC:19026,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2153518,-,-,-,-,0,32.270.816.660.261,n,-,-,-,-,-,-
DMRT2,HGNC:2935,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1330307,-,-,-,-,0,245.944.697.075.137,n,-,-,-,-,-,-
DMTF1,HGNC:14603,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1344415,-,-,-,-,278.293.135.435.993,109.860.075.393.146,n,-,-,-,-,-,-
DNMT1,HGNC:2976,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:94912,-,-,-,-,735.621.521.335.807,-610.062.344.662.322,y,omim_disease,"CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT|NEUROPATHY, HEREDITARY SENSORY, TYPE IE",-,-,-,-
DOT1L,HGNC:24948,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2143886,-,-,abnormal retina vasculature morphology,-,714.285.714.285.714,-130.899.360.751.103,n,-,-,-,-,-,-
DRAP1,HGNC:3019,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1913806,-,-,-,-,339.517.625.231.911,-422.345.431.016.217,n,-,-,-,-,-,-
DRGX,HGNC:21536,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2148204,subviable,"preweaning lethality, incomplete penetrance|preweaning lethality, complete penetrance|embryonic growth retardation",enlarged spleen|enlarged lymph nodes|abnormal spleen morphology|abnormal uterus morphology|abnormal adrenal gland morphology|abnormal kidney morphology|abnormal vitreous body morphology|abnormal liver morphology|enlarged testis|abnormal lymph node morphology|small kidney|abnormal heart morphology|enlarged heart|abnormal skin morphology|abnormal testis morphology|abnormal seminal vesicle morphology,-,927.643.784.786.642,-447.447.740.137.854,n,-,-,-,-,-,-
E2F3,HGNC:3115,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1096340,lethal,"no spontaneous movement|preweaning lethality, complete penetrance|abnormal embryo size",impaired glucose tolerance|no spontaneous movement|abnormal snout morphology|increased total body fat amount|corneal opacity|abnormal lens morphology|increased startle reflex|abnormal jejunum morphology,-,167.903.525.046.382,-332.076.068.214.386,n,-,-,-,-,-,-
E2F4,HGNC:3118,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103012,-,-,-,-,463.821.892.393.321,-894.519.278.374.155,n,-,-,-,-,-,-
E4F1,HGNC:3121,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109530,-,-,-,-,457.328.385.899.814,-490.736.111.061.032,n,-,-,-,-,-,-
EBF2,HGNC:19090,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:894332,subviable,"abnormal facial morphology|preweaning lethality, incomplete penetrance|female infertility|abnormal head shape|abnormal placenta vasculature|abnormal blood vessel morphology|no spontaneous movement",enlarged spleen|abnormal liver morphology|abnormal heart morphology|abnormal spleen morphology|no spontaneous movement|small spleen|abnormal skin morphology|abnormal brain morphology|shortened ST segment|enlarged heart|abnormal kidney morphology|abnormal vitreous body morphology|enlarged kidney,-,185.528.756.957.328,540.189.155.799.554,n,-,-,-,-,-,-
EBF3,HGNC:19087,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:894289,-,-,-,-,278.293.135.435.993,-371.935.812.671.438,n,omim_disease,"HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME",dd,"Intellectual Disability, Ataxia, and Facial Dysmorphism",definitive,monoallelic_autosomal
EGR2,HGNC:3239,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95296,-,-,-,-,278.293.135.435.993,-201.904.039.119.593,n,omim_disease,"CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D|HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS|NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE",dd,"NEUROPATHY, CONGENITAL HYPOMYELINATING, 1",definitive,biallelic_autosomal
EGR3,HGNC:3240,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1306780,-,-,-,-,0,43.820.002.483.753,n,-,-,-,-,-,-
ELF3,HGNC:3318,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1101781,subviable,"preweaning lethality, incomplete penetrance",-,-,927.643.784.786.642,-489.020.527.619.086,n,-,-,-,-,-,-
ELF5,HGNC:3320,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1335079,-,-,-,-,927.643.784.786.642,-110.834.811.507.979,n,-,-,-,-,-,-
ELK3,HGNC:3325,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:101762,-,abnormal retina vasculature morphology|abnormal eye morphology|decreased prepulse inhibition|abnormal retina blood vessel pattern,increased circulating cholesterol level|increased circulating alkaline phosphatase level|increased circulating HDL cholesterol level,-,927.643.784.786.642,107.784.113.109.898,n,-,-,-,-,-,-
EN1,HGNC:3342,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95389,-,-,-,-,0,-157.637.948.977.093,n,omim_disease,"ENDOVE SYNDROME, LIMB-BRAIN TYPE",-,-,-,-
ERF,HGNC:3444,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109637,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",enlarged heart|abnormal uterus morphology|abnormal embryo size|abnormal heart morphology|urinary bladder obstruction|embryonic growth retardation|abnormal snout morphology|decreased locomotor activity|hydrometra|abnormal tooth morphology,-,0,370.737.777.605.327,n,omim_disease,CHITAYAT SYNDROME|CRANIOSYNOSTOSIS 4,dd,"COMPLEX CRANIOSYNOSTOSIS|Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia",definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
ERG,HGNC:3446,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95415,lethal,"preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation",abnormal eye posterior chamber depth|increased heart left ventricle size|thick ventricular wall|abnormal spleen morphology|decreased leukocyte cell number|abnormal coat appearance,-,927.643.784.786.642,-437.347.398.977.949,n,-,-,-,-,-,-
ESRRB,HGNC:3473,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1346832,-,-,-,-,0,399.809.755.807.008,n,omim_disease,"DEAFNESS, AUTOSOMAL RECESSIVE 35",-,-,-,-
ETS1,HGNC:3488,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95455,-,-,-,-,834.879.406.307.978,269.145.469.666.271,n,-,-,-,-,-,-
ETS2,HGNC:3489,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95456,-,-,-,-,371.057.513.914.657,10.189.192.341.157,n,-,-,-,-,-,-
ETV2,HGNC:3491,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99253,-,-,-,-,927.643.784.786.642,-347.759.150.618.924,n,-,-,-,-,-,-
ETV5,HGNC:3494,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1096867,-,-,-,-,102.040.816.326.531,-221.877.939.223.273,n,-,-,-,-,-,-
ETV6,HGNC:3495,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109336,lethal,"preweaning lethality, complete penetrance",abnormal heart morphology|increased blood uric acid level|enlarged heart atrium|decreased circulating calcium level|enlarged heart|increased large unstained cell number|small liver|abnormal liver morphology|decreased circulating total protein level|increased kidney weight|increased spleen weight|thrombocytopenia|decreased circulating cholesterol level|decreased erythrocyte cell number|abnormal heart weight|decreased circulating HDL cholesterol level|abnormal heart shape|decreased circulating serum albumin level|decreased bone mineral density,-,120.593.692.022.263,-120.028.954.102.597,n,omim_disease,"LEUKEMIA, ACUTE MYELOID|THROMBOCYTOPENIA 5",-,-,-,-
EVX1,HGNC:3506,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95461,-,-,-,-,927.643.784.786.642,350.393.343.114.186,n,-,-,-,-,-,-
EVX2,HGNC:3507,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95462,-,-,-,-,185.528.756.957.328,-359.382.453.243.547,n,-,-,-,-,-,-
FEV,HGNC:18562,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2449712,-,-,-,-,556.586.270.871.985,-607.689.122.478.759,n,-,-,-,-,-,-
FLI1,HGNC:3749,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95554,-,-,-,-,510.204.081.632.653,-845.262.155.147.085,n,omim_disease,"BLEEDING DISORDER, PLATELET-TYPE, 21",-,-,-,-
FOS,HGNC:3796,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95574,subviable,"preweaning lethality, incomplete penetrance",decreased lean body mass|increased total body fat amount,-,649.350.649.350.649,-523.478.079.587.144,n,-,-,-,-,-,-
FOSL1,HGNC:13718,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107179,-,-,-,-,305.194.805.194.805,-380.917.801.026.922,n,-,-,-,-,-,-
FOSL2,HGNC:3798,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102858,-,-,-,-,426.716.141.001.855,-162.492.201.677.061,n,-,-,-,-,-,-
FOXA1,HGNC:5021,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347472,-,-,-,-,463.821.892.393.321,-179.368.653.220.763,n,-,-,-,-,-,-
FOXB1,HGNC:3799,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1927549,-,-,-,-,0,519.450.767.467.178,n,-,-,-,-,-,-
FOXC1,HGNC:3800,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347466,-,-,-,-,185.528.756.957.328,368.668.732.907.082,n,omim_disease,"ANTERIOR SEGMENT DYSGENESIS 3|AXENFELD-RIEGER SYNDROME, TYPE 3",dd,AXENFELD-RIEGER SYNDROME TYPE 3,definitive,monoallelic_autosomal
FOXC2,HGNC:3801,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347481,-,-,-,-,269.016.697.588.126,-169.820.925.631.203,n,omim_disease,LYMPHEDEMA-DISTICHIASIS SYNDROME,dd,LYMPHEDEMA-DISTICHIASIS SYNDROME,definitive,monoallelic_autosomal
FOXD1,HGNC:3802,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347463,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXD3,HGNC:3804,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347473,-,-,-,-,927.643.784.786.642,-870.711.580.739.099,n,omim_disease,"AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1",-,-,-,-
FOXE1,HGNC:3806,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1353500,-,-,-,-,463.821.892.393.321,-392.618.783.275.709,n,omim_disease,"BAMFORTH-LAZARUS SYNDROME|THYROID CANCER, NONMEDULLARY, 4",dd,BAMFORTH-LAZARUS SYNDROME,definitive,biallelic_autosomal
FOXF1,HGNC:3809,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347470,-,-,-,-,120.593.692.022.263,245.454.390.077.013,n,omim_disease,ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS,dd,ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS,definitive,monoallelic_autosomal
FOXF2,HGNC:3810,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347479,-,-,-,-,927.643.784.786.642,24.037.214.577.613,n,-,-,-,-,-,-
FOXH1,HGNC:3814,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347465,-,-,-,-,0,-351.908.756.903.178,n,-,-,-,-,-,-
FOXI1,HGNC:3815,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1096329,-,-,-,-,0,7.957.845.428.487,n,omim_disease,"DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT",-,-,-,-
FOXJ1,HGNC:3816,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347474,-,-,-,-,185.528.756.957.328,-576.429.064.707.744,n,omim_disease,"CILIARY DYSKINESIA, PRIMARY, 43",dd,Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry,strong,monoallelic_autosomal
FOXL1,HGNC:3817,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347469,-,-,-,-,185.528.756.957.328,-283.250.196.717.689,n,-,-,-,-,-,-
FOXL2,HGNC:1092,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1349428,-,-,-,-,435.992.578.849.722,-226.478.894.745.075,n,omim_disease,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS|PREMATURE OVARIAN FAILURE 3",dd,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS SYNDROME",strong,monoallelic_autosomal
FOXM1,HGNC:3818,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1347487,-,-,-,-,11.873.840.445.269,-24.974.950.222.815,n,-,-,-,-,-,-
FOXN1,HGNC:12765,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102949,subviable,"preweaning lethality, incomplete penetrance|abnormal skin morphology|athymia|abnormal thymus morphology",hydrometra|small superior vagus ganglion,-,463.821.892.393.321,-143.270.100.308.765,n,omim_disease,"T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY|T-CELL LYMPHOPENIA, INFANTILE, WITH OR WITHOUT NAIL DYSTROPHY, AUTOSOMAL DOMINANT",dd,ALOPECIA AND T-CELL IMMUNODEFICIENCY,definitive,biallelic_autosomal
FOXN4,HGNC:21399,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2151057,-,-,-,-,194.805.194.805.195,-172.478.537.162.948,n,-,-,-,-,-,-
FOXO1,HGNC:3819,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1890077,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",increased mean corpuscular volume|increased circulating bilirubin level|decreased erythrocyte cell number|hyperactivity,-,194.805.194.805.195,-111.444.894.943.355,n,omim_disease,RHABDOMYOSARCOMA 2,-,-,-,-
FOXP1,HGNC:3823,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1914004,lethal,"preweaning lethality, complete penetrance",hyperactivity|increased lean body mass,-,927.643.784.786.642,397.846.394.368.039,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES,dd,INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES,definitive,monoallelic_autosomal
FOXP2,HGNC:13875,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2148705,-,-,increased body weight,-,185.528.756.957.328,614.677.517.360.714,n,omim_disease,SPEECH-LANGUAGE DISORDER 1,dd,SPEECH-LANGUAGE DISORDER 1,strong,monoallelic_autosomal
FOXP3,HGNC:6106,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1891436,-,-,-,-,0,38.883.897.011.482,n,omim_disease,"IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED",dd,IPEX SYNDROME,definitive,monoallelic_X_hem
FOXP4,HGNC:20842,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1921373,-,-,-,-,371.057.513.914.657,-379.238.930.588.092,n,-,-,dd,FOXP4-related Developmental Disorder,limited,monoallelic_autosomal
FOXQ1,HGNC:20951,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1298228,-,-,-,-,0,104.694.566.107.818,n,-,-,-,-,-,-
GATA1,HGNC:4170,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95661,-,-,-,-,649.350.649.350.649,-678.854.632.120.716,n,omim_disease,"ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES|ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO|DOWN SYNDROME|THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED|THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA",-,-,-,-
GATA2,HGNC:4171,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95662,lethal,"abnormal embryo size|embryonic growth retardation|embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",abnormal auditory brainstem response|enlarged epididymis|absent epididymis|abnormal embryo size|abnormal epididymis morphology|embryonic growth retardation|abnormal ovary morphology|abnormal kidney morphology,-,148.423.005.565.863,-267.581.199.655.205,n,omim_disease,"LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA|IMMUNODEFICIENCY 21|LEUKEMIA, ACUTE MYELOID|MYELODYSPLASTIC SYNDROME",dd,EMBERGER SYNDROME,definitive,monoallelic_autosomal
GATA3,HGNC:4172,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95663,-,-,-,-,565.862.708.719.852,-14.516.690.932.195,n,omim_disease,"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DYSPLASIA SYNDROME",dd,"HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE",definitive,monoallelic_autosomal
GATA4,HGNC:4173,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95664,-,-,-,-,371.057.513.914.657,119.175.587.048.408,n,omim_disease,TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE|ATRIAL SEPTAL DEFECT 2|ATRIOVENTRICULAR SEPTAL DEFECT 4|TETRALOGY OF FALLOT|VENTRICULAR SEPTAL DEFECT 1,dd,ATRIAL SEPTAL DEFECT TYPE 2,definitive,monoallelic_autosomal
GATAD2A,HGNC:29989,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2384585,-,-,-,-,195.732.838.589.981,-360.507.226.955.233,n,-,-,-,-,-,-
GCM1,HGNC:4197,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:108045,-,-,-,-,185.528.756.957.328,204.456.566.990.969,n,-,-,-,-,-,-
GCM2,HGNC:4198,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1861438,-,-,-,-,927.643.784.786.642,-109.794.543.816.184,n,omim_disease,"HYPERPARATHYROIDISM 4|HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2",-,-,-,-
GFI1B,HGNC:4238,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1276578,lethal,"prenatal lethality|preweaning lethality, complete penetrance",increased circulating bilirubin level|decreased neutrophil cell number|increased total body fat amount|increased lymphocyte cell number|increased circulating serum albumin level,-,371.057.513.914.657,-614.275.352.421.125,n,omim_disease,"BLEEDING DISORDER, PLATELET-TYPE, 17",-,-,-,-
GLI2,HGNC:4318,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95728,-,-,-,-,185.528.756.957.328,-316.516.470.062.725,n,omim_disease,CULLER-JONES SYNDROME|HOLOPROSENCEPHALY 9,dd,GLI2-RELATED HOLOPROSENCEPHALY,definitive,monoallelic_autosomal
GLI3,HGNC:4319,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95729,-,-,-,-,0,519.302.451.330.262,n,omim_disease,"GREIG CEPHALOPOLYSYNDACTYLY SYNDROME|PALLISTER-HALL SYNDROME|POLYDACTYLY, POSTAXIAL, TYPE A1|POLYDACTYLY, PREAXIAL IV",dd,GREIG CEPHALOPOLYSYNDACTYLY SYNDROME|PALLISTER-HALL SYNDROME,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
GRHL2,HGNC:2799,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2182543,lethal,"abnormal head shape|abnormal optic vesicle formation|abnormal pericardium morphology|abnormal neural tube closure|embryonic growth retardation|abnormal craniofacial morphology|syndactyly|abnormal heart morphology|preweaning lethality, complete penetrance|abnormal midbrain development|abnormal neural tube morphology|abnormal limb morphology|abnormal hindbrain development|abnormal abdominal wall morphology|exencephaly|abnormal forebrain development",abnormal placenta morphology|abnormal blood vessel morphology|increased freezing behavior|increased startle reflex,-,584.415.584.415.584,-147.879.688.268.669,n,omim_disease,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 4|DEAFNESS, AUTOSOMAL DOMINANT 28|ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME",dd,ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME,strong,biallelic_autosomal
GRHL3,HGNC:25839,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2655333,-,-,increased circulating calcium level|increased startle reflex|decreased circulating alkaline phosphatase level|abnormal retina morphology|increased circulating glucose level|increased circulating phosphate level|decreased circulating triglyceride level|abnormal eye morphology|abnormal locomotor activation|decreased blood urea nitrogen level|increased circulating amylase level,-,0,535.344.064.487.622,n,omim_disease,VAN DER WOUDE SYNDROME 2,dd,VAN DER WOUDE SYNDROME,definitive,monoallelic_autosomal
GSC,HGNC:4612,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:95841,-,-,-,-,0,305.435.489.465.531,n,omim_disease,"SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND SKELETAL ABNORMALITIES",-,-,-,-
GSX1,HGNC:20374,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95842,-,-,-,-,927.643.784.786.642,201.371.616.654.263,n,-,-,-,-,-,-
GSX2,HGNC:24959,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95843,-,-,-,-,185.528.756.957.328,-633.421.273.678.678,n,omim_disease,DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2,-,-,-,-
GTF2I,HGNC:4659,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1202722,-,-,-,-,23.191.094.619.666,-17.865.086.003.035,n,-,-,-,-,-,-
GTF2IRD1,HGNC:4661,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1861942,-,-,-,-,0,-800.227.279.061.065,n,-,-,-,-,-,-
HAND1,HGNC:4807,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103577,-,-,-,-,185.528.756.957.328,-1.682.545.273.951,n,-,-,-,-,-,-
HAND2,HGNC:4808,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103580,-,-,-,-,139.146.567.717.996,188.842.188.382.783,n,-,-,-,-,-,-
HELT,HGNC:33783,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:3040955,-,-,-,-,0,148.065.744.004.402,n,-,-,-,-,-,-
HES7,HGNC:15977,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2135679,-,-,-,-,296.846.011.131.725,-214.631.284.825.937,n,omim_disease,"SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE",-,-,-,-
HESX1,HGNC:4877,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96071,lethal,"anophthalmia|cleft palate|abnormal facial morphology|preweaning lethality, complete penetrance|abnormal head shape|facial cleft",-,-,278.293.135.435.993,-110.812.977.628.705,n,omim_disease,SEPTOOPTIC DYSPLASIA,dd,SEPTOOPTIC DYSPLASIA|HESX1-RELATED COMBINED PITUITARY HORMONE DEFICIENCY,strong|strong,biallelic_autosomal|monoallelic_autosomal
HEY2,HGNC:4881,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1341884,-,-,-,-,0,64.066.178.704.708,n,-,-,-,-,-,-
HHEX,HGNC:4901,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96086,-,-,-,-,834.879.406.307.978,-171.181.157.254.587,n,-,-,-,-,-,-
HIC1,HGNC:4909,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1338010,-,-,-,-,463.821.892.393.321,-257.874.640.770.653,n,-,-,-,-,-,-
HIF1A,HGNC:4910,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:106918,-,-,-,-,927.643.784.786.642,116.979.102.318.759,n,-,-,-,-,-,-
HINFP,HGNC:17850,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2429620,-,-,-,-,996.289.424.860.854,-187.763.728.942.545,y,-,-,-,-,-,-
HLX,HGNC:4978,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:96109,-,-,-,-,371.057.513.914.657,-197.621.315.741.771,n,-,-,-,-,-,-
HMX1,HGNC:5017,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107178,-,-,-,-,185.528.756.957.328,957.793.134.632.733,n,omim_disease,OCULOAURICULAR SYNDROME,dd,OCULOAURICULAR SYNDROME,strong,biallelic_autosomal
HMX2,HGNC:5018,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107159,viable,abnormal kidney morphology|enlarged kidney|atrophy|polycystic kidney|chronic inflammation|hyperplasia|hydronephrosis|abnormal auditory brainstem response|neoplasia|increased bone mineral content|increased kidney weight|dysplasia,-,-,0,814.955.880.535.675,n,-,-,-,-,-,-
HMX3,HGNC:5019,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107160,-,decreased grip strength|decreased circulating triglyceride level|decreased circulating free fatty acids level|abnormal defecation|hyperactivity|decreased body weight|abnormal gait|abnormal locomotor activation|abnormal behavior|decreased prepulse inhibition,decreased body weight,-,371.057.513.914.657,-189.105.996.922.129,n,-,-,-,-,-,-
HOXA1,HGNC:5099,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96170,-,-,-,-,927.643.784.786.642,-189.700.899.780.235,n,omim_disease,ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME,dd,BOSLEY-SALIH-ALORAINY SYNDROME,definitive,biallelic_autosomal
HOXA2,HGNC:5103,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96174,lethal,"preweaning lethality, complete penetrance",decreased prepulse inhibition|decreased circulating creatinine level|improved glucose tolerance|abnormal auditory brainstem response|decreased respiratory quotient|abnormal gait|abnormal snout morphology,-,0,859.540.202.102.709,n,omim_disease,"MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE",-,-,-,-
HOXA3,HGNC:5104,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96175,-,-,-,-,185.528.756.957.328,-485.901.727.240.801,n,-,-,-,-,-,-
HOXA5,HGNC:5106,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96177,-,-,-,-,0,-589.857.309.365.497,n,-,-,-,-,-,-
HOXA13,HGNC:5102,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96173,-,-,-,-,371.057.513.914.657,-40.050.680.942.011,n,omim_disease,"PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS|HAND-FOOT-GENITAL SYNDROME",dd,HAND-FOOT-GENITAL SYNDROME,definitive,monoallelic_autosomal
HOXB1,HGNC:5111,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96182,-,-,-,-,927.643.784.786.642,-200.733.142.569.378,n,omim_disease,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3",dd,"FACIAL PARESIS, HEREDITARY CONGENITAL, 3",strong,biallelic_autosomal
HOXB2,HGNC:5113,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96183,-,-,-,-,927.643.784.786.642,-15.544.944.181.386,n,-,-,-,-,-,-
HOXB3,HGNC:5114,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96184,-,-,-,-,649.350.649.350.649,-296.196.781.884.441,n,-,-,-,-,-,-
HOXB4,HGNC:5115,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96185,-,-,-,-,185.528.756.957.328,-223.905.877.402.481,n,-,-,-,-,-,-
HOXC4,HGNC:5126,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96195,-,-,-,-,417.439.703.153.989,-226.937.284.949.429,n,-,-,-,-,-,-
HOXC8,HGNC:5129,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96198,-,-,-,-,278.293.135.435.993,-12.747.819.147.908,n,-,-,-,-,-,-
HOXC13,HGNC:5125,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99560,-,-,-,-,482.374.768.089.054,-254.833.688.722.864,n,omim_disease,"ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE",dd,PURE HAIR AND NAIL ECTODERMAL DYSPLASIA,definitive,biallelic_autosomal
HOXD3,HGNC:5137,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96207,-,-,-,-,0,375.527.471.794.367,n,-,-,-,-,-,-
HOXD11,HGNC:5134,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96203,-,-,-,-,111.317.254.174.397,-142.961.667.873.654,n,-,-,-,-,-,-
HOXD12,HGNC:5135,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96204,-,-,-,-,0,-852.547.126.115.191,n,-,-,-,-,-,-
HOXD13,HGNC:5136,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96205,-,-,-,-,862.708.719.851.577,-253.350.592.558.328,n,omim_disease,"BRACHYDACTYLY-SYNDACTYLY SYNDROME|BRACHYDACTYLY, TYPE D|BRACHYDACTYLY, TYPE E1|SYNDACTYLY, TYPE V|SYNPOLYDACTYLY 1",dd,BRACHYDACTYLY-SYNDACTYLY SYNDROME,definitive,monoallelic_autosomal
HSF1,HGNC:5224,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96238,subviable,"abnormal embryo size|preweaning lethality, incomplete penetrance",decreased circulating glucose level|abnormal sleep behavior,-,373.840.445.269.017,-456.023.234.980.901,n,-,-,-,-,-,-
HSF2,HGNC:5225,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96239,viable,mydriasis|increased circulating sodium level|abnormal retina blood vessel morphology|decreased circulating glucose level,-,-,278.293.135.435.993,-733.990.873.781.271,n,-,-,-,-,-,-
IKZF1,HGNC:13176,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1342540,-,-,-,-,213.358.070.500.928,307.698.382.075.937,n,omim_disease,"IMMUNODEFICIENCY, COMMON VARIABLE, 13",-,-,-,-
IKZF2,HGNC:13177,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1342541,viable,-,-,-,278.293.135.435.993,107.647.978.026.477,n,-,-,-,-,-,-
IRF6,HGNC:6121,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1859211,-,increased circulating creatinine level|increased circulating aspartate transaminase level|increased circulating creatine kinase level,-,-,371.057.513.914.657,-359.037.860.293.927,n,omim_disease,"POPLITEAL PTERYGIUM SYNDROME|VAN DER WOUDE SYNDROME 1|OROFACIAL CLEFT 6, SUSCEPTIBILITY TO",dd,VAN DER WOUDE SYNDROME|POPLITEAL PTERYGIUM SYNDROME,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
ISL2,HGNC:18524,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109156,-,-,-,-,371.057.513.914.657,801.751.812.818.026,n,-,-,-,-,-,-
KAT7,HGNC:17016,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2182799,-,-,-,-,242.115.027.829.314,-367.143.526.693.561,n,-,-,-,-,-,-
KCMF1,HGNC:20589,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1921537,-,-,-,-,896.103.896.103.896,-953.420.046.760.482,y,-,-,-,-,-,-
KDM2B,HGNC:13610,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1354737,-,-,increased neutrophil cell number|decreased heart left ventricle size|decreased circulating glucose level|decreased circulating phosphate level|decreased circulating serum albumin level|decreased lymphocyte cell number,-,556.586.270.871.985,-401.880.946.474.381,n,-,-,-,-,-,-
KLF1,HGNC:6345,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1342771,-,-,-,-,157.699.443.413.729,-17.158.243.487.024,n,omim_disease,"BLOOD GROUP--LUTHERAN INHIBITOR|ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV|FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6",dd,"ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV",definitive,monoallelic_autosomal
KLF2,HGNC:6347,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1342772,-,-,-,-,742.115.027.829.314,-68.980.843.464.563,n,-,-,-,-,-,-
KLF3,HGNC:16516,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1342773,-,-,-,-,556.586.270.871.985,-87.618.701.601.154,n,-,-,-,-,-,-
KLF4,HGNC:6348,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1342287,viable,decreased grip strength,-,-,927.643.784.786.642,-672.506.487.710.318,n,-,-,-,-,-,-
KLF5,HGNC:6349,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1338056,-,-,-,-,226.345.083.487.941,-350.953.433.619.854,n,-,-,-,-,-,-
KLF6,HGNC:2235,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1346318,-,-,-,-,185.528.756.957.328,-139.721.332.345.693,n,-,-,-,-,-,-
LBX1,HGNC:16960,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104867,-,-,-,-,0,-217.439.894.277.146,n,omim_disease,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 3",-,-,-,-
LHX1,HGNC:6593,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99783,-,-,"increased startle reflex|decreased circulating alkaline phosphatase level|increased CD8-positive, alpha-beta T cell number",-,649.350.649.350.649,-109.769.928.002.663,n,-,-,-,-,-,-
LHX2,HGNC:6594,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96785,-,-,-,-,0,122.458.166.117.094,n,-,-,-,-,-,-
LHX3,HGNC:6595,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102673,-,-,-,-,278.293.135.435.993,-830.781.599.917.272,n,omim_disease,"PITUITARY HORMONE DEFICIENCY, COMBINED, 3",dd,PITUITARY HORMONE DEFICIENCY COMBINED TYPE 3,definitive,biallelic_autosomal
LHX4,HGNC:21734,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101776,-,-,-,-,102.040.816.326.531,-16.871.640.378.059,n,omim_disease,"PITUITARY HORMONE DEFICIENCY, COMBINED, 4",dd,LHX4-RELATED COMBINED PITUITARY HORMONE DEFICIENCY,definitive,monoallelic_autosomal
LHX6,HGNC:21735,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1306803,subviable,"preweaning lethality, incomplete penetrance",decreased locomotor activity,-,185.528.756.957.328,-520.053.520.333.155,n,-,-,-,-,-,-
LHX8,HGNC:28838,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1096343,-,-,-,-,927.643.784.786.642,562.259.650.914.552,n,-,-,-,-,-,-
LIN28A,HGNC:15986,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1890546,-,-,-,-,834.879.406.307.978,-14.850.938.926.414,n,-,-,-,-,-,-
LMX1A,HGNC:6653,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1888519,-,-,-,-,0,438.784.746.494.461,n,omim_disease,"DEAFNESS, AUTOSOMAL DOMINANT 7",-,-,-,-
LMX1B,HGNC:6654,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1100513,-,-,-,-,371.057.513.914.657,200.189.047.690.971,n,omim_disease,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 10|NAIL-PATELLA SYNDROME,dd,NAIL-PATELLA SYNDROME,definitive,monoallelic_autosomal
MAF,HGNC:6776,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96909,lethal,"microphthalmia|edema|preweaning lethality, complete penetrance|embryonic growth retardation|abnormal placenta vasculature|abnormal placenta morphology|abnormal blood vessel morphology",decreased prepulse inhibition|abnormal spleen morphology|enlarged heart|abnormal heart morphology|enlarged kidney|abnormal kidney morphology|enlarged ovary|urinary bladder obstruction|enlarged spleen|abnormal liver morphology|hyperplasia|abnormal ovary morphology|increased freezing behavior|small kidney|small liver|microphthalmia|increased circulating bilirubin level|small spleen,-,194.805.194.805.195,-145.591.560.428.299,n,omim_disease,"AYME-GRIPP SYNDROME|CATARACT 21, MULTIPLE TYPES",dd,"CATARACT 21, MULTIPLE TYPES",definitive,monoallelic_autosomal
MAFG,HGNC:6781,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:96911,-,-,-,-,23.191.094.619.666,-173.748.651.035.422,n,-,-,-,-,-,-
MAX,HGNC:6913,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:96921,-,-,-,-,869.202.226.345.083,-8.100.387.766.827,y,omim_disease,PHEOCHROMOCYTOMA,-,-,-,-
MBD3,HGNC:6918,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1333812,-,-,-,-,269.016.697.588.126,-938.846.061.851.281,n,-,-,-,-,-,-
MBD4,HGNC:6919,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1333850,-,-,-,-,0,-636.584.044.149.784,n,omim_disease,"TUMOR PREDISPOSITION SYNDROME 2|MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1",-,-,-,-
MECOM,HGNC:3498,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95457,lethal,"preweaning lethality, complete penetrance",decreased lean body mass|limb grasping|increased blood urea nitrogen level|decreased prepulse inhibition|thrombocytopenia|decreased erythrocyte cell number|increased circulating amylase level|decreased hemoglobin content|increased startle reflex|abnormal locomotor activation|increased bone mineral content|increased total body fat amount|increased lean body mass|abnormal auditory brainstem response|abnormal startle reflex,-,120.593.692.022.263,-909.404.509.547.382,n,-,-,dd,Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia,strong,monoallelic_autosomal
MEF2A,HGNC:6993,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99532,-,-,-,-,0,208.543.141.326.553,n,omim_disease,"CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1",-,-,-,-
MEF2C,HGNC:6996,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99458,-,-,-,-,296.846.011.131.725,-294.602.868.054.284,n,omim_disease,"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, STEREOTYPIC HAND MOVEMENTS, AND IMPAIRED LANGUAGE",dd,INTELLECTUAL DEVELOPMENTAL DISORDER-STEREOTYPIC MOVEMENTS-EPILEPSY AND/OR CEREBRAL MALFORMATIONS,definitive,monoallelic_autosomal
MEOX2,HGNC:7014,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103219,-,-,-,-,927.643.784.786.642,190.565.718.375.755,n,-,-,-,-,-,-
MESP1,HGNC:29658,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107785,-,-,-,-,927.643.784.786.642,-110.950.722.861.547,n,-,-,-,-,-,-
MESP2,HGNC:29659,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1096325,-,-,-,-,185.528.756.957.328,-44.097.606.056.612,n,omim_disease,"SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE",dd,SPONDYLOCOSTAL DYSOSTOSIS TYPE 2,definitive,biallelic_autosomal
MITF,HGNC:7105,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104554,-,-,-,-,185.528.756.957.328,-56.821.796.732.576,n,omim_disease,"COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS|TIETZ ALBINISM-DEAFNESS SYNDROME|WAARDENBURG SYNDROME, TYPE 2A|MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8",dd,"TIETZ SYNDROME|WAARDENBURG SYNDROME TYPE 2A|Coloboma, Osteopetrosis, Microphthalmia, Macrocephaly, Albinism, and Deafness",definitive|definitive|strong,monoallelic_autosomal|monoallelic_autosomal|biallelic_autosomal
MIXL1,HGNC:13363,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1351322,-,-,-,-,454.545.454.545.455,-20.292.982.768.111,n,-,-,-,-,-,-
MNT,HGNC:7188,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109150,-,-,-,-,315.398.886.827.458,-798.528.398.613.247,n,-,-,-,-,-,-
MSGN1,HGNC:14907,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1860483,-,-,-,-,0,561.089.310.930.139,n,-,-,-,-,-,-
MSX1,HGNC:7391,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97168,lethal,"cleft palate|cyanosis|abnormal facial morphology|preweaning lethality, complete penetrance",increased heart weight|decreased thigmotaxis|increased circulating free fatty acids level,-,0,236.799.014.637.706,n,omim_disease,"WITKOP SYNDROME|OROFACIAL CLEFT 5|TOOTH AGENESIS, SELECTIVE, 1",dd,CLEFT LIP +/- CLEFT PALATE,definitive,monoallelic_autosomal
MTF1,HGNC:7428,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:101786,lethal,"microphthalmia|abnormal forebrain morphology|preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation|abnormal embryo size|anophthalmia|embryonic growth retardation|abnormal craniofacial morphology",abnormal retina morphology|increased circulating aspartate transaminase level|decreased circulating glucose level|increased circulating potassium level,-,723.562.152.133.581,-188.571.558.020.285,n,-,-,dd,INTELLECTUAL DISABILITY,limited,monoallelic_autosomal
MTF2,HGNC:29535,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:105050,-,-,-,-,102.040.816.326.531,-889.456.732.480.333,n,-,-,-,-,-,-
MYB,HGNC:7545,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97249,subviable,"pallor|preweaning lethality, incomplete penetrance",enlarged heart|abnormal heart morphology,-,108.534.322.820.037,-297.356.198.016.767,n,-,-,-,-,-,-
MYBL2,HGNC:7548,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101785,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",-,-,38.126.159.554.731,-427.508.178.017.216,n,-,-,-,-,-,-
MYC,HGNC:7553,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97250,lethal,"preweaning lethality, complete penetrance",short tibia|increased startle reflex|decreased body length|decreased bone mineral content|decreased fluid intake|abnormal bone structure|increased grip strength|decreased prepulse inhibition|decreased bone mineral density,-,942.486.085.343.228,-160.238.321.127.256,y,omim_disease,BURKITT LYMPHOMA,-,-,-,-
MYCN,HGNC:7559,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97357,-,-,-,-,306.122.448.979.592,-141.171.753.319.051,n,omim_disease,FEINGOLD SYNDROME 1,dd,FEINGOLD SYNDROME TYPE 1,definitive,monoallelic_autosomal
MYF5,HGNC:7565,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97252,-,-,-,-,556.586.270.871.985,-121.714.612.192.506,n,omim_disease,"OPHTHALMOPLEGIA, EXTERNAL, WITH RIB AND VERTEBRAL ANOMALIES",dd,"External Ophthalmoplegia, Rib, and Vertebral Anomalies",strong,biallelic_autosomal
MYF6,HGNC:7566,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97253,-,-,-,-,185.528.756.957.328,-959.003.682.245.686,n,-,-,-,-,-,-
MYOG,HGNC:7612,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97276,-,-,-,-,463.821.892.393.321,-187.944.956.596.699,n,-,-,-,-,-,-
MYT1,HGNC:7622,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1100535,-,-,-,-,834.879.406.307.978,-354.604.089.252.669,n,-,-,dd,OAVS/Goldenhar syndrome,limited,monoallelic_autosomal
NANOG,HGNC:20857,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,-,-,-,-,-,-,38.961.038.961.039,-189.175.856.931.688,n,-,-,-,-,-,-
NCOA3,HGNC:7670,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1276535,subviable,"persistence of hyaloid vascular system|abnormal tooth morphology|preweaning lethality, incomplete penetrance",persistence of hyaloid vascular system|impaired glucose tolerance|increased circulating bilirubin level|abnormal tooth morphology,-,463.821.892.393.321,-726.289.249.746.726,n,-,-,-,-,-,-
NEUROG1,HGNC:7764,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107754,-,-,-,-,185.528.756.957.328,-382.150.357.654.129,n,-,-,-,-,-,-
NEUROG2,HGNC:13805,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109619,-,-,-,-,0,681.013.410.048.387,n,-,-,-,-,-,-
NFAT5,HGNC:7774,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1859333,subviable,"preweaning lethality, incomplete penetrance",prolonged RR interval|improved glucose tolerance|decreased hematocrit,-,742.115.027.829.314,-344.976.063.754.022,n,-,-,-,-,-,-
NFATC1,HGNC:7775,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102469,-,-,-,-,927.643.784.786.642,614.653.335.610.456,n,-,-,-,-,-,-
NFE2,HGNC:7780,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97308,-,-,-,-,102.040.816.326.531,-123.968.927.259.472,n,-,-,-,-,-,-
NFE2L1,HGNC:7781,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99421,-,-,-,-,333.951.762.523.191,-157.442.258.062.048,n,-,-,-,-,-,-
NFIA,HGNC:7784,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:108056,-,-,-,-,166.975.881.261.596,-968.185.366.017.261,n,omim_disease,BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS,dd,Macrocephaly with intellectual disability,strong,monoallelic_autosomal
NFIB,HGNC:7785,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103188,-,-,-,-,12.987.012.987.013,-118.139.412.594.979,n,omim_disease,"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",dd,"MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT",strong,monoallelic_autosomal
NFIX,HGNC:7788,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97311,-,-,prolonged RR interval|increased circulating alkaline phosphatase level|decreased heart rate|hyperactivity|increased basophil cell number|increased mean platelet volume|abnormal retina morphology,-,278.293.135.435.993,154.699.056.271.121,n,omim_disease,MALAN SYNDROME|MARSHALL-SMITH SYNDROME,dd,MARSHALL-SMITH SYNDROME,definitive,monoallelic_autosomal
NFKB1,HGNC:7794,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97312,viable,decreased body length|increased circulating aspartate transaminase level|decreased lean body mass|increased circulating LDL cholesterol level|increased leukocyte cell number|abnormal cornea morphology|increased circulating alanine transaminase level|decreased circulating sodium level|abnormal skin condition|increased circulating free fatty acids level|abnormal coat/hair pigmentation|increased circulating alkaline phosphatase level|decreased circulating calcium level|decreased circulating serum albumin level|increased lactate dehydrogenase level,-,-,12.987.012.987.013,-176.379.130.117.294,n,omim_disease,"IMMUNODEFICIENCY, COMMON VARIABLE, 12, WITH AUTOIMMUNITY",-,-,-,-
NFYA,HGNC:7804,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97316,-,-,abnormal head morphology|decreased body weight|decreased body length|increased circulating calcium level|increased bone mineral density|increased circulating creatinine level|thrombocytosis|increased IgG1 level|abnormal eye morphology|decreased grip strength|increased circulating fructosamine level|abnormal retina pigmentation|abnormal startle reflex|decreased circulating serum albumin level|increased leukocyte cell number,-,11.595.547.309.833,-305.261.476.859.451,n,-,-,-,-,-,-
NKX2-1,HGNC:11825,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:108067,-,-,-,-,194.805.194.805.195,-638.874.371.163.611,n,omim_disease,"CHOREA, BENIGN HEREDITARY|CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY DYSFUNCTION|THYROID CANCER, NONMEDULLARY, 1",dd,"CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESS",definitive,monoallelic_autosomal
NKX2-3,HGNC:7836,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97348,-,-,-,-,278.293.135.435.993,-597.894.217.178.664,n,-,-,-,-,-,-
NKX2-5,HGNC:2488,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97350,-,-,-,-,927.643.784.786.642,-154.974.784.224.351,n,omim_disease,"ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION DEFECTS|CONOTRUNCAL HEART MALFORMATIONS|HYPOPLASTIC LEFT HEART SYNDROME 2|HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5|TETRALOGY OF FALLOT|VENTRICULAR SEPTAL DEFECT 3",dd,ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS|TETRALOGY OF FALLOT|CONGENITAL HYPOTHYROIDISM NON-GOITROUS TYPE 5,definitive|definitive|definitive,monoallelic_autosomal|monoallelic_autosomal|monoallelic_autosomal
NKX3-2,HGNC:951,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:108015,-,-,-,-,0,431.214.043.819.029,n,omim_disease,SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA,dd,SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA,definitive,biallelic_autosomal
NME2,HGNC:7850,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97356,viable,abnormal liver morphology|abnormal kidney morphology|abnormal uterus morphology|abnormal stomach morphology|enlarged uterus|enlarged kidney,-,-,414.656.771.799.629,-475.248.065.019.885,n,-,-,-,-,-,-
NOTO,HGNC:31839,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:3053002,-,-,-,-,148.423.005.565.863,-169.805.358.128.858,n,-,-,-,-,-,-
NPAS3,HGNC:19311,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1351610,lethal,"no spontaneous movement|unresponsive to tactile stimuli|preweaning lethality, complete penetrance",unresponsive to tactile stimuli|no spontaneous movement|increased startle reflex,-,371.057.513.914.657,-122.994.128.010.038,n,-,-,-,-,-,-
NR2C2,HGNC:7972,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1352466,subviable,"preweaning lethality, incomplete penetrance|embryonic lethality prior to tooth bud stage",impaired glucose tolerance,-,649.350.649.350.649,-107.807.818.667.739,n,-,-,-,-,-,-
NR3C1,HGNC:7978,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:95824,-,-,-,-,463.821.892.393.321,-233.794.677.626.744,n,omim_disease,"GLUCOCORTICOID RESISTANCE, GENERALIZED",-,-,-,-
NR3C2,HGNC:7979,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99459,-,-,increased startle reflex,-,0,168.480.710.531.353,n,omim_disease,"HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION IN PREGNANCY|PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT",-,-,-,-
NR4A2,HGNC:7981,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1352456,-,-,-,-,371.057.513.914.657,-577.667.059.879.617,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH LANGUAGE IMPAIRMENT AND EARLY-ONSET DOPA-RESPONSIVE DYSTONIA-PARKINSONISM,dd,NR4A2-related developmental disorder (monoallelic),strong,monoallelic_autosomal
NR4A3,HGNC:7982,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1352457,-,-,-,-,927.643.784.786.642,25.763.541.533.557,n,omim_disease,"CHONDROSARCOMA, EXTRASKELETAL MYXOID",-,-,-,-
NR5A1,HGNC:7983,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1346833,-,-,-,-,278.293.135.435.993,-956.297.421.604.755,n,omim_disease,"46,XX SEX REVERSAL 4|46,XY SEX REVERSAL 3|PREMATURE OVARIAN FAILURE 7|SPERMATOGENIC FAILURE 8",-,-,-,-
NR5A2,HGNC:7984,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1346834,-,-,-,-,463.821.892.393.321,-251.255.300.547.886,n,-,-,-,-,-,-
NRF1,HGNC:7996,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1332235,-,-,-,-,998.144.712.430.427,-169.452.039.745.039,y,-,-,-,-,-,-
OLIG2,HGNC:9398,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1355331,-,-,-,-,0,-387.850.937.847.087,n,-,-,-,-,-,-
OLIG3,HGNC:18003,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2149955,-,-,-,-,278.293.135.435.993,-103.304.823.573.155,n,-,-,-,-,-,-
OSR1,HGNC:8111,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1344424,-,-,-,-,0,906.918.947.198.279,n,-,-,-,-,-,-
OSR2,HGNC:15830,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1930813,-,-,-,-,0,-120.485.036.753.638,n,-,-,-,-,-,-
OTP,HGNC:8518,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99835,lethal,"preweaning lethality, complete penetrance",increased circulating iron level,-,185.528.756.957.328,-657.013.759.162.558,n,-,-,-,-,-,-
OTX2,HGNC:8522,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97451,-,-,-,-,556.586.270.871.985,511.295.902.895.819,n,omim_disease,"MICROPHTHALMIA, SYNDROMIC 5|PITUITARY HORMONE DEFICIENCY, COMBINED, 6",dd,MICROPHTHALMIA SYNDROMIC TYPE 5,definitive,monoallelic_autosomal
OVOL2,HGNC:15804,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1338039,-,-,-,-,120.593.692.022.263,-112.270.477.441.471,n,omim_disease,"CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1",-,-,-,-
PAX2,HGNC:8616,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97486,-,-,-,-,0,-616.652.275.341.319,n,omim_disease,FOCAL SEGMENTAL GLOMERULOSCLEROSIS 7|PAPILLORENAL SYNDROME,dd,RENAL-COLOBOMA SYNDROME,definitive,monoallelic_autosomal
PAX3,HGNC:8617,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97487,-,-,-,-,157.699.443.413.729,-303.544.859.887.055,n,omim_disease,"CRANIOFACIAL-DEAFNESS-HAND SYNDROME|RHABDOMYOSARCOMA 2|WAARDENBURG SYNDROME, TYPE 1|WAARDENBURG SYNDROME, TYPE 3",dd,"WAARDENBURG SYNDROME, TYPE 1|Waardenburg syndrome type 3",definitive|moderate,monoallelic_autosomal|biallelic_autosomal
PAX5,HGNC:8619,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97489,lethal,"preweaning lethality, complete penetrance",increased circulating lipase level|decreased leukocyte cell number|immune system phenotype|hyperactivity|increased circulating triglyceride level|increased CD4-positive NK T cell number|increased memory-marker CD4-positive NK T cell number|abnormal auditory brainstem response|increased circulating amylase level|impaired glucose tolerance,-,333.951.762.523.191,-787.278.268.754.781,n,omim_disease,"LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3",-,-,-,-
PAX7,HGNC:8621,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97491,lethal|subviable,"preweaning lethality, complete penetrance|preweaning lethality, incomplete penetrance",decreased circulating triglyceride level,-,185.528.756.957.328,212.654.695.565.719,n,omim_disease,"MYOPATHY, CONGENITAL, PROGRESSIVE, WITH SCOLIOSIS|RHABDOMYOSARCOMA 2",-,-,-,-
PAX8,HGNC:8622,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97492,-,-,-,-,658.627.087.198.516,-176.258.090.848.779,n,omim_disease,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2",dd,CONGENITAL HYPOTHYROIDISM NON-GOITROUS TYPE 2,definitive,monoallelic_autosomal
PAX9,HGNC:8623,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:97493,-,-,-,-,185.528.756.957.328,801.981.561.087.468,n,omim_disease,"TOOTH AGENESIS, SELECTIVE, 3",dd,"TOOTH AGENESIS, SELECTIVE, 3",definitive,monoallelic_autosomal
PBX1,HGNC:8632,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97495,-,-,-,-,463.821.892.393.321,513.917.950.394.635,n,omim_disease,"CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY",dd,PBX1-related developmental disorder (monoallelic),strong,monoallelic_autosomal
PCGF2,HGNC:12929,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99161,lethal,"preweaning lethality, complete penetrance",abnormal testis morphology|abnormal lumbar vertebrae morphology|small testis|abnormal spleen morphology|increased bone mineral content|small spleen,-,176.252.319.109.462,-197.399.215.555.795,n,omim_disease,TURNPENNY-FRY SYNDROME,dd,INTELLECTUAL DISABILITY|Craniofacial Neurological Cardiovascular and Skeletal Features,strong|definitive,monoallelic_autosomal|monoallelic_autosomal
PHF21A,HGNC:24156,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2384756,-,-,-,-,371.057.513.914.657,-617.871.897.995.933,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH BEHAVIORAL ABNORMALITIES AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT SEIZURES,dd,POTOCKI-SHAFFER SYNDROME,strong,monoallelic_autosomal
PHOX2A,HGNC:691,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106633,-,-,-,-,222.634.508.348.794,-158.991.167.563.151,n,omim_disease,"FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2",-,-,-,-
PHOX2B,HGNC:9143,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1100882,-,-,-,-,556.586.270.871.985,844.256.436.822.009,n,omim_disease,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, 1|NEUROBLASTOMA, SUSCEPTIBILITY TO, 2",dd,"CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL, WITH OR WITHOUT HIRSCHSPRUNG DISEASE",definitive,monoallelic_autosomal
PITX2,HGNC:9005,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109340,lethal,"preweaning lethality, complete penetrance|prenatal lethality",enlarged heart|increased grip strength|irregularly shaped pupil|abnormal optic disk morphology|corneal opacity|abnormal tooth morphology|small testis,-,185.528.756.957.328,468.547.091.643.062,n,omim_disease,"ANTERIOR SEGMENT DYSGENESIS 4|AXENFELD-RIEGER SYNDROME, TYPE 1|RING DERMOID OF CORNEA",dd,RING DERMOID OF CORNEA|AXENFELD-RIEGER SYNDROME TYPE 1,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
PKNOX1,HGNC:9022,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1201409,-,-,decreased IgG1 level|decreased mature B cell number|decreased B cell number|abnormal urination|decreased circulating triglyceride level|decreased mean corpuscular hemoglobin concentration|decreased hemoglobin content|decreased T cell number,-,927.643.784.786.642,-430.744.410.625.592,n,-,-,-,-,-,-
PLAGL1,HGNC:9046,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1100874,-,-,-,-,927.643.784.786.642,494.485.067.549.513,n,-,-,-,-,-,-
PLAGL2,HGNC:9047,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1933165,-,-,-,-,742.115.027.829.314,-149.879.283.523.849,n,-,-,-,-,-,-
POU2F1,HGNC:9212,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101898,-,-,-,-,769.944.341.372.913,-254.971.523.334.899,n,-,-,-,-,-,-
POU2F2,HGNC:9213,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101897,-,-,-,-,185.528.756.957.328,773.013.140.289.203,n,-,-,-,-,-,-
POU4F1,HGNC:9218,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102525,-,-,-,-,927.643.784.786.642,226.226.427.461.374,n,omim_disease,"ATAXIA, INTENTION TREMOR, AND HYPOTONIA SYNDROME, CHILDHOOD-ONSET",dd,"POU4F1-related ataxia, intention tremor, and hypotonia syndrome",strong,monoallelic_autosomal
POU5F1,HGNC:9221,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,-,-,-,-,-,-,278.293.135.435.993,-637.327.090.536.664,n,-,-,-,-,-,-
PPARD,HGNC:9235,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:101884,-,-,-,-,185.528.756.957.328,-99.254.268.715.225,n,-,-,-,-,-,-
PRDM1,HGNC:9346,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99655,lethal,"preweaning lethality, complete penetrance",-,-,176.252.319.109.462,-828.925.008.902.049,n,-,-,-,-,-,-
PRDM16,HGNC:14000,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1917923,-,-,-,-,185.528.756.957.328,-709.090.012.588.792,n,omim_disease,LEFT VENTRICULAR NONCOMPACTION 8,-,-,-,-
PROP1,HGNC:9455,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109330,-,-,-,-,927.643.784.786.642,-964.998.930.216.208,n,omim_disease,"PITUITARY HORMONE DEFICIENCY, COMBINED, 2",dd,PROP1-RELATED COMBINED PITUITARY HORMONE DEFICIENCY,definitive,biallelic_autosomal
PROX1,HGNC:9459,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97772,-,-,-,-,278.293.135.435.993,-165.929.514.144.271,n,-,-,-,-,-,-
PRRX1,HGNC:9142,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97712,-,-,-,-,278.293.135.435.993,-381.230.113.614.157,n,omim_disease,AGNATHIA-OTOCEPHALY COMPLEX,dd,AGNATHIA-OTOCEPHALY COMPLEX monoallelic|AGNATHIA-OTOCEPHALY COMPLEX biallelic,limited|limited,monoallelic_autosomal|biallelic_autosomal
PTF1A,HGNC:23734,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1328312,-,-,-,-,0,-221.461.609.801.487,n,omim_disease,PANCREATIC AGENESIS 2|PANCREATIC AND CEREBELLAR AGENESIS,dd,"DIABETES MELLITUS, PERMANENT NEONATAL, WITH CEREBELLAR AGENESIS|PANCREATIC AGENESIS",definitive|definitive,biallelic_autosomal|biallelic_autosomal
RARA,HGNC:9864,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:97856,-,-,-,-,834.879.406.307.978,-54.034.377.423.958,n,omim_disease,ACUTE PROMYELOCYTIC LEUKEMIA,-,-,-,-
RAX,HGNC:18662,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109632,-,-,-,-,371.057.513.914.657,-262.420.783.681.423,n,omim_disease,"MICROPHTHALMIA, SYNDROMIC 16",dd,MICROPHTHALMIA ISOLATED TYPE 3,definitive,biallelic_autosomal
RBPJ,HGNC:5724,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:96522,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",increased grip strength|improved glucose tolerance|increased circulating bilirubin level|decreased circulating HDL cholesterol level,-,185.528.756.957.328,-597.120.282.695.333,n,omim_disease,ADAMS-OLIVER SYNDROME 3,dd,ADAMS OLIVER SYNDROME,strong,monoallelic_autosomal
RELA,HGNC:9955,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103290,-,-,-,-,276.437.847.866.419,-410.445.717.541.205,n,omim_disease,"MUCOCUTANEOUS ULCERATION, CHRONIC",-,-,-,-
RELB,HGNC:9956,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:103289,-,-,-,-,148.423.005.565.863,-688.446.501.837.145,n,omim_disease,IMMUNODEFICIENCY 53,-,-,-,-
REST,HGNC:9966,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104897,lethal,"preweaning lethality, complete penetrance",abnormal auditory brainstem response|decreased heart rate|decreased mean platelet volume,-,324.675.324.675.325,-198.926.555.965.362,n,omim_disease,"DEAFNESS, AUTOSOMAL DOMINANT 27|FIBROMATOSIS, GINGIVAL, 5|WILMS TUMOR 6",-,-,-,-
RFX1,HGNC:9982,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:105982,-,-,-,-,185.528.756.957.328,-799.285.654.688.752,n,-,-,-,-,-,-
RFX3,HGNC:9984,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:106582,-,-,-,-,0,943.597.345.236.449,n,-,-,-,-,-,-
RFX6,HGNC:21478,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2445208,lethal,"preweaning lethality, complete penetrance",hydrometra|abnormal uterus morphology|impaired glucose tolerance,-,463.821.892.393.321,-331.720.252.608.153,n,omim_disease,MITCHELL-RILEY SYNDROME,dd,MARTINEZ-FRIAS SYNDROME,definitive,biallelic_autosomal
RORA,HGNC:10258,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:104661,subviable,"preweaning lethality, incomplete penetrance",increased circulating alkaline phosphatase level,-,927.643.784.786.642,253.358.876.514.957,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA,dd,INTELLECTUAL DISABILITY,strong,monoallelic_autosomal
RUNX2,HGNC:10472,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99829,-,-,abnormal clavicle morphology|abnormal cranium morphology|abnormal pelvic girdle bone morphology|abnormal vertebrae morphology|abnormal bone structure|abnormal zygomatic bone morphology|increased lean body mass|abnormal humerus morphology|abnormal vertebral arch morphology|decreased bone mineral content,-,473.098.330.241.187,-211.587.764.473.237,n,omim_disease,CLEIDOCRANIAL DYSPLASIA 1|METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY,dd,CLEIDOCRANIAL DYSPLASIA,definitive,monoallelic_autosomal
RXRA,HGNC:10477,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98214,-,-,-,-,25.974.025.974.026,-109.589.597.061.201,n,-,-,-,-,-,-
RXRB,HGNC:10478,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98215,-,-,-,-,927.643.784.786.642,-177.936.869.037.667,n,-,-,-,-,-,-
SAFB,HGNC:10520,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2146974,-,-,-,-,547.309.833.024.119,-221.047.569.247.615,n,-,-,-,-,-,-
SALL1,HGNC:10524,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1889585,-,-,-,-,556.586.270.871.985,-328.572.965.214.383,n,omim_disease,TOWNES-BROCKS SYNDROME 1,dd,TOWNES-BROCKS SYNDROME,definitive,monoallelic_autosomal
SALL3,HGNC:10527,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109295,-,-,-,-,0,-393.690.213.430.246,n,-,-,-,-,-,-
SALL4,HGNC:15924,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2139360,-,-,-,-,834.879.406.307.978,-835.614.732.458.469,n,omim_disease,IVIC SYNDROME|DUANE-RADIAL RAY SYNDROME,dd,DUANE-RADIAL RAY SYNDROME,definitive,monoallelic_autosomal
SATB1,HGNC:10541,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:105084,lethal|subviable,"preweaning lethality, incomplete penetrance|preweaning lethality, complete penetrance",increased bone mineral content|increased bone mineral density|increased exploration in new environment|hyperactivity|increased circulating aspartate transaminase level|abnormal auditory brainstem response|abnormal vitreous body morphology,-,927.643.784.786.642,-492.397.457.360.863,n,omim_disease,DEVELOPMENTAL DELAY WITH DYSMORPHIC FACIES AND DENTAL ANOMALIES|KOHLSCHUTTER-TONZ SYNDROME-LIKE,dd,SATB1-related developmental disorder (monoallelic),moderate,monoallelic_autosomal
SATB2,HGNC:21637,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2679336,lethal,"abnormal craniofacial morphology|preweaning lethality, complete penetrance",enlarged lymph nodes|abnormal uterus morphology|increased mean corpuscular volume|increased circulating alkaline phosphatase level,-,120.593.692.022.263,786.911.006.036.946,n,omim_disease,GLASS SYNDROME,dd,GLASS SYNDROME,definitive,monoallelic_autosomal
SETDB1,HGNC:10761,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1934229,lethal,"preweaning lethality, complete penetrance","neoplasm|hyperplasia|increased bone mineral density|increased CD4-positive, alpha beta T cell number|increased startle reflex",-,336.734.693.877.551,-428.262.290.683.249,n,-,-,-,-,-,-
SHOX2,HGNC:10854,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1201673,lethal,"preweaning lethality, complete penetrance|prenatal lethality prior to heart atrial septation",decreased thigmotaxis,-,927.643.784.786.642,-194.317.562.980.606,n,-,-,-,-,-,-
SIM1,HGNC:10882,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98306,-,-,-,-,927.643.784.786.642,-383.605.856.740.977,n,-,-,dd,Severe obesity with neurobehavioral features,definitive,monoallelic_autosomal
SIM2,HGNC:10883,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98307,-,-,-,-,185.528.756.957.328,124.646.535.614.961,n,-,-,-,-,-,-
SIX1,HGNC:10887,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102780,lethal,"edema|preweaning lethality, complete penetrance|embryonic growth retardation|abnormal blood vessel morphology|abnormal craniofacial morphology|abnormal placenta morphology",abnormal spleen morphology|enlarged spleen|abnormal skin morphology|abnormal placenta morphology|decreased prepulse inhibition|decreased heart rate|abnormal heart morphology|small spleen|abnormal blood vessel morphology|edema|enlarged heart|abnormal kidney morphology|abnormal placenta vasculature|abnormal uterus morphology|decreased leukocyte cell number|prolonged RR interval|decreased circulating calcium level|enlarged kidney|small kidney,-,25.974.025.974.026,-197.698.559.243.281,n,omim_disease,"BRANCHIOOTIC SYNDROME 3|DEAFNESS, AUTOSOMAL DOMINANT 23",dd,BRANCHIOOTIC SYNDROME TYPE 3|Non-syndromic craniosynostosis,definitive|strong,monoallelic_autosomal|monoallelic_autosomal
SKI,HGNC:10896,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98310,lethal,"preweaning lethality, complete penetrance",-,-,927.643.784.786.642,-254.047.304.187.907,n,omim_disease,SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME,dd,SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME,definitive,monoallelic_autosomal
SKIL,HGNC:10897,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106203,subviable,"preweaning lethality, incomplete penetrance|increased heart left ventricle size",-,-,185.528.756.957.328,-123.674.648.968.874,n,-,-,-,-,-,-
SMAD1,HGNC:6767,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:109452,-,-,-,-,0,8.566.108.960.022,n,-,-,-,-,-,-
SMAD5,HGNC:6771,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1328787,-,-,-,-,NA,NA,-,-,-,-,-,-,-
SNAI1,HGNC:11128,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98330,-,-,-,-,927.643.784.786.642,797.930.710.270.548,n,-,-,-,-,-,-
SOX2,HGNC:11195,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98364,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",abnormal optic disk morphology|abnormal retina blood vessel morphology|atrophy|developmental dysplasia|enhanced contextual conditioning behavior|irregularly shaped pupil|abnormal brain morphology,-,454.545.454.545.455,-183.271.405.815.709,n,omim_disease,"MICROPHTHALMIA, SYNDROMIC 3",dd,MICROPHTHALMIA SYNDROMIC TYPE 3,definitive,monoallelic_autosomal
SOX3,HGNC:11199,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98365,-,-,-,-,185.528.756.957.328,-353.070.703.341.068,n,omim_disease,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, WITH PANHYPOPITUITARISM|PANHYPOPITUITARISM, X-LINKED",dd,SEX REVERSAL TYPE 3|INTELLECTUAL DEVELOPMENTAL DISORDER X-LINKED WITH ISOLATED GROWTH HORMONE DEFICIENCY,definitive|definitive,monoallelic_X_het|monoallelic_X_hem
SOX4,HGNC:11200,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98366,lethal,"abnormal neural tube morphology|abnormal heart morphology|preweaning lethality, complete penetrance|abnormal neural tube closure|abnormal hindbrain development",abnormal uterus morphology|abnormal brain morphology|decreased brain size|enlarged gallbladder|enlarged uterus|abnormal gallbladder morphology,-,194.805.194.805.195,-659.184.075.448.784,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY AND DYSMORPHIC FACIES,dd,Neurodevelopmental Disease Associated with Mild Dysmorphism,strong,monoallelic_autosomal
SOX5,HGNC:11201,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98367,-,-,-,-,556.586.270.871.985,-414.424.094.438.337,n,omim_disease,LAMB-SHAFFER SYNDROME,dd,12P12.5 INTRAGENIC DELETIONS ASSOCIATED WITH INTELLECTUAL DISABILITY,strong,monoallelic_autosomal
SOX6,HGNC:16421,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98368,-,-,-,-,0,764.068.798.748.644,n,omim_disease,TOLCHIN-LE CAIGNEC SYNDROME,dd,SOX6-related neurodevelopmental syndrome,strong,monoallelic_autosomal
SOX9,HGNC:11204,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98371,-,-,-,-,147.495.361.781.076,-284.945.909.075.364,n,omim_disease,CAMPOMELIC DYSPLASIA,dd,PIERRE ROBIN SEQUENCE|CAMPOMELIC DYSPLASIA,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
SOX10,HGNC:11190,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98358,-,-,-,-,100.185.528.756.957,-303.838.923.934.319,n,omim_disease,"PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE|WAARDENBURG SYNDROME, TYPE 2E|WAARDENBURG SYNDROME, TYPE 4C",dd,"PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATING LEUKODYSTROPHY, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE|YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME|WAARDENBURG SYNDROME TYPE 2E",definitive|definitive|definitive,monoallelic_autosomal|monoallelic_autosomal|monoallelic_autosomal
SOX11,HGNC:11191,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98359,-,-,-,-,166.975.881.261.596,-29.995.769.480.099,n,omim_disease,INTELLECTUAL DEVELOPMENTAL DISORDER WITH MICROCEPHALY AND WITH OR WITHOUT OCULAR MALFORMATIONS OR HYPOGONADOTROPIC HYPOGONADISM,dd,SOX11-related neurodevelopmental disorder,definitive,monoallelic_autosomal
SOX17,HGNC:18122,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107543,-,-,-,-,12.987.012.987.013,-346.925.712.253.706,n,omim_disease,VESICOURETERAL REFLUX 3,dd,VESICOURETERAL REFLUX TYPE 3,definitive,monoallelic_autosomal
SOX18,HGNC:11194,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103559,viable,increased circulating sodium level|decreased thigmotaxis|abnormal behavior|increased circulating alkaline phosphatase level|increased mean corpuscular hemoglobin,-,-,0,62.059.763.243.628,n,omim_disease,HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME|HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME,-,-,-,-
SP1,HGNC:11205,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98372,-,-,-,-,946.196.660.482.375,-212.352.698.193.885,n,-,-,-,-,-,-
SP2,HGNC:11207,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1926162,-,-,-,-,593.692.022.263.451,-249.605.411.844.875,n,-,-,-,-,-,-
SP3,HGNC:11208,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1277166,-,-,-,-,649.350.649.350.649,-145.978.625.485.127,n,-,-,-,-,-,-
SP4,HGNC:11209,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107595,-,-,-,-,0,554.048.362.879.598,n,-,-,-,-,-,-
SP7,HGNC:17321,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2153568,-,-,-,-,463.821.892.393.321,-14.700.328.154.335,n,omim_disease,"OSTEOGENESIS IMPERFECTA, TYPE XII",-,-,-,-
SPDEF,HGNC:17257,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1353422,-,-,-,-,157.699.443.413.729,-703.064.448.988.547,n,-,-,-,-,-,-
SPEN,HGNC:17575,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1891706,-,-,-,-,927.643.784.786.642,-678.627.195.167.257,n,omim_disease,RADIO-TARTAGLIA SYNDROME,dd,SPEN-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
SPIC,HGNC:29549,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1341168,-,-,-,-,454.545.454.545.455,-275.783.641.866.733,n,-,-,-,-,-,-
SREBF1,HGNC:11289,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107606,-,-,-,-,189.239.332.096.475,-316.018.840.189.272,n,omim_disease,"IFAP SYNDROME 2|MUCOEPITHELIAL DYSPLASIA, HEREDITARY",-,-,-,-
SREBF2,HGNC:11290,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:107585,-,-,-,-,417.439.703.153.989,-79.985.292.361.302,n,-,-,-,-,-,-
SRF,HGNC:11291,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:106658,-,-,-,-,631.725.417.439.703,-617.181.924.301.804,y,-,-,-,-,-,-
STAT1,HGNC:11362,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103063,viable,increased neutrophil cell number|increased monocyte cell number|decreased lymphocyte cell number|decreased mean corpuscular volume|enlarged lymph nodes|increased lymphocyte cell number|increased eosinophil cell number|decreased mean corpuscular hemoglobin|abnormal gait|increased large unstained cell number|increased basophil cell number|decreased bone mineral content|decreased circulating alkaline phosphatase level|increased leukocyte cell number|impaired righting response,-,-,927.643.784.786.642,113.198.649.367.498,n,omim_disease,IMMUNODEFICIENCY 31A|IMMUNODEFICIENCY 31B|IMMUNODEFICIENCY 31C,-,-,-,-
STAT3,HGNC:11364,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103038,-,-,-,-,166.975.881.261.596,-116.669.798.825.098,n,omim_disease,"AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1|HYPER-IgE RECURRENT INFECTION SYNDROME 1, AUTOSOMAL DOMINANT",-,-,-,-
STAT5A,HGNC:11366,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103036,-,-,-,-,352.504.638.218.924,-234.254.480.646.256,n,-,-,-,-,-,-
STAT5B,HGNC:11367,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103035,-,-,-,-,166.975.881.261.596,-164.155.843.381.148,n,omim_disease,"GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 1, AUTOSOMAL RECESSIVE|GROWTH HORMONE INSENSITIVITY SYNDROME WITH IMMUNE DYSREGULATION 2, AUTOSOMAL DOMINANT",dd,GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY,strong,biallelic_autosomal
TAL1,HGNC:11556,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98480,-,-,-,-,0,-105.236.865.964.249,n,-,-,-,-,-,-
TAL2,HGNC:11557,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99540,-,-,-,-,0,124.298.874.204.394,n,-,-,-,-,-,-
TBP,HGNC:11588,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:101838,-,-,-,-,970.315.398.886.827,-94.021.497.115.274,y,omim_disease,"SPINOCEREBELLAR ATAXIA 17|PARKINSON DISEASE, LATE-ONSET",-,-,-,-
TBX1,HGNC:11592,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98493,lethal,"preweaning lethality, complete penetrance|abnormal placenta morphology",persistence of hyaloid vascular system|anophthalmia|abnormal placenta morphology|abnormal pancreas morphology|abnormal skin morphology|abnormal eye morphology,-,157.699.443.413.729,-167.873.239.579.078,n,omim_disease,CONOTRUNCAL HEART MALFORMATIONS|DIGEORGE SYNDROME|TETRALOGY OF FALLOT|VELOCARDIOFACIAL SYNDROME,dd,22Q11.2 DELETION SYNDROME,definitive,monoallelic_autosomal
TBX2,HGNC:11597,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98494,-,-,-,-,176.252.319.109.462,-163.180.895.363.445,n,omim_disease,VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION,-,-,-,-
TBX3,HGNC:11602,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98495,-,embryonic lethality prior to organogenesis,microphthalmia|abnormal spleen morphology|abnormal eye morphology|abnormal lymph node morphology|increased grip strength|enlarged spleen,-,176.252.319.109.462,-140.199.662.206.134,n,omim_disease,ULNAR-MAMMARY SYNDROME,dd,ULNAR-MAMMARY SYNDROME,definitive,monoallelic_autosomal
TBX4,HGNC:11603,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102556,lethal,"preweaning lethality, complete penetrance|abnormal embryo size|embryonic lethality prior to tooth bud stage|pale yolk sac",developmental dysplasia|hyperplasia|arthrosis,-,0,-574.160.333.818.574,n,omim_disease,"AMELIA, POSTERIOR, WITH PELVIC AND PULMONARY HYPOPLASIA SYNDROME|ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION",dd,SMALL PATELLA SYNDROME|Posterior Amelia with Pelvic and Pulmonary Hypoplasia,definitive|limited,monoallelic_autosomal|biallelic_autosomal
TBX5,HGNC:11604,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102541,-,-,-,-,0,-232.605.403.245.213,n,omim_disease,HOLT-ORAM SYNDROME,dd,HOLT-ORAM SYNDROME,definitive,monoallelic_autosomal
TBX6,HGNC:11605,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:102539,-,-,-,-,278.293.135.435.993,-118.257.054.415.454,n,omim_disease,SPONDYLOCOSTAL DYSOSTOSIS 5,-,-,-,-
TBX10,HGNC:11593,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1261436,viable,-,-,-,120.593.692.022.263,-164.655.457.639.484,n,-,-,-,-,-,-
TBX15,HGNC:11594,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1277234,-,-,-,-,556.586.270.871.985,-107.374.604.783.451,n,omim_disease,COUSIN SYNDROME,dd,"Cousin Syndrome; Craniofacial Dysmorphism, Hypoplasia of Scapula and Pelvis, and Short Stature",definitive,biallelic_autosomal
TBX18,HGNC:11595,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1923615,-,-,-,-,278.293.135.435.993,456.325.998.495.096,n,omim_disease,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2,dd,CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2,strong,monoallelic_autosomal
TBX20,HGNC:11598,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1888496,lethal,"hemorrhage|abnormal heart morphology|abnormal neural tube closure|abnormal blood vessel morphology|abnormal visceral yolk sac morphology|prenatal lethality prior to heart atrial septation|abnormal vitelline vasculature morphology|abnormal heart looping|preweaning lethality, complete penetrance|abnormal pharyngeal arch morphology|abnormal forebrain development|abnormal embryo turning|abnormal neural tube morphology",small heart|increased neutrophil cell number|abnormal placenta morphology|decreased circulating serum albumin level|abnormal heart morphology|decreased circulating total protein level,-,0,945.815.261.470.793,n,omim_disease,ATRIAL SEPTAL DEFECT 4,dd,ATRIAL SEPTAL DEFECT TYPE 4,definitive,monoallelic_autosomal
TBX22,HGNC:11600,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2389465,viable,increased mean corpuscular hemoglobin,-,increased circulating HDL cholesterol level,0,634.567.012.847.263,n,omim_disease,"ABRUZZO-ERICKSON SYNDROME|CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED",dd,"CLEFT PALATE, X-LINKED",definitive,monoallelic_X_hem
TCF3,HGNC:11633,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98510,-,-,-,-,333.951.762.523.191,-38.828.190.062.214,n,omim_disease,"AGAMMAGLOBULINEMIA 8A, AUTOSOMAL DOMINANT|AGAMMAGLOBULINEMIA 8B, AUTOSOMAL RECESSIVE",-,-,-,-
TCF7L1,HGNC:11640,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1202876,-,-,abnormal vibrissa morphology|abnormal cornea morphology|increased circulating creatine kinase level|corneal opacity|decreased circulating HDL cholesterol level|abnormal snout morphology|increased leukocyte cell number,-,742.115.027.829.314,-148.688.164.021.411,n,-,-,-,-,-,-
TCF12,HGNC:11623,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101877,-,-,-,-,927.643.784.786.642,-232.116.238.252.538,n,omim_disease,CRANIOSYNOSTOSIS 3|HYPOGONADOTROPIC HYPOGONADISM 26 WITH OR WITHOUT ANOSMIA,dd,TCF12-related neurodevelopmental disorder with coronal craniosynostosis,definitive,monoallelic_autosomal
TCF15,HGNC:11627,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:104664,-,-,-,-,0,97.333.775.316.752,n,-,-,-,-,-,-
TCF21,HGNC:11632,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1202715,lethal,"abnormal blood vessel morphology|edema|abnormal placenta morphology|preweaning lethality, complete penetrance|abnormal placenta vasculature","small spleen|abnormal ovary morphology|edema|enlarged kidney|abnormal kidney morphology|enlarged testis|abnormal testis morphology|preweaning lethality, incomplete penetrance|abnormal spleen morphology|persistence of hyaloid vascular system|microphthalmia|anophthalmia|embryonic growth retardation|abnormal placenta morphology|abnormal eye morphology|increased circulating calcium level",-,927.643.784.786.642,-905.913.928.999.338,n,-,-,-,-,-,-
TEAD1,HGNC:11714,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:101876,lethal,"embryonic lethality prior to tooth bud stage|abnormal embryo size|preweaning lethality, complete penetrance|abnormal embryo turning",decreased prepulse inhibition|decreased cornea thickness|abnormal eye anterior chamber depth|impaired glucose tolerance|increased total body fat amount|abnormal tooth morphology,-,167.903.525.046.382,-23.903.104.272.104,n,omim_disease,SVEINSSON CHORIORETINAL ATROPHY,-,-,-,-
TEAD2,HGNC:11715,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:104904,-,-,-,-,0,-427.872.895.111.329,n,-,-,-,-,-,-
TEAD4,HGNC:11717,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:106907,-,-,-,-,315.398.886.827.458,-192.400.995.384.347,n,-,-,-,-,-,-
TERF1,HGNC:11728,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:109634,-,-,-,-,798.701.298.701.299,-689.646.988.323.544,y,-,-,-,-,-,-
TERF2,HGNC:11729,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1195972,-,-,-,-,NA,NA,-,-,-,-,-,-,-
TET2,HGNC:25941,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2443298,-,-,-,-,0,807.534.770.260.586,n,omim_disease,IMMUNODEFICIENCY 75|MYELODYSPLASTIC SYNDROME,-,-,-,-
TFAP2A,HGNC:11742,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:104671,-,-,-,-,371.057.513.914.657,-169.909.608.723.029,n,omim_disease,BRANCHIOOCULOFACIAL SYNDROME,dd,BRANCHIOOCULOFACIAL SYNDROME,definitive,monoallelic_autosomal
TFAP2B,HGNC:11743,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:104672,lethal,"preweaning lethality, complete penetrance",abnormal optic disk morphology|increased grip strength|iris synechia|corneal deposits,-,12.987.012.987.013,-44.065.699.664.452,n,omim_disease,CHAR SYNDROME|PATENT DUCTUS ARTERIOSUS 2,dd,CHAR SYNDROME,definitive,monoallelic_autosomal
TFAP2C,HGNC:11744,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:106032,-,-,-,-,519.480.519.480.519,-200.245.172.533.781,n,-,-,-,-,-,-
TFAP4,HGNC:11745,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103239,viable,prolonged RR interval|increased lean body mass|enlarged heart|decreased circulating creatinine level|abnormal heart morphology|abnormal lumbar vertebrae morphology|decreased thymus weight|increased mean corpuscular volume|decreased liver weight|decreased circulating glucose level|decreased body length|decreased total body fat amount|abnormal sacral vertebrae morphology|abnormal uterus morphology|decreased heart rate|increased red blood cell distribution width,-,-,173.469.387.755.102,-317.110.191.087.747,n,-,-,-,-,-,-
TFCP2L1,HGNC:17925,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:2444691,-,-,-,-,0,-445.338.626.808.364,n,-,-,-,-,-,-
TFDP1,HGNC:11749,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,-,-,-,-,-,-,551.020.408.163.265,-566.517.961.507.905,y,-,-,-,-,-,-
TFEB,HGNC:11753,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:103270,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",increased lean body mass|decreased circulating alkaline phosphatase level|decreased hemoglobin content|decreased lean body mass|unresponsive to tactile stimuli|increased total body fat amount|trunk curl,-,185.528.756.957.328,214.783.408.083.389,n,-,-,-,-,-,-
TGIF1,HGNC:11776,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1194497,-,-,-,-,575.139.146.567.718,-144.518.247.694.252,n,omim_disease,HOLOPROSENCEPHALY 4,dd,HOLOPROSENCEPHALY,definitive,monoallelic_autosomal
THAP11,HGNC:23194,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1930964,-,-,-,-,493.506.493.506.493,-527.960.715.278.866,y,-,-,-,-,-,-
THRA,HGNC:11796,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98742,subviable,"preweaning lethality, incomplete penetrance",hyperactivity|abnormal contextual conditioning behavior|increased circulating creatinine level|limb grasping|increased blood urea nitrogen level|abnormal heart left ventricle morphology|increased bone mineral density|decreased exploration in new environment|decreased startle reflex|increased bone mineral content|decreased grip strength|increased hematocrit|decreased total retina thickness|abnormal retina inner nuclear layer morphology|increased startle reflex|decreased body length|abnormal bone structure|short tibia|increased vertical activity|improved glucose tolerance|decreased total body fat amount|increased circulating alkaline phosphatase level,-,120.593.692.022.263,-88.993.733.651.304,n,omim_disease,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6",dd,"HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6",definitive,monoallelic_autosomal
TLX2,HGNC:5057,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1350935,-,-,-,-,927.643.784.786.642,131.033.959.222.542,n,-,-,-,-,-,-
TLX3,HGNC:13532,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1351209,-,-,-,-,185.528.756.957.328,-123.568.804.859.665,n,-,-,-,-,-,-
TP53,HGNC:11998,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98834,subviable,"abnormal retina morphology|increased large unstained cell number|increased startle reflex|preweaning lethality, incomplete penetrance|persistence of hyaloid vascular system",decreased circulating creatine kinase level,-,278.293.135.435.993,266.837.954.403.045,n,omim_disease,"BONE MARROW FAILURE SYNDROME 5|BREAST CANCER|HEPATOCELLULAR CARCINOMA|LI-FRAUMENI SYNDROME|PANCREATIC CANCER|ADRENOCORTICAL CARCINOMA, HEREDITARY|BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7|PAPILLOMA OF CHOROID PLEXUS|COLORECTAL CANCER|GLIOMA SUSCEPTIBILITY 1|OSTEOGENIC SARCOMA",-,-,-,-
TP63,HGNC:15979,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1330810,-,-,-,-,834.879.406.307.978,-71.919.014.881.006,n,omim_disease,"ADULT SYNDROME|ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3|ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE|LIMB-MAMMARY SYNDROME|OROFACIAL CLEFT 8|RAPP-HODGKIN SYNDROME|SPLIT-HAND/FOOT MALFORMATION 4",dd,ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE|LIMB-MAMMARY SYNDROME,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
TP73,HGNC:12003,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1336991,subviable,"preweaning lethality, incomplete penetrance",increased eosinophil cell number|thrombocytosis|increased blood urea nitrogen level|decreased spleen weight,-,120.593.692.022.263,-917.427.266.585.757,n,omim_disease,"CILIARY DYSKINESIA, PRIMARY, 47, AND LISSENCEPHALY",dd,TP73-related ciliary dyskinesia and lissencephaly,strong,biallelic_autosomal
TRPS1,HGNC:12340,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1927616,lethal,"preweaning lethality, complete penetrance",decreased fasting circulating glucose level,-,157.699.443.413.729,871.559.060.573.482,n,omim_disease,"TRICHORHINOPHALANGEAL SYNDROME, TYPE I|TRICHORHINOPHALANGEAL SYNDROME, TYPE III",dd,TRICHO-RHINO-PHALANGEAL SYNDROME TYPE 1,definitive,monoallelic_autosomal
TSHZ1,HGNC:10669,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1346031,-,-,-,-,0,437.489.166.565.329,n,omim_disease,"AURAL ATRESIA, CONGENITAL",dd,"AURAL ATRESIA, CONGENITAL",limited,monoallelic_autosomal
TSHZ2,HGNC:13010,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2153084,-,-,-,-,0,-132.941.632.939.495,n,-,-,-,-,-,-
TSHZ3,HGNC:30700,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2442819,-,-,-,-,927.643.784.786.642,612.492.598.041.175,n,-,-,-,-,-,-
TWIST1,HGNC:12428,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98872,-,-,abnormal digit morphology|abnormal vertebrae morphology|abnormal autopod morphology|abnormal nail morphology|decreased total body fat amount|abnormal cranium morphology|abnormal vertebral arch morphology|increased lean body mass|abnormal zygomatic bone morphology|abnormal brain morphology|abnormal pelvic girdle bone morphology|increased grip strength,-,371.057.513.914.657,663.687.341.664.488,n,omim_disease,CRANIOSYNOSTOSIS 1|ROBINOW-SORAUF SYNDROME|SAETHRE-CHOTZEN SYNDROME|SWEENEY-COX SYNDROME,dd,SAETHRE-CHOTZEN SYNDROME,definitive,monoallelic_autosomal
UNCX,HGNC:33194,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:108013,-,-,-,-,0,340.376.523.103.522,n,-,-,-,-,-,-
USF2,HGNC:12594,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99961,-,-,-,-,992.578.849.721.707,-256.949.964.783.885,n,-,-,-,-,-,-
VAX1,HGNC:12660,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1277163,subviable,"preweaning lethality, incomplete penetrance",abnormal sinus arrhythmia|decreased circulating glucose level|increased circulating alkaline phosphatase level,-,0,155.936.267.326.049,n,omim_disease,"MICROPHTHALMIA, SYNDROMIC 11",-,-,-,-
VEZF1,HGNC:12949,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1313291,-,-,-,-,974.025.974.025.974,-263.853.253.057.116,n,-,-,-,-,-,-
VSX2,HGNC:1975,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:88401,-,-,-,-,0,-565.476.633.747.884,n,omim_disease,"MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3|MICROPHTHALMIA, ISOLATED 2",dd,MICROPHTHALMIA WITH CATARACTS AND IRIS ABNORMALITIES|MICROPHTHALMIA ISOLATED TYPE 2,definitive|definitive,biallelic_autosomal|biallelic_autosomal
WT1,HGNC:12796,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98968,-,-,-,-,742.115.027.829.314,24.345.546.991.892,n,omim_disease,"DENYS-DRASH SYNDROME|FRASIER SYNDROME|MEACHAM SYNDROME|MESOTHELIOMA, MALIGNANT|NEPHROTIC SYNDROME, TYPE 4|WILMS TUMOR 1",dd,DENYS-DRASH SYNDROME,definitive,monoallelic_autosomal
XBP1,HGNC:12801,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:98970,lethal,"preweaning lethality, complete penetrance",cataract|increased grip strength|decreased T cell number|abnormal vertebral arch morphology|thrombocytopenia|abnormal lens morphology|vertebral fusion|decreased lymphocyte cell number|abnormal urination|decreased leukocyte cell number|abnormal behavior|increased total body fat amount|abnormal bone mineralization|decreased circulating cholesterol level|increased bone mineral content|decreased red blood cell distribution width|increased mean corpuscular hemoglobin|decreased circulating triglyceride level|persistence of hyaloid vascular system|increased lean body mass|increased body weight|increased mean corpuscular volume|decreased large unstained cell number,-,463.821.892.393.321,-162.123.612.724.038,n,omim_disease,MAJOR AFFECTIVE DISORDER 7,-,-,-,-
XPA,HGNC:12814,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99135,-,-,-,-,371.057.513.914.657,-483.796.691.684.027,n,omim_disease,"XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A",dd,"XERODERMA PIGMENTOSUM, GROUP A",definitive,biallelic_autosomal
YBX1,HGNC:8014,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99146,-,-,-,-,9.860.853.432.282,-111.078.543.091.441,y,-,-,-,-,-,-
YY1,HGNC:12856,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99150,-,-,-,-,847.866.419.294.991,-778.563.930.042.401,y,omim_disease,GABRIELE-DE VRIES SYNDROME,dd,INTELLECTUAL DISABILITY,definitive,monoallelic_autosomal
ZBTB7A,HGNC:18078,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1335091,-,-,-,-,119.666.048.237.477,-275.732.457.038.424,n,omim_disease,"MACROCEPHALY, NEURODEVELOPMENTAL DELAY, LYMPHOID HYPERPLASIA, AND PERSISTENT FETAL HEMOGLOBIN",dd,ZBTB7A-associated developmental disorder,limited,monoallelic_autosomal
ZBTB17,HGNC:12936,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:107410,-,-,-,-,935.992.578.849.722,-852.924.924.701.683,y,-,-,-,-,-,-
ZBTB20,HGNC:13503,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1929213,-,-,-,-,0,477.759.507.321.739,n,omim_disease,PRIMROSE SYNDROME,dd,PRIMROSE SYNDROME,definitive,monoallelic_autosomal
ZEB1,HGNC:11642,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1344313,-,-,-,-,352.504.638.218.924,-568.524.278.125.024,n,omim_disease,"CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6|CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3",dd,CORNEAL DYSTROPHY FUCHS ENDOTHELIAL TYPE 6,limited,monoallelic_autosomal
ZEB2,HGNC:14881,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1344407,-,-,-,-,14.100.185.528.757,-290.487.569.624.046,n,omim_disease,MOWAT-WILSON SYNDROME,dd,MOWAT-WILSON SYNDROME,definitive,monoallelic_autosomal
ZFAT,HGNC:19899,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2681865,lethal,"preweaning lethality, complete penetrance",abnormal tooth morphology|enlarged heart|enlarged thymus|abnormal digit morphology|abnormal thymus morphology|enlarged spleen|abnormal spleen morphology|abnormal heart morphology,-,194.805.194.805.195,-68.724.563.041.573,n,omim_disease,"AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3",-,-,-,-
ZFP42,HGNC:30949,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99187,viable,-,increased heart weight|decreased thigmotaxis|decreased circulating serum albumin level|hyperactivity,-,0,745.974.206.985.075,n,-,-,-,-,-,-
ZFP57,HGNC:18791,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:99204,-,-,-,-,102.040.816.326.531,-133.864.425.029.956,n,omim_disease,"DIABETES MELLITUS, TRANSIENT NEONATAL, 1",dd,"DIABETES MELLITUS, 6Q24-RELATED TRANSIENT NEONATAL",definitive,biallelic_autosomal
ZFPM1,HGNC:19762,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1095400,-,-,-,-,241.187.384.044.527,-110.475.304.600.628,n,-,-,-,-,-,-
ZFPM2,HGNC:16700,approved_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:1334444,-,-,-,-,0,32.113.052.772.911,n,omim_disease,"46,XY SEX REVERSAL 9|DIAPHRAGMATIC HERNIA 3|TETRALOGY OF FALLOT",dd,ZFPM2-associated malformation syndrome|DIAPHRAGMATIC HERNIA 3,limited|limited,monoallelic_autosomal|monoallelic_autosomal
ZFX,HGNC:12869,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:99211,-,-,-,-,177.179.962.894.249,-278.959.498.038.729,n,-,-,-,-,-,-
ZIC1,HGNC:12872,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106683,-,-,-,-,0,647.570.588.823.246,n,omim_disease,CRANIOSYNOSTOSIS 6|STRUCTURAL BRAIN ANOMALIES WITH IMPAIRED INTELLECTUAL DEVELOPMENT AND CRANIOSYNOSTOSIS,dd,CRANIOSYNOSTOSIS 6,definitive,monoallelic_autosomal
ZIC2,HGNC:12873,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106679,-,-,-,-,556.586.270.871.985,-239.086.963.123.493,n,omim_disease,HOLOPROSENCEPHALY 5,dd,HOLOPROSENCEPHALY,definitive,monoallelic_autosomal
ZIC3,HGNC:12874,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:106676,-,-,-,-,0,-155.450.221.635.316,n,omim_disease,"HETEROTAXY, VISCERAL, 1, X-LINKED|VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS",dd,"VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS|HETEROTAXY SYNDROME",definitive|definitive,monoallelic_X_hem|monoallelic_X_hem
ZIC5,HGNC:20322,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1929518,-,-,-,-,185.528.756.957.328,-953.498.667.956.384,n,-,-,-,-,-,-
ZNF24,HGNC:13032,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1929704,-,-,-,-,556.586.270.871.985,-817.859.294.890.675,n,-,-,-,-,-,-
ZNF148,HGNC:12933,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1332234,lethal,"unresponsive to tactile stimuli|abnormal embryo size|preweaning lethality, complete penetrance",abnormal kidney morphology|unresponsive to tactile stimuli|increased bone mineral density|abnormal skin coloration,-,927.643.784.786.642,-497.817.207.933.849,n,omim_disease,"GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES",dd,ZNF148-related developmental disorder (monoallelic),strong,monoallelic_autosomal
ZNF274,HGNC:13068,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1890378,-,-,-,-,NA,NA,-,-,-,-,-,-,-
ZNF335,HGNC:15807,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:2682313,-,-,-,-,990.723.562.152.133,-109.935.660.306.673,y,omim_disease,"MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE",-,-,-,-
ZNF385A,HGNC:17521,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1352495,-,-,-,-,649.350.649.350.649,-151.575.766.732.896,n,-,-,-,-,-,-
ZNF423,HGNC:16762,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1891217,lethal,"preweaning lethality, complete penetrance",increased circulating alkaline phosphatase level|decreased locomotor activity,-,0,102.924.254.701.373,n,omim_disease,NEPHRONOPHTHISIS 14,-,-,-,-
ZNF830,HGNC:28291,approved_symbol,gene_with_protein_product,-,-,NWU,-,-,-,y,MGI:1914233,lethal,"embryonic lethality prior to tooth bud stage|preweaning lethality, complete penetrance",abnormal gait|abnormal retina morphology,-,100,-127.468.600.527.979,y,-,-,-,-,-,-
T,HGNC:11515,previous_symbol,gene_with_protein_product,-,-,NWU,UCSF,-,-,y,MGI:98472,-,-,-,-,NA,NA,-,omim_disease,"SACRAL AGENESIS WITH VERTEBRAL ANOMALIES|NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO",-,-,-,-
ACTL6A,HGNC:24124,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1861453,lethal,"preweaning lethality, complete penetrance",decreased exploration in new environment|decreased mean corpuscular hemoglobin,-,987.012.987.012.987,-152.745.603.964.649,y,-,-,-,-,-,-
ACTL6B,HGNC:160,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1933548,subviable,"female infertility|preweaning lethality, incomplete penetrance",abnormal auditory brainstem response|hyperactivity|increased exploration in new environment,-,0,204.204.223.520.697,n,omim_disease,DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 76|INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS,dd,"EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE|INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS",definitive|limited,biallelic_autosomal|monoallelic_autosomal
ACTR5,HGNC:14671,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1924748,lethal,"preweaning lethality, complete penetrance|abnormal embryo size|abnormal embryo turning|embryonic growth retardation|abnormal midbrain development|abnormal forebrain development|abnormal hindbrain development|embryonic lethality prior to tooth bud stage",increased exploration in new environment,-,974.025.974.025.974,-243.387.421.188.606,n,-,-,-,-,-,-
ACTR6,HGNC:24025,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1914269,lethal,"preweaning lethality, complete penetrance",increased circulating glycerol level,-,761.595.547.309.833,-695.542.676.575.281,y,-,-,-,-,-,-
ACTR8,HGNC:14672,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1860775,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",decreased hemoglobin content|increased circulating sodium level|decreased erythrocyte cell number|decreased hematocrit|decreased bone mineral density,-,935.992.578.849.722,-93.408.511.869.528,y,-,-,-,-,-,-
ANP32E,HGNC:16673,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1913721,-,decreased body weight,-,-,62.152.133.580.705,-274.694.221.442.704,n,-,-,-,-,-,-
ARID2,HGNC:18037,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1924294,lethal,"preweaning lethality, complete penetrance",-,-,227.272.727.272.727,-347.172.159.130.482,n,omim_disease,COFFIN-SIRIS SYNDROME 6,dd,ARID2-Coffin-Siris like disorder,strong,monoallelic_autosomal
ARID3C,HGNC:21209,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3650624,-,-,-,-,278.293.135.435.993,-361.509.470.407.205,n,-,-,-,-,-,-
ARID5A,HGNC:17361,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443039,-,-,-,-,343.228.200.371.058,-219.903.701.747.272,n,-,-,-,-,-,-
ASCL3,HGNC:740,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1928820,-,-,-,-,0,696.979.586.022.307,n,-,-,-,-,-,-
ASCL4,HGNC:24311,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1914591,viable,increased leukocyte cell number|absent vibrissae,-,-,649.350.649.350.649,-540.936.534.836.005,n,-,-,-,-,-,-
ASCL5,HGNC:33169,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2685043,viable,increased circulating creatine kinase level|abnormal heart morphology|abnormal thymus morphology|abnormal digit morphology|abnormal skin morphology|enlarged thymus|increased circulating total protein level|enlarged heart|abnormal spleen morphology,-,-,157.699.443.413.729,-15.866.235.893.724,n,-,-,-,-,-,-
ATF1,HGNC:783,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1298366,-,-,-,-,12.987.012.987.013,-145.690.013.694.408,n,-,-,-,-,-,-
ATF3,HGNC:785,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109384,viable,abnormal retina morphology|decreased locomotor activity,-,-,0,485.135.007.231.839,n,-,-,-,-,-,-
ATF5,HGNC:790,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2141857,-,-,-,-,556.586.270.871.985,-141.383.406.612.416,n,-,-,-,-,-,-
ATF6,HGNC:791,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1926157,-,-,-,-,12.987.012.987.013,-947.974.411.046.704,n,omim_disease,ACHROMATOPSIA 7,-,-,-,-
ATF6B,HGNC:2349,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:105121,subviable,"preweaning lethality, incomplete penetrance",abnormal skin morphology|scaly skin,-,742.115.027.829.314,-129.447.494.660.419,n,-,-,-,-,-,-
ATF7,HGNC:792,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443472,viable,increased startle reflex|decreased prepulse inhibition|increased bone mineral density|persistence of hyaloid vascular system,-,-,473.098.330.241.187,-22.408.493.994.992,n,-,-,-,-,-,-
BAZ1A,HGNC:960,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1309478,viable,male infertility|increased mean platelet volume|increased grip strength|dysplasia|aspermia|decreased exploration in new environment|decreased mean corpuscular hemoglobin|decreased mean corpuscular hemoglobin concentration|abnormal stomach morphology|spermatogenesis defect,-,-,102.040.816.326.531,-126.274.629.579.715,n,-,-,-,-,-,-
BAZ1B,HGNC:961,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1353499,-,decreased body weight,abnormal startle reflex|decreased circulating total protein level|decreased body weight|decreased circulating HDL cholesterol level|decreased circulating cholesterol level|increased circulating chloride level,-,909.090.909.090.909,-285.104.253.416.462,n,-,-,-,-,-,-
BAZ2A,HGNC:962,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2151152,viable,increased circulating alkaline phosphatase level|increased blood urea nitrogen level|small epididymis|spermatogenesis defect|increased circulating sodium level|compression|dysplasia|small kidney|hypospermia|hypertrophy|hyperplasia|abnormal spleen morphology|decreased fasting circulating glucose level|abnormal skin morphology|small testis,-,-,834.879.406.307.978,-91.168.358.589.857,n,-,-,-,-,-,-
BRD7,HGNC:14310,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1349766,-,-,tremors|increased circulating glucose level|increased blood uric acid level|abnormal behavior|decreased circulating LDL cholesterol level|abnormal coat/ hair morphology|abnormal vocalization|decreased leukocyte cell number|decreased body weight,-,890.538.033.395.176,-281.651.039.482.855,n,-,-,-,-,-,-
BRD8,HGNC:19874,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1925906,lethal,"preweaning lethality, complete penetrance",abnormal behavior,-,366.419.294.990.724,-441.348.899.775.406,n,-,-,-,-,-,-
BRD9,HGNC:25818,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2145317,lethal,"preweaning lethality, complete penetrance",cataract|enlarged urinary bladder|abnormal seminal vesicle morphology|decreased bone mineral content|small adrenal glands|increased neutrophil cell number|small uterus|abnormal skin morphology,-,204.081.632.653.061,406.624.002.740.935,n,-,-,-,-,-,-
CBX3,HGNC:1553,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:108515,-,-,-,-,371.057.513.914.657,-77.819.385.602.397,n,-,-,-,-,-,-
CDX1,HGNC:1805,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:88360,-,-,-,-,0,594.593.951.517.647,n,-,-,-,-,-,-
CDX4,HGNC:1808,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:88362,-,-,-,-,0,-815.028.087.585.931,n,-,-,-,-,-,-
CEBPD,HGNC:1835,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103573,-,-,-,-,176.252.319.109.462,-187.821.173.031.872,n,-,-,-,-,-,-
CEBPE,HGNC:1836,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103572,-,-,-,-,927.643.784.786.642,-155.009.914.405.648,n,omim_disease,IMMUNODEFICIENCY 108 WITH AUTOINFLAMMATION|SPECIFIC GRANULE DEFICIENCY 1,-,-,-,-
CEBPZ,HGNC:24218,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109386,-,-,increased total body fat amount,-,970.315.398.886.827,-100.095.865.529.979,y,-,-,-,-,-,-
CECR2,HGNC:1840,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1923799,lethal,"abnormal hindbrain morphology|preweaning lethality, complete penetrance|abnormal forebrain morphology|abnormal craniofacial morphology|abnormal midbrain morphology|abnormal neural tube closure",abnormal neural tube closure|increased circulating alkaline phosphatase level|enlarged lymph nodes|abnormal QT variability|abnormal midbrain morphology|abnormal forebrain morphology|decreased exploration in new environment|abnormal hindbrain morphology,-,NA,NA,-,-,-,-,-,-,-
CENPB,HGNC:1852,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:88376,-,-,-,-,102.040.816.326.531,-355.686.218.014.995,n,-,-,-,-,-,-
CENPS,HGNC:23163,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1917178,viable,-,-,-,NA,NA,-,-,-,-,-,-,-
CENPT,HGNC:25787,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443939,subviable,"preweaning lethality, incomplete penetrance|preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",decreased heart rate|increased cornea thickness,-,763.450.834.879.406,-649.534.565.823.753,y,omim_disease,SHORT STATURE AND MICROCEPHALY WITH GENITAL ANOMALIES,-,-,-,-
CENPX,HGNC:11422,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:894324,subviable,"decreased locomotor activity|preweaning lethality, incomplete penetrance",-,-,106.679.035.250.464,-268.110.756.368.495,n,-,-,-,-,-,-
CHD3,HGNC:1918,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1344395,viable,hyperactivity|decreased circulating phosphate level,-,-,927.643.784.786.642,-702.898.615.247.057,n,omim_disease,SNIJDERS BLOK-CAMPEAU SYNDROME,dd,Macrocephaly and impaired speech and language,strong,monoallelic_autosomal
CHD4,HGNC:1919,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1344380,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",-,-,951.762.523.191.095,-112.429.779.433.378,y,omim_disease,SIFRIM-HITZ-WEISS SYNDROME,dd,Syndromic INTELLECTUAL DISABILITY with or without congenital heart disease,definitive,monoallelic_autosomal
CHD7,HGNC:20626,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2444748,-,-,decreased body weight|decreased lean body mass|decreased body length|abnormal locomotor activation|increased circulating glucose level,-,185.528.756.957.328,-201.249.088.263.901,n,omim_disease,CHARGE SYNDROME|HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA,dd,CHARGE SYNDROME,definitive,monoallelic_autosomal
CHRAC1,HGNC:13544,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2135796,viable,-,-,-,194.805.194.805.195,-129.485.389.149.113,n,-,-,-,-,-,-
CREB3,HGNC:2347,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99946,subviable,"preweaning lethality, incomplete penetrance",decreased brain weight|hyperactivity|enlarged epididymis|decreased body length|abnormal epididymis morphology,-,463.821.892.393.321,-116.658.373.006.912,n,-,-,-,-,-,-
CREB3L1,HGNC:18856,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347062,viable,-,increased circulating alkaline phosphatase level,-,0,786.157.061.358.873,n,omim_disease,"OSTEOGENESIS IMPERFECTA, TYPE XVI",-,-,-,-
CREB3L3,HGNC:18855,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2384786,-,-,-,-,927.643.784.786.642,38.821.546.115.351,n,omim_disease,HYPERTRIGLYCERIDEMIA 2,-,-,-,-
CREB3L4,HGNC:18854,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1916603,-,-,-,-,927.643.784.786.642,-620.728.117.857.717,n,-,-,-,-,-,-
CREBL2,HGNC:2350,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1889385,-,-,-,-,0,260.940.269.803.515,n,-,-,-,-,-,-
CREBZF,HGNC:24905,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2675296,viable,decreased grip strength,-,-,185.528.756.957.328,-689.298.732.802.224,n,-,-,-,-,-,-
DDX21,HGNC:2744,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1860494,lethal,"preweaning lethality, complete penetrance",increased cornea thickness,-,978.664.192.949.907,-103.055.171.178.001,y,-,-,-,-,-,-
DEK,HGNC:2768,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1926209,-,-,-,-,0,968.993.054.433.301,n,-,-,-,-,-,-
DMAP1,HGNC:18291,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1913483,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",-,-,989.795.918.367.347,-106.862.090.317.061,y,-,-,-,-,-,-
DPF1,HGNC:20225,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1352748,viable,hyperactivity|decreased grip strength,-,-,0,-336.140.336.919.364,n,-,-,-,-,-,-
DPF2,HGNC:9964,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109529,lethal,"preweaning lethality, complete penetrance|abnormal embryo size|edema|abnormal craniofacial morphology|abnormal limb morphology|abnormal heart morphology|abnormal tail morphology|pallor",abnormal seminal vesicle morphology|abnormal kidney morphology,-,336.734.693.877.551,-413.870.887.670.058,n,omim_disease,COFFIN-SIRIS SYNDROME 7,dd,Coffin Siris like disorder,strong,monoallelic_autosomal
DPF3,HGNC:17427,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1917377,viable,decreased bone mineral content|decreased locomotor activity|decreased circulating calcium level|decreased prepulse inhibition|decreased grip strength,-,-,0,712.229.663.953.301,n,-,-,-,-,-,-
DUX1,HGNC:3079,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
DUX3,HGNC:3081,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
DUX4,HGNC:50800,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
DUXA,HGNC:32179,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,125.231.910.946.197,-35.466.955.120.326,n,-,-,-,-,-,-
ELF1,HGNC:3316,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107180,-,-,-,-,556.586.270.871.985,-115.277.452.477.344,n,-,-,-,-,-,-
ELF2,HGNC:3317,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1916507,-,-,-,-,454.545.454.545.455,-224.789.751.557.461,n,-,-,-,-,-,-
ELF4,HGNC:3319,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1928377,-,-,-,-,371.057.513.914.657,-396.807.621.346.634,n,omim_disease,"AUTOINFLAMMATORY SYNDROME, FAMILIAL, X-LINKED, BEHCET-LIKE 2",-,-,-,-
EP400,HGNC:11958,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1276124,lethal,"preweaning lethality, complete penetrance",-,-,980.519.480.519.481,-103.873.819.346.089,y,-,-,-,-,-,-
ERCC6,HGNC:3438,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1100494,-,-,-,-,927.643.784.786.642,-615.309.527.759.495,n,omim_disease,"DE SANCTIS-CACCHIONE SYNDROME|CEREBROOCULOFACIOSKELETAL SYNDROME 1|COCKAYNE SYNDROME B|PREMATURE OVARIAN FAILURE 11|UV-SENSITIVE SYNDROME 1|LUNG CANCER|MACULAR DEGENERATION, AGE-RELATED, 5",dd,UV-SENSITIVE SYNDROME,definitive,biallelic_autosomal
ESR1,HGNC:3467,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1352467,-,-,-,-,111.317.254.174.397,-736.530.348.836.975,n,omim_disease,"BREAST CANCER|ESTROGEN RESISTANCE|MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO",-,-,-,-
ESR2,HGNC:3468,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109392,-,increased total body fat amount|decreased bone mineral content|decreased bone mineral density|decreased leukocyte cell number|decreased lean body mass|thin ventricular wall|decreased lymphocyte cell number|increased circulating serum albumin level,-,-,278.293.135.435.993,-320.286.624.659.261,n,omim_disease,OVARIAN DYSGENESIS 8,-,-,-,-
ESRRA,HGNC:3471,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1346831,viable,increased grip strength|hyperactivity|increased startle reflex|increased mean corpuscular hemoglobin concentration|shortened PQ interval|decreased vertical activity|increased circulating alanine transaminase level,-,-,154.916.512.059.369,-320.395.450.949.048,n,-,-,-,-,-,-
ETV1,HGNC:3490,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99254,-,-,-,-,927.643.784.786.642,658.281.679.231.647,n,-,-,-,-,-,-
ETV3,HGNC:3492,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1350926,viable,-,-,-,556.586.270.871.985,-463.200.814.189.693,n,-,-,-,-,-,-
ETV3L,HGNC:33834,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3646099,-,-,-,-,927.643.784.786.642,-348.153.116.341.381,n,-,-,-,-,-,-
ETV4,HGNC:3493,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99423,-,-,-,-,927.643.784.786.642,-230.628.868.041.173,n,-,-,-,-,-,-
ETV7,HGNC:18160,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,185.528.756.957.328,-202.559.384.275.696,n,-,-,-,-,-,-
FOXA3,HGNC:5023,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347477,-,-,-,-,927.643.784.786.642,-481.304.467.033.742,n,-,-,-,-,-,-
FOXB2,HGNC:23315,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347468,-,-,-,-,0,-457.424.233.680.325,n,-,-,-,-,-,-
FOXD2,HGNC:3803,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347471,-,-,-,-,0,-167.890.126.968.983,n,-,-,-,-,-,-
FOXD4,HGNC:3805,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,968.460.111.317.254,-110.473.933.236.355,y,-,-,-,-,-,-
FOXD4L1,HGNC:18521,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXD4L3,HGNC:18523,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXD4L4,HGNC:23762,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXD4L5,HGNC:18522,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXD4L6,HGNC:31986,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXE3,HGNC:3808,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1353569,viable,abnormal testis morphology|abnormal eye morphology|hyperactivity|microphthalmia|increased vertical activity|corneal opacity|small testis|abnormal skin morphology|anophthalmia|increased exploration in new environment,-,-,0,-263.447.824.217.337,n,omim_disease,"ANTERIOR SEGMENT DYSGENESIS 2|CATARACT 34, MULTIPLE TYPES|AORTIC ANEURYSM, FAMILIAL THORACIC 11, SUSCEPTIBILITY TO",dd,CONGENITAL PRIMARY APHAKIA|ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS,definitive|definitive,biallelic_autosomal|monoallelic_autosomal
FOXI2,HGNC:32448,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3028075,viable,decreased circulating glucose level,-,-,0,741.744.983.392.361,n,-,-,-,-,-,-
FOXI3,HGNC:35123,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3511278,-,-,-,-,NA,NA,-,-,-,dd,FOXI3-related microtia and craniofacial microsomia,limited,monoallelic_autosomal
FOXJ2,HGNC:24818,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1926805,-,-,-,-,0,-276.173.005.065.226,n,-,-,-,-,-,-
FOXJ3,HGNC:29178,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443432,lethal,"preweaning lethality, complete penetrance|increased circulating calcium level|unresponsive to tactile stimuli|increased circulating alkaline phosphatase level|tremors",abnormal skin coloration|abnormal sinus arrhythmia|unresponsive to tactile stimuli|abnormal coat appearance|increased bone mineral content|abnormal coat/ hair morphology|abnormal eye morphology|decreased total body fat amount|increased leukocyte cell number,-,927.643.784.786.642,-334.871.127.050.141,n,-,-,-,-,-,-
FOXK1,HGNC:23480,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347488,-,-,-,-,11.595.547.309.833,-222.626.913.831.711,n,-,-,-,-,-,-
FOXK2,HGNC:6036,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1916087,viable,abnormal bone structure|decreased bone mineral content|decreased grip strength|decreased bone mineral density,-,-,0,862.016.562.361.381,n,-,-,-,-,-,-
FOXN2,HGNC:5281,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347478,-,-,-,-,927.643.784.786.642,-28.513.659.837.681,n,-,-,-,-,-,-
FOXN3,HGNC:1928,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1918625,lethal,"preweaning lethality, complete penetrance",decreased prepulse inhibition,-,927.643.784.786.642,-584.811.112.627.939,n,-,-,-,-,-,-
FOXO3,HGNC:3821,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,25.974.025.974.026,-155.753.192.968.551,n,-,-,-,-,-,-
FOXO4,HGNC:7139,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1891915,viable,male infertility,-,enlarged heart|abnormal heart morphology|abnormal urinary bladder morphology,927.643.784.786.642,194.413.105.223.863,n,-,-,-,-,-,-
FOXO6,HGNC:24814,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2676586,-,-,-,-,NA,NA,-,-,-,-,-,-,-
FOXR1,HGNC:29980,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2685961,subviable,"preweaning lethality, incomplete penetrance",enlarged urinary bladder|small spleen|small ovary|abnormal seminal vesicle morphology,-,371.057.513.914.657,935.777.768.946.246,n,-,-,-,-,-,-
FOXR2,HGNC:30469,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3511682,-,-,-,-,0,206.003.688.874.707,n,-,-,-,-,-,-
FOXS1,HGNC:3735,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:95546,-,-,-,-,185.528.756.957.328,-746.375.759.760.773,n,-,-,-,-,-,-
GATA5,HGNC:15802,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109497,viable,abnormal kidney morphology,-,-,185.528.756.957.328,-427.646.232.262.883,n,omim_disease,"CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5",-,-,-,-
GATAD2B,HGNC:30778,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443225,lethal,"preweaning lethality, complete penetrance",decreased locomotor activity|increased mean corpuscular volume|increased monocyte cell number|increased circulating alkaline phosphatase level,-,742.115.027.829.314,-135.221.976.760.391,n,omim_disease,GAND SYNDROME,dd,NONSPECIFIC SEVERE ID,definitive,monoallelic_autosomal
GBX1,HGNC:4185,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:95667,viable,decreased locomotor activity|enlarged urinary bladder|abnormal retina blood vessel morphology|decreased exploration in new environment|abnormal retina vasculature morphology|syndactyly|abnormal behavior|increased circulating glucose level|vertebral fusion|abnormal gait|abnormal optic disk morphology|increased anxiety-related response|increased circulating alkaline phosphatase level|limb grasping|increased thigmotaxis|rib fusion,-,-,0,280.392.763.268.567,n,-,-,-,-,-,-
GLI1,HGNC:4317,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:95727,-,-,-,-,454.545.454.545.455,-255.228.032.492.465,n,omim_disease,"POLYDACTYLY, POSTAXIAL, TYPE A8|POLYDACTYLY, PREAXIAL I",-,-,-,-
GLI4,HGNC:4320,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,398.886.827.458.256,-196.822.577.309.074,n,-,-,-,-,-,-
GLIS1,HGNC:29525,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2386723,-,-,-,-,927.643.784.786.642,-258.683.480.168.778,n,-,-,-,-,-,-
GLIS2,HGNC:29450,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1932535,-,-,-,-,556.586.270.871.985,-114.710.668.284.768,n,omim_disease,NEPHRONOPHTHISIS 7,dd,NEPHRONOPHTHISIS 7,strong,biallelic_autosomal
GSC2,HGNC:4613,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:892006,-,-,-,-,463.821.892.393.321,-797.649.498.687.195,n,-,-,-,-,-,-
HDAC2,HGNC:4853,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1097691,-,-,-,-,194.805.194.805.195,-232.646.015.082.581,n,-,-,-,-,-,-
HES2,HGNC:16005,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1098624,-,-,-,-,185.528.756.957.328,-542.945.015.160.387,n,-,-,-,-,-,-
HES3,HGNC:26226,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:104877,-,-,-,-,185.528.756.957.328,-114.439.986.967.236,n,-,-,-,-,-,-
HES4,HGNC:24149,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,-40.418.720.319.019,n,-,-,-,-,-,-
HES6,HGNC:18254,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859852,-,-,-,-,463.821.892.393.321,-106.350.837.890.946,n,-,-,-,-,-,-
HEYL,HGNC:4882,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1860511,viable,abnormal sleep behavior,-,-,0,-731.190.834.416.301,n,-,-,-,-,-,-
HIF3A,HGNC:15825,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859778,-,-,-,-,185.528.756.957.328,803.919.112.513.805,n,-,-,-,-,-,-
HNF4G,HGNC:5026,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1353604,viable,abnormal auditory brainstem response|abnormal kidney morphology|small kidney,-,-,371.057.513.914.657,169.701.733.250.082,n,-,-,-,-,-,-
HOXA4,HGNC:5105,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96176,viable,abnormal liver morphology|abnormal uterus morphology|small kidney|small liver|abnormal kidney morphology,-,-,0,459.089.776.779.953,n,-,-,-,-,-,-
HOXA6,HGNC:5107,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96178,-,-,-,-,371.057.513.914.657,-110.134.997.407.492,n,-,-,-,-,-,-
HOXA7,HGNC:5108,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96179,-,-,-,-,0,871.465.473.456.372,n,-,-,-,-,-,-
HOXA9,HGNC:5109,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96180,-,-,-,-,306.122.448.979.592,-183.910.729.511.537,n,-,-,-,-,-,-
HOXA10,HGNC:5100,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96171,viable,enlarged heart|increased bone mineral content|abnormal heart morphology,-,-,278.293.135.435.993,-636.127.934.422.848,n,-,-,-,-,-,-
HOXA11,HGNC:5101,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96172,-,-,-,-,834.879.406.307.978,-131.994.206.531.747,n,omim_disease,RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 1,dd,Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia,limited,monoallelic_autosomal
HOXB5,HGNC:5116,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96186,-,-,-,-,556.586.270.871.985,-176.680.527.799.638,n,-,-,-,-,-,-
HOXB6,HGNC:5117,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96187,-,-,-,-,185.528.756.957.328,-120.093.611.880.733,n,-,-,-,-,-,-
HOXB7,HGNC:5118,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96188,-,-,-,-,371.057.513.914.657,-100.476.806.701.156,n,-,-,-,-,-,-
HOXB8,HGNC:5119,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96189,-,-,-,-,371.057.513.914.657,-141.186.336.207.748,n,-,-,-,-,-,-
HOXB9,HGNC:5120,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96190,-,-,-,-,25.974.025.974.026,-204.890.650.230.064,n,-,-,-,-,-,-
HOXB13,HGNC:5112,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107730,subviable,"preweaning lethality, incomplete penetrance",-,-,371.057.513.914.657,-135.232.859.271.926,n,omim_disease,"PROSTATE CANCER, HEREDITARY, 9",-,-,-,-
HOXC5,HGNC:5127,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96196,-,-,-,-,222.634.508.348.794,-194.441.922.663.105,n,-,-,-,-,-,-
HOXC6,HGNC:5128,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96197,-,-,-,-,176.252.319.109.462,-180.428.564.666.156,n,-,-,-,-,-,-
HOXC9,HGNC:5130,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96199,-,-,-,-,222.634.508.348.794,-153.774.304.389.895,n,-,-,-,-,-,-
HOXC10,HGNC:5122,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96192,-,-,-,-,10.760.667.903.525,-31.202.778.450.095,n,-,-,-,-,-,-
HOXC11,HGNC:5123,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96193,-,male infertility,-,-,102.040.816.326.531,-171.594.264.065.587,n,-,-,-,-,-,-
HOXC12,HGNC:5124,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96194,viable,tremors|abnormal tail length,-,-,556.586.270.871.985,-753.625.004.490.066,n,-,-,-,-,-,-
HOXD1,HGNC:5132,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96201,-,-,-,-,185.528.756.957.328,5.614.771.597.384,n,-,-,-,-,-,-
HOXD4,HGNC:5138,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96208,-,-,-,-,927.643.784.786.642,-438.503.723.986.354,n,-,-,-,-,-,-
HOXD8,HGNC:5139,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96209,-,-,-,-,927.643.784.786.642,-50.998.778.169.128,n,-,-,-,-,-,-
HOXD9,HGNC:5140,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96210,-,-,-,-,649.350.649.350.649,-153.709.952.886.718,n,-,-,-,-,-,-
HOXD10,HGNC:5133,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96202,-,-,-,-,278.293.135.435.993,-108.822.399.603.626,n,omim_disease,"VERTICAL TALUS, CONGENITAL",-,-,-,-
HSF4,HGNC:5227,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1347058,viable,increased heart weight|abnormal iris pigmentation|cataract|irregularly shaped pupil|increased circulating alanine transaminase level|abnormal cornea morphology|abnormal lens morphology,-,-,371.057.513.914.657,-145.246.948.653.985,n,omim_disease,"CATARACT 5, MULTIPLE TYPES",dd,"CATARACT 5, MULTIPLE TYPES",definitive,monoallelic_autosomal
HSF5,HGNC:26862,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2685585,viable,male infertility,-,-,463.821.892.393.321,-160.903.498.975.483,n,-,-,-,-,-,-
HSFX1,HGNC:29603,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
HSFX2,HGNC:32701,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
HSFY1,HGNC:18568,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
HSFY2,HGNC:23950,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
ING3,HGNC:14587,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1919027,-,-,-,-,547.309.833.024.119,-555.983.768.438.149,y,-,-,-,-,-,-
INO80,HGNC:26956,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1915392,lethal|subviable,"preweaning lethality, incomplete penetrance|preweaning lethality, complete penetrance",decreased locomotor activity|prolonged QRS complex duration|decreased exploration in new environment|abnormal vocalization|increased aggression|abnormal seminal vesicle morphology,-,814.471.243.042.672,-678.026.832.281.555,y,-,-,-,-,-,-
INO80B,HGNC:13324,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1917270,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",-,-,37.291.280.148.423,-447.626.199.158.228,n,-,-,-,-,-,-
INO80C,HGNC:26994,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443014,lethal,"abnormal tail morphology|abnormal embryo size|abnormal hindbrain morphology|embryonic growth retardation|prenatal lethality prior to heart atrial septation|anophthalmia|abnormal heart morphology|preweaning lethality, complete penetrance",increased vertical activity|eye hemorrhage,-,102.040.816.326.531,-456.494.623.161.004,n,-,-,-,-,-,-
INO80D,HGNC:25997,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3027003,subviable,"abnormal embryo size|preweaning lethality, incomplete penetrance|embryonic growth retardation",decreased total retina thickness|increased lean body mass|decreased locomotor activity|abnormal retina outer nuclear layer morphology|decreased total body fat amount,-,463.821.892.393.321,231.884.405.714.978,n,-,-,-,-,-,-
IRF1,HGNC:6116,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96590,viable,-,-,-,371.057.513.914.657,-383.035.425.653.442,n,omim_disease,GASTRIC CANCER|LUNG CANCER,-,-,-,-
IRF2,HGNC:6117,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96591,-,-,-,-,250.463.821.892.393,190.519.939.083.141,n,-,-,-,-,-,-
IRF3,HGNC:6118,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859179,viable,abnormal heart morphology|small kidney|enlarged lymph nodes|abnormal kidney morphology|small heart,-,-,185.528.756.957.328,159.945.164.740.795,n,omim_disease,"ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7",-,-,-,-
IRF4,HGNC:6119,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1096873,viable,enlarged lymph nodes|enlarged spleen|abnormal spleen morphology|abnormal thymus morphology|abnormal startle reflex|decreased lymphocyte cell number|enlarged thymus|increased neutrophil cell number|abnormal lymph node morphology|increased spleen weight,-,-,630.797.773.654.917,-139.570.324.549.151,n,omim_disease,"SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8",-,-,-,-
IRF5,HGNC:6120,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1350924,lethal|viable,"preweaning lethality, complete penetrance|decreased CD4-positive, alpha-beta memory T cell number|decreased leukocyte cell number",-,-,371.057.513.914.657,-121.680.289.784.219,n,omim_disease,"INFLAMMATORY BOWEL DISEASE 14|SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10",-,-,-,-
IRF7,HGNC:6122,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859212,viable,abnormal retina morphology,-,-,185.528.756.957.328,-209.725.902.136.681,n,omim_disease,IMMUNODEFICIENCY 39,-,-,-,-
IRF8,HGNC:5358,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96395,viable,decreased fasting circulating glucose level|increased circulating total protein level|thrombocytopenia|increased mean corpuscular hemoglobin|increased circulating sodium level|decreased circulating free fatty acids level|decreased erythrocyte cell number|increased mean corpuscular volume,-,-,12.987.012.987.013,197.899.319.678.666,n,omim_disease,IMMUNODEFICIENCY 32A|IMMUNODEFICIENCY 32B,-,-,-,-
IRF9,HGNC:6131,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107587,-,-,-,-,371.057.513.914.657,-684.298.670.914.622,n,omim_disease,"IMMUNODEFICIENCY 65, SUSCEPTIBILITY TO VIRAL INFECTIONS",-,-,-,-
IRX1,HGNC:14358,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1197515,lethal,"preweaning lethality, complete penetrance|embryonic growth retardation|abnormal craniofacial morphology|abnormal abdominal wall morphology|abnormal embryo size",decreased thigmotaxis|decreased locomotor activity,-,927.643.784.786.642,-705.538.052.554.613,n,-,-,-,-,-,-
IRX2,HGNC:14359,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1197526,-,-,-,-,556.586.270.871.985,-104.754.728.222.513,n,-,-,-,-,-,-
IRX3,HGNC:14360,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1197522,viable,abnormal snout morphology|decreased bone mineral content|abnormal cornea morphology|increased grip strength|decreased fasting circulating glucose level,-,-,556.586.270.871.985,-994.243.985.462.598,n,-,-,-,-,-,-
IRX4,HGNC:6129,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1355275,-,-,-,-,0,138.267.712.253.524,n,-,-,-,-,-,-
IRX5,HGNC:14361,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859086,-,-,-,-,371.057.513.914.657,-185.078.664.145.084,n,omim_disease,HAMAMY SYNDROME,dd,"HYPERTELORISM, SEVERE, WITH MIDFACE PROMINENCE, MYOPIA, INTELLECTUAL DEVELOPMENTAL DISORDER, AND BONE FRAGILITY",strong,biallelic_autosomal
IRX6,HGNC:14675,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1927642,viable,abnormal liver morphology|abnormal coat/hair pigmentation|abnormal skin coloration|abnormal eye morphology|abnormal seminal vesicle morphology|increased hematocrit|increased circulating phosphate level,-,-,371.057.513.914.657,-5.669.188.026.422,n,-,-,-,-,-,-
JUNB,HGNC:6205,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96647,lethal,"abnormal embryo turning|abnormal embryo size|abnormal midbrain development|embryonic growth retardation|preweaning lethality, complete penetrance|abnormal neural tube morphology|abnormal forebrain development|embryonic lethality prior to tooth bud stage|abnormal neural tube closure|abnormal hindbrain development",increased spleen weight,-,13.543.599.257.885,-271.873.853.935.209,n,-,-,-,-,-,-
JUND,HGNC:6206,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96648,-,-,-,-,139.146.567.717.996,-132.610.127.136.179,n,-,-,-,-,-,-
KAT5,HGNC:5275,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1932051,lethal,"embryonic lethality prior to tooth bud stage|embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",abnormal eye morphology|increased hemoglobin content,-,984.230.055.658.627,-113.342.822.976.011,y,omim_disease,"NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SLEEP DISTURBANCE, AND BRAIN ABNORMALITIES",dd,KAT5-related Neurodevelopmental Syndrome,strong,monoallelic_autosomal
KDM1A,HGNC:29079,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1196256,lethal,"preweaning lethality, complete penetrance",small spleen|decreased grip strength|increased eosinophil cell number|small heart|increased basophil cell number|decreased locomotor activity|small lung|increased mean platelet volume|small kidney|small liver,-,287.569.573.283.859,-172.479.716.659.251,n,omim_disease,"CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES",dd,Developmental delay and distinctive facial features,strong,monoallelic_autosomal
KLF8,HGNC:6351,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2442430,viable,-,-,-,927.643.784.786.642,-426.336.863.706.797,n,-,-,dd,NONSYNDROMIC INTELLECTUAL DEVELOPMENTAL DISORDER,limited,monoallelic_X_het
KLF9,HGNC:1123,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1333856,viable,abnormal heart morphology|enlarged heart,-,-,927.643.784.786.642,-547.189.890.390.949,n,-,-,-,-,-,-
KLF10,HGNC:11810,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1101353,-,-,-,-,139.146.567.717.996,-114.759.022.109.565,n,-,-,-,-,-,-
KLF11,HGNC:11811,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2653368,-,-,-,-,0,-25.133.551.631.567,n,omim_disease,"MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7",-,-,-,-
KLF12,HGNC:6346,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1333796,-,-,decreased circulating serum albumin level|abnormal retina inner nuclear layer morphology|decreased circulating calcium level|increased cornea thickness,-,0,932.718.428.776.703,n,-,-,-,-,-,-
KLF13,HGNC:13672,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1354948,-,-,-,-,927.643.784.786.642,450.738.138.005.744,n,-,-,-,-,-,-
KLF14,HGNC:23025,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3577024,viable,increased red blood cell distribution width|decreased mean corpuscular hemoglobin|increased circulating alanine transaminase level|increased vertical activity,-,-,278.293.135.435.993,-42.447.608.142.824,n,-,-,-,-,-,-
KLF15,HGNC:14536,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1929988,-,-,-,-,0,23.976.125.114.727,n,-,-,-,-,-,-
KLF16,HGNC:16857,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2153049,subviable,"abnormal embryo size|preweaning lethality, incomplete penetrance",increased mean corpuscular volume|prolonged QRS complex duration|decreased circulating glucose level|increased circulating phosphate level|decreased leukocyte cell number|prolonged QT interval|increased mean corpuscular hemoglobin|decreased circulating total protein level,-,186.456.400.742.115,-34.666.021.257.022,n,-,-,-,-,-,-
KLF17,HGNC:18830,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2181068,viable,-,-,-,102.040.816.326.531,-162.532.812.848.151,n,-,-,-,-,-,-
L3MBTL1,HGNC:15905,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2676663,-,-,-,-,649.350.649.350.649,-157.614.841.108.967,n,-,-,-,-,-,-
LIN28B,HGNC:32207,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3584032,viable,decreased exploration in new environment,-,-,111.317.254.174.397,-453.543.869.547.335,n,-,-,-,-,-,-
LIN54,HGNC:25397,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2140902,-,-,-,-,164.192.949.907.236,-296.213.035.673.434,n,-,-,-,-,-,-
MAFK,HGNC:6782,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99951,-,-,-,-,148.423.005.565.863,-122.977.469.798.363,n,-,-,-,-,-,-
MBD2,HGNC:6917,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1333813,viable,-,-,-,194.805.194.805.195,-519.224.039.539.413,n,-,-,-,-,-,-
MCRS1,HGNC:6960,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1858420,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",increased circulating chloride level,-,942.486.085.343.228,-833.124.553.387.933,y,-,-,-,-,-,-
MECP2,HGNC:6990,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99918,-,-,-,-,0,825.842.642.685.561,n,omim_disease,"ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS|INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC 13|INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, LUBS TYPE|RETT SYNDROME|AUTISM, SUSCEPTIBILITY TO, X-LINKED 3",dd,RETT SYNDROME (RTT)|INTELLECTUAL DEVELOPMENTAL DISORDER SYNDROMIC X-LINKED LUBS TYPE|CHROMOSOME XQ28 DUPLICATION SYNDROME|ENCEPHALOPATHY NEONATAL SEVERE DUE TO MECP2 MUTATIONS,definitive|definitive|definitive|definitive,monoallelic_X_het|monoallelic_X_hem|monoallelic_X_hem|monoallelic_X_hem
MEF2B,HGNC:6995,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:104526,viable,abnormal snout morphology,-,-,222.634.508.348.794,-180.676.352.530.492,n,-,-,-,-,-,-
MEF2D,HGNC:6997,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99533,-,-,-,-,12.987.012.987.013,-100.347.161.697.719,n,-,-,-,-,-,-
MEIS3,HGNC:29537,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:108519,-,abnormal thymus morphology|abnormal urinary bladder morphology|hyperactivity|enlarged thymus|abnormal spleen morphology|impaired glucose tolerance|decreased lung tissue damping|abnormal eye morphology|small testis|abnormal liver morphology|abnormal tooth color|decreased lung elastance|cystolithiasis|abnormal tooth morphology|decreased heart rate|microphthalmia|small liver|abnormal skin morphology|abnormal seminal vesicle morphology|abnormal testis morphology,-,-,742.115.027.829.314,-125.457.050.760.059,n,-,-,-,-,-,-
MEOX1,HGNC:7013,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103220,-,-,-,-,927.643.784.786.642,-347.385.415.252.102,n,omim_disease,"KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE",dd,KLIPPEL-FEIL ANOMALY,strong,biallelic_autosomal
MTA1,HGNC:7410,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2150037,-,decreased circulating LDL cholesterol level|abnormal behavior|abnormal bone mineralization|decreased mean corpuscular volume|abnormal skin morphology|increased thermal nociceptive threshold|absent pinna reflex|decreased body weight|abnormal rib morphology|decreased lumbar vertebrae number|decreased sacral vertebrae number|abnormal tail morphology|increased total body fat amount|trunk curl|abnormal skin pigmentation|increased lean body mass|decreased caudal vertebrae number,decreased caudal vertebrae number|decreased body weight|decreased lumbar vertebrae number|decreased sacral vertebrae number,-,0,-545.993.036.540.722,n,-,-,-,-,-,-
MTA2,HGNC:7411,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1346340,-,-,-,-,714.285.714.285.714,-231.472.193.993.793,n,-,-,-,-,-,-
MTA3,HGNC:23784,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2151172,-,increased circulating alkaline phosphatase level,trunk curl|decreased hemoglobin content|increased body weight|increased circulating creatinine level,-,185.528.756.957.328,31.369.933.079.789,n,-,-,-,-,-,-
MYBBP1A,HGNC:7546,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106181,lethal,"preweaning lethality, complete penetrance",increased hemoglobin content|increased circulating alkaline phosphatase level|thrombocytosis|increased erythrocyte cell number|increased startle reflex|increased circulating sodium level|increased hematocrit,-,842.300.556.586.271,-727.195.875.157.369,y,-,-,-,-,-,-
MYBL1,HGNC:7547,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99925,-,-,-,-,834.879.406.307.978,471.431.306.431.848,n,-,-,-,-,-,-
MYCL,HGNC:7555,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:96799,-,-,-,-,371.057.513.914.657,-436.456.118.061.715,n,-,-,-,-,-,-
MYO1C,HGNC:7597,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106612,-,-,-,-,185.528.756.957.328,-256.558.584.150.597,n,-,-,-,-,-,-
MYOD1,HGNC:7611,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97275,-,-,-,-,111.317.254.174.397,-488.870.618.840.605,n,omim_disease,"MYOPATHY, CONGENITAL, WITH DIAPHRAGMATIC DEFECTS, RESPIRATORY INSUFFICIENCY, AND DYSMORPHIC FACIES",-,-,-,-
NANOGNB,HGNC:24958,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,927.643.784.786.642,-30.603.798.860.147,n,-,-,-,-,-,-
NANOGP8,HGNC:23106,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-
NEUROD6,HGNC:13804,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106593,-,-,-,-,0,635.726.375.909.691,n,-,-,-,-,-,-
NFATC2,HGNC:7776,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:102463,-,-,-,-,742.115.027.829.314,101.245.347.528.656,n,omim_disease,"JOINT CONTRACTURES, OSTEOCHONDROMAS, AND B-CELL LYMPHOMA",-,-,-,-
NFATC4,HGNC:7778,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1920431,viable,increased heart weight|decreased fasting circulating glucose level|increased circulating sodium level,-,-,0,-420.625.593.303.312,n,-,-,-,-,-,-
NFRKB,HGNC:7802,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2442410,-,-,-,-,462.894.248.608.534,-489.920.504.582.618,n,-,-,-,-,-,-
NKX1-1,HGNC:24975,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109346,-,-,-,-,NA,NA,-,-,-,-,-,-,-
NKX1-2,HGNC:31652,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:104806,-,-,-,-,927.643.784.786.642,-909.975.776.782.287,n,-,-,-,-,-,-
NKX2-4,HGNC:7837,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97349,-,-,-,-,463.821.892.393.321,117.168.063.034.831,n,-,-,-,-,-,-
NKX2-6,HGNC:32940,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97351,-,increased circulating alanine transaminase level|increased circulating potassium level,-,-,NA,NA,-,omim_disease,CONOTRUNCAL HEART MALFORMATIONS,-,-,-,-
NKX2-8,HGNC:16364,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1270158,-,-,-,-,185.528.756.957.328,-140.429.125.752.415,n,-,-,-,-,-,-
NKX3-1,HGNC:7838,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97352,-,-,-,-,0,-244.428.543.074.775,n,-,-,-,-,-,-
OLIG1,HGNC:16983,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1355334,-,hyperactivity|decreased circulating phosphate level,-,-,278.293.135.435.993,-403.316.136.261.594,n,-,-,-,-,-,-
PAX1,HGNC:8615,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97485,-,-,-,-,0,-238.778.117.237.254,n,omim_disease,"OTOFACIOCERVICAL SYNDROME 2, WITH T-CELL DEFICIENCY",dd,OTOFACIOCERVICAL SYNDROME,strong,biallelic_autosomal
PBRM1,HGNC:30064,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1923998,lethal,"preweaning lethality, complete penetrance",decreased circulating creatinine level|abnormal gait|abnormal kidney morphology|increased mean platelet volume|decreased prepulse inhibition,-,343.228.200.371.058,-134.419.293.701.798,n,omim_disease,"RENAL CELL CARCINOMA, NONPAPILLARY",-,-,-,-
PHF10,HGNC:18250,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1919307,lethal,"preweaning lethality, complete penetrance",-,-,12.987.012.987.013,180.191.225.308.711,n,-,-,-,-,-,-
PITX3,HGNC:9006,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1100498,viable,increased grip strength|anophthalmia|increased body temperature|decreased body weight|hyperactivity|abnormal bone structure|decreased locomotor activity|increased coping response|abnormal motor learning|abnormal motor coordination/balance|decreased vertical activity|abnormal sleep behavior|increased fasting circulating glucose level|decreased exploration in new environment|decreased circulating triglyceride level|increased heart rate|shortened ST segment,-,-,185.528.756.957.328,-71.954.352.916.961,n,omim_disease,"ANTERIOR SEGMENT DYSGENESIS 1|CATARACT 11, MULTIPLE TYPES",dd,ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS,definitive,monoallelic_autosomal
POLE3,HGNC:13546,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1933378,-,-,increased grip strength,-,175.324.675.324.675,-298.064.233.464.385,n,-,-,-,-,-,-
POU1F1,HGNC:9210,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97588,subviable,"preweaning lethality, complete penetrance|preweaning lethality, incomplete penetrance",-,-,371.057.513.914.657,-306.412.515.529.263,n,omim_disease,"PITUITARY HORMONE DEFICIENCY, COMBINED OR ISOLATED, 1",dd,POU1F1-RELATED COMBINED PITUITARY HORMONE DEFICIENCY,definitive,biallelic_autosomal
POU2AF1,HGNC:9211,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:105086,viable,decreased lymphocyte cell number|increased neutrophil cell number|decreased spleen weight|decreased leukocyte cell number,-,-,38.961.038.961.039,-683.587.366.726.048,n,-,-,-,-,-,-
POU3F4,HGNC:9217,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:101894,-,-,-,-,0,105.413.657.102.191,n,omim_disease,"DEAFNESS, X-LINKED 2",-,-,-,-
POU4F2,HGNC:9219,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:102524,-,-,-,-,0,-524.023.478.591.682,n,-,-,-,-,-,-
POU4F3,HGNC:9220,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:102523,-,-,-,-,0,769.550.349.939.526,n,-,-,-,-,-,-
POU5F1B,HGNC:9223,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,360.853.432.282.004,-434.427.832.224.317,n,-,-,-,-,-,-
POU5F2,HGNC:26367,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1922757,-,-,-,-,927.643.784.786.642,-86.016.124.987.365,n,-,-,-,-,-,-
POU6F1,HGNC:9224,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:102935,-,-,-,-,463.821.892.393.321,-132.251.836.669.703,n,-,-,-,-,-,-
POU6F2,HGNC:21694,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2443631,-,-,-,-,0,402.948.565.302.633,n,omim_disease,WILMS TUMOR 5,-,-,-,-
PRDM2,HGNC:9347,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107628,viable,increased eosinophil cell number|increased mean corpuscular hemoglobin concentration|increased mean corpuscular hemoglobin|increased basophil cell number|increased circulating creatinine level|decreased hematocrit|increased grip strength,-,-,0,779.762.944.172.261,n,-,-,-,-,-,-
PRDM4,HGNC:9348,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1920093,viable,abnormal iris morphology|decreased total body fat amount|microphthalmia|impaired glucose tolerance|enlarged urinary bladder|abnormal heart left ventricle morphology|increased lean body mass|increased circulating amylase level|absent spleen|increased cardiac muscle contractility|abnormal cornea morphology|abnormal gait|thick ventricular wall,-,-,927.643.784.786.642,123.285.829.078.376,n,-,-,-,-,-,-
PRDM5,HGNC:9349,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1918029,viable,abnormal skin morphology|hyperplasia|dysplasia|decreased exploration in new environment|abnormal optic disk morphology|abnormal auditory brainstem response|fibro-osseous lesion|small testis,-,-,0,667.439.304.995.999,n,omim_disease,BRITTLE CORNEA SYNDROME 2,-,-,-,-
PRDM6,HGNC:9350,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2684938,-,-,-,-,0,622.394.957.061.823,n,omim_disease,PATENT DUCTUS ARTERIOSUS 3,dd,Isolated Nonsyndromic Patent Ductus Arteriosus.,limited,monoallelic_autosomal
PRDM8,HGNC:13993,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1924880,viable,increased freezing behavior|decreased locomotor activity|abnormal heart left ventricle morphology|impaired glucose tolerance|hyperactivity|abnormal heart morphology|enlarged uterus|abnormal uterus morphology|increased lung elastance|increased airway resistance|abnormal thymus morphology|small heart|increased anxiety-related response|increased circulating sodium level|decreased body weight|abnormal inspiratory capacity|enlarged thymus|increased heart rate,increased prepulse inhibition|abnormal tooth morphology|increased airway resistance|abnormal spleen morphology|abnormal thymus morphology|small spleen|enlarged thymus|abnormal skin morphology|abnormal seminal vesicle morphology,-,927.643.784.786.642,-357.449.436.220.729,n,omim_disease,"EPILEPSY, PROGRESSIVE MYOCLONIC, 10",-,-,-,-
PRDM9,HGNC:13994,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,760.842.862.811.007,n,-,-,-,-,-,-
PRDM10,HGNC:13995,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2682952,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",decreased grip strength|decreased total body fat amount|increased lean body mass|decreased bone mineral content,-,763.450.834.879.406,-672.838.086.607.609,y,-,-,-,-,-,-
PRDM12,HGNC:13997,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2685844,lethal,"preweaning lethality, complete penetrance",abnormal embryo size|shortened QRS complex duration|decreased locomotor activity|increased circulating cholesterol level|decreased exploration in new environment,-,927.643.784.786.642,-731.596.275.645.123,n,omim_disease,"NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VIII",dd,HEREDITARY SENSORY & AUTONOMIC NEUROPATHY TYPE VIII,definitive,biallelic_autosomal
PRDM13,HGNC:13998,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2448528,viable,increased spleen weight|abnormal spleen morphology,-,-,185.528.756.957.328,251.753.731.356.967,n,omim_disease,"CEREBELLAR DYSFUNCTION, IMPAIRED INTELLECTUAL DEVELOPMENT, AND HYPOGONADOTROPIC HYPOGONADISM|PONTOCEREBELLAR HYPOPLASIA, TYPE 17",dd,PRDM13-related olivopentocerebellar hypoplasia syndrome,moderate,biallelic_autosomal
PRDM14,HGNC:14001,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3588194,subviable|viable,"defective growth and differentiation process|decreased bone mineral density|hyperactivity|abnormal bone structure|increased total body fat amount|osteopenia|impaired glucose tolerance|short tibia|hypoplasia|male infertility|decreased bone mineral content|female infertility|preweaning lethality, incomplete penetrance|decreased respiratory quotient|developmental and structural abnormality|abnormal eye anterior chamber depth|decreased lean body mass|increased effector memory T-helper cell number|abnormal rib morphology",-,-,371.057.513.914.657,-547.525.329.767.535,n,-,-,-,-,-,-
PRDM15,HGNC:13999,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1930121,subviable,"preweaning lethality, incomplete penetrance",thick ventricular wall|increased heart left ventricle size,-,185.528.756.957.328,228.639.370.971.294,n,-,-,dd,PRDM15-related renal and neurodevelopmental disorder,limited,biallelic_autosomal
RB1,HGNC:9884,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:97874,-,-,-,-,0,128.398.353.216.156,n,omim_disease,BLADDER CANCER|OSTEOGENIC SARCOMA|RETINOBLASTOMA,-,-,-,-
RBBP4,HGNC:9887,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1194912,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis|prenatal lethality prior to heart atrial septation",small liver|enlarged kidney|abnormal liver morphology|abnormal eye morphology|abnormal bone structure|increased bone mineral content|increased body length|abnormal gallbladder morphology|enlarged spleen|abnormal kidney morphology|abnormal spleen morphology,-,993.506.493.506.494,-128.877.765.228.804,y,-,-,-,-,-,-
RBBP7,HGNC:9890,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1194910,-,-,-,-,510.204.081.632.653,-103.114.588.294.166,n,-,-,-,-,-,-
RCOR1,HGNC:17441,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106340,-,-,-,-,260.667.903.525.046,-364.952.767.743.132,n,-,-,-,-,-,-
RFX2,HGNC:9983,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106583,-,-,-,-,371.057.513.914.657,-591.279.101.329.536,n,-,-,-,-,-,-
RFX5,HGNC:9986,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1858421,-,-,-,-,408.163.265.306.122,-222.469.492.940.898,n,omim_disease,"BARE LYMPHOCYTE SYNDROME, TYPE II",-,-,-,-
RFX7,HGNC:25777,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2442675,subviable,"preweaning lethality, incomplete penetrance",decreased locomotor activity|decreased fasting circulating glucose level|abnormal retina morphology|decreased thigmotaxis,-,NA,NA,-,-,-,-,-,-,-
RFX8,HGNC:37253,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3588206,viable,male infertility|female infertility,-,-,927.643.784.786.642,-853.429.645.626.347,n,-,-,-,-,-,-
RUVBL1,HGNC:10474,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1928760,-,-,increased blood urea nitrogen level|increased circulating creatinine level|increased mean corpuscular hemoglobin concentration|increased mean corpuscular volume,-,100,-202.574.853.878.093,y,-,-,-,-,-,-
RUVBL2,HGNC:10475,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1342299,-,-,-,-,100,-182.036.022.289.594,y,-,-,-,-,-,-
SALL2,HGNC:10526,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1354373,-,-,-,-,927.643.784.786.642,-617.515.447.269.966,n,omim_disease,"COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE",-,-,-,-
SF3B1,HGNC:10768,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1932339,-,-,-,-,998.144.712.430.427,-168.535.297.081.997,y,omim_disease,MYELODYSPLASTIC SYNDROME,-,-,-,-
SFMBT1,HGNC:20255,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859609,subviable,"preweaning lethality, incomplete penetrance",-,-,371.057.513.914.657,-175.952.268.811.664,n,-,-,-,-,-,-
SIRT7,HGNC:14935,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2385849,-,-,-,-,204.081.632.653.061,-146.175.659.193.002,n,-,-,-,-,-,-
SIX4,HGNC:10890,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106034,-,-,-,-,185.528.756.957.328,-278.941.469.355.548,n,-,-,-,-,-,-
SIX5,HGNC:10891,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:106220,-,-,-,-,0,-841.472.525.977.183,n,omim_disease,BRANCHIOOTORENAL SYNDROME 2,dd,BRANCHIOOTORENAL SYNDROME TYPE 2,definitive,monoallelic_autosomal
SIX6,HGNC:10892,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1341840,-,-,-,-,0,-628.087.320.636.719,n,omim_disease,OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY,dd,"MICROPHTHALMIA, ISOLATED, WITH CATARACT 2",limited,monoallelic_autosomal
SMAD3,HGNC:6769,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1201674,-,-,decreased lymphocyte cell number|decreased circulating alkaline phosphatase level|decreased exploration in new environment,-,927.643.784.786.642,-446.213.729.787.537,n,omim_disease,LOEYS-DIETZ SYNDROME 3,dd,SMAD3-RELATED LOEYS-DIETZ SYNDROME,definitive,monoallelic_autosomal
SMAD9,HGNC:6774,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1859993,-,-,-,-,0,-170.805.897.228.196,n,omim_disease,"PULMONARY HYPERTENSION, PRIMARY, 2",-,-,-,-
SMARCA1,HGNC:11097,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1935127,-,-,-,-,927.643.784.786.642,211.763.056.678.246,n,-,-,-,-,-,-
SMARCA4,HGNC:11100,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:88192,-,-,-,-,310.760.667.903.525,-368.255.369.718.951,n,omim_disease,COFFIN-SIRIS SYNDROME 4|RHABDOID TUMOR PREDISPOSITION SYNDROME 2,dd,COFFIN SIRIS|RHABDOID TUMOR PREDISPOSITION SYNDROME 2,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
SMARCA5,HGNC:11101,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1935129,-,-,-,-,464.749.536.178.108,-489.818.657.252.115,n,-,-,-,-,-,-
SMARCB1,HGNC:11103,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1328366,lethal,"preweaning lethality, complete penetrance|embryonic lethality prior to organogenesis",decreased prepulse inhibition|abnormal skin coloration|increased cornea thickness|abnormal eye anterior chamber depth|abnormal coat appearance,-,774.582.560.296.846,-73.896.012.733.166,y,omim_disease,COFFIN-SIRIS SYNDROME 3|RHABDOID TUMOR PREDISPOSITION SYNDROME 1|SCHWANNOMATOSIS 1,dd,RHABDOID PREDISPOSITION SYNDROME 1|EHMT1-like SYNDROME,definitive|definitive,monoallelic_autosomal|monoallelic_autosomal
SMARCC1,HGNC:11104,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1203524,-,-,-,-,510.204.081.632.653,-197.742.927.858.146,n,-,-,-,-,-,-
SMARCD1,HGNC:11106,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1933623,-,-,-,-,123.376.623.376.623,-21.703.389.828.455,n,omim_disease,COFFIN-SIRIS SYNDROME 11,dd,SYNDROMIC INTELLECTUAL DISABILITY,strong,monoallelic_autosomal
SMARCD2,HGNC:11107,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1933621,subviable,"edema|preweaning lethality, incomplete penetrance",edema|increased mean corpuscular volume|decreased prepulse inhibition,-,194.805.194.805.195,-173.881.028.745.293,n,omim_disease,SPECIFIC GRANULE DEFICIENCY 2,-,-,-,-
SMARCE1,HGNC:11109,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1927347,-,-,decreased mean corpuscular hemoglobin|decreased mean corpuscular volume|decreased locomotor activity,-,894.248.608.534.323,-947.468.630.647.239,y,omim_disease,"COFFIN-SIRIS SYNDROME 5|MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO",dd,COFFIN SIRIS,strong,monoallelic_autosomal
SNAI3,HGNC:18411,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1353563,subviable,"preweaning lethality, incomplete penetrance",-,-,185.528.756.957.328,-577.315.287.501.945,n,-,-,-,-,-,-
SOX8,HGNC:11203,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98370,-,-,-,-,185.528.756.957.328,302.260.205.902.006,n,-,-,-,-,-,-
SOX12,HGNC:11198,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98360,-,-,-,-,278.293.135.435.993,505.152.826.530.673,n,-,-,-,-,-,-
SOX13,HGNC:11192,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98361,-,long tibia|increased startle reflex|abnormal tail movements|increased mean corpuscular volume|increased mean corpuscular hemoglobin concentration|decreased erythrocyte cell number,-,-,0,108.938.582.779.463,n,-,-,-,-,-,-
SOX14,HGNC:11193,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98362,viable,decreased thigmotaxis|limb grasping|abnormal behavior|hyperactivity|enlarged thymus|abnormal gait|increased freezing behavior|increased airway resistance|increased lung tissue damping|abnormal snout morphology|trunk curl|decreased locomotor activity|increased grip strength|abnormal thymus morphology|abnormal lymph node morphology|microphthalmia|increased aggression|small kidney|abnormal vocalization|decreased startle reflex|abnormal skin morphology|abnormal eye morphology|abnormal spleen morphology|enlarged lymph nodes|male infertility|small seminal vesicle|decreased body weight|abnormal seminal vesicle morphology,enlarged heart|increased lung tissue damping|abnormal spleen morphology|abnormal thymus morphology|abnormal heart morphology|increased prepulse inhibition|enlarged thymus|abnormal auditory brainstem response|microphthalmia|small kidney|abnormal eye morphology|small heart,-,927.643.784.786.642,241.869.539.476.753,n,-,-,-,-,-,-
SOX15,HGNC:11196,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98363,-,-,-,-,250.463.821.892.393,-220.537.327.743.708,n,-,-,-,-,-,-
SOX30,HGNC:30635,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1341157,viable,abnormal retina inner nuclear layer morphology|persistence of hyaloid vascular system|increased fasting circulating glucose level,-,-,204.081.632.653.061,-226.664.612.695.224,n,-,-,-,-,-,-
SP5,HGNC:14529,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1927715,viable,increased vertical activity|decreased fasting circulating glucose level|increased grip strength|hyperactivity,-,-,185.528.756.957.328,-651.999.601.439.676,n,-,-,-,-,-,-
SP6,HGNC:14530,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1932575,-,-,-,-,278.293.135.435.993,-115.543.905.721.156,n,omim_disease,"AMELOGENESIS IMPERFECTA, TYPE IK",-,-,-,-
SP9,HGNC:30690,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3574660,-,-,-,-,148.423.005.565.863,-106.893.101.756.369,n,-,-,-,-,-,-
SP100,HGNC:11206,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109561,-,-,-,-,0,756.190.219.007.863,n,-,-,-,-,-,-
SP110,HGNC:5401,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1923364,-,-,-,-,649.350.649.350.649,-265.300.803.636.445,n,omim_disease,"HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY|MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO",-,-,-,-
SP140,HGNC:17133,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,819.468.141.516.167,n,-,-,-,-,-,-
SP140L,HGNC:25105,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,966.859.503.192.975,n,-,-,-,-,-,-
SPIB,HGNC:11242,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:892986,-,-,-,-,185.528.756.957.328,344.966.581.266.375,n,-,-,-,-,-,-
SRCAP,HGNC:16974,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2444036,-,-,abnormal hair growth|thrombocytopenia,-,99.443.413.729.128,-11.519.032.590.407,y,omim_disease,"DEVELOPMENTAL DELAY, HYPOTONIA, MUSCULOSKELETAL DEFECTS, AND BEHAVIORAL ABNORMALITIES|FLOATING-HARBOR SYNDROME",dd,FLOATING-HARBOR SYNDROME|SRCAP-related Neurodevelopmental Disorder,definitive|strong,monoallelic_autosomal|monoallelic_autosomal
SRY,HGNC:11311,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98660,-,-,-,-,NA,NA,-,omim_disease,"46,XX SEX REVERSAL 1|46,XY SEX REVERSAL 1",dd,46XY SEX REVERSAL 1,definitive,monoallelic_X_hem
SS18L1,HGNC:15592,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2444061,-,-,-,-,0,-258.492.761.060.495,n,-,-,-,-,-,-
SSRP1,HGNC:11327,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107912,-,-,-,-,100,-146.663.554.293.619,y,-,-,-,-,-,-
STAT2,HGNC:11363,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103039,-,-,-,-,742.115.027.829.314,-929.992.882.331.133,n,omim_disease,IMMUNODEFICIENCY 44|PSEUDO-TORCH SYNDROME 3,dd,Viral induced severe multiorgan dysfunction associated with impaired mitochondrial fission|Recessive gain of function causing increased interferon signalling,limited|limited,biallelic_autosomal|biallelic_autosomal
STAT4,HGNC:11365,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103062,viable,abnormal kidney morphology|corneal opacity|small kidney,-,-,0,244.002.772.610.376,n,omim_disease,"SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11",-,-,-,-
STAT6,HGNC:11368,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:103034,-,-,-,-,371.057.513.914.657,-10.826.562.895.859,n,-,-,-,-,-,-
SUPT16H,HGNC:11465,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1890948,-,-,-,-,100,-183.150.086.113.057,y,omim_disease,NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND THIN CORPUS CALLOSUM,dd,SUPT16H-related neurodevelopmental disorder,limited,monoallelic_autosomal
TBX19,HGNC:11596,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1891158,-,-,-,-,0,-160.408.114.527.656,n,omim_disease,"ACTH DEFICIENCY, ISOLATED",-,-,-,-
TBX21,HGNC:11599,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1888984,-,-,-,-,463.821.892.393.321,-102.440.952.540.656,n,omim_disease,"IMMUNODEFICIENCY 88|ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE",-,-,-,-
TCF7,HGNC:11639,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98507,-,-,-,-,241.187.384.044.527,-244.074.505.901.831,n,-,-,-,-,-,-
TCF20,HGNC:11631,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:108399,-,decreased lean body mass|increased total body fat amount|decreased bone mineral content|increased circulating alkaline phosphatase level|decreased body length|increased circulating insulin level|increased circulating creatine kinase level|increased circulating aspartate transaminase level,-,-,927.643.784.786.642,-39.520.328.234.552,n,omim_disease,DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES,dd,TCF20 syndrome,definitive,monoallelic_autosomal
TCF23,HGNC:18602,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1934960,viable,-,-,-,0,825.677.583.478.797,n,-,-,-,-,-,-
TCF24,HGNC:32275,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:3780500,-,-,-,-,0,452.466.510.491.873,n,-,-,-,-,-,-
TCFL5,HGNC:11646,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2672878,-,-,-,-,12.987.012.987.013,-913.480.456.315.797,n,-,-,-,-,-,-
TEAD3,HGNC:11716,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:109241,viable,decreased bone trabecula number|decreased circulating serum albumin level|increased circulating creatinine level|increased circulating magnesium level|increased bone trabecular spacing,-,-,862.708.719.851.577,-293.417.703.040.244,n,-,-,-,-,-,-
TFAP2D,HGNC:15581,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2153466,-,-,-,-,927.643.784.786.642,-164.091.112.190.782,n,-,-,-,-,-,-
TFAP2E,HGNC:30774,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2679630,-,-,-,-,185.528.756.957.328,-529.126.078.459.014,n,-,-,-,-,-,-
TFCP2,HGNC:11748,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98509,-,-,-,-,0,210.265.881.758.972,n,-,-,-,-,-,-
TFDP2,HGNC:11751,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107167,-,-,-,-,278.293.135.435.993,-723.874.215.580.574,n,-,-,-,-,-,-
TFDP3,HGNC:24603,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,259.534.580.669.303,n,-,-,-,-,-,-
TFE3,HGNC:11752,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98511,-,-,-,-,0,366.878.291.363.811,n,omim_disease,"INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, WITH PIGMENTARY MOSAICISM AND COARSE FACIES|RENAL CELL CARCINOMA, Xp11-ASSOCIATED",dd,Intellectual disability with pigmentary mosaicism and storage disorder|TFE3-related intellectual disability with pigmentary mosaicism,definitive|definitive,monoallelic_X_het|monoallelic_X_hem
TFEC,HGNC:11754,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1333760,viable,increased circulating cholesterol level|increased circulating alanine transaminase level,-,-,0,144.216.106.524.456,n,-,-,-,-,-,-
TFPT,HGNC:13630,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1916964,-,-,-,-,547.309.833.024.119,-182.014.603.389.081,n,-,-,-,-,-,-
THAP1,HGNC:20856,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1921004,lethal,"embryonic growth retardation|preweaning lethality, complete penetrance|embryonic lethality prior to tooth bud stage",abnormal cornea morphology|increased grip strength,-,87.847.866.419.295,-123.444.409.365.683,y,omim_disease,"DYSTONIA 6, TORSION",dd,"DYSTONIA 6, TORSION",strong,monoallelic_autosomal
THAP2,HGNC:20854,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1914066,-,-,-,-,0,319.145.235.433.461,n,-,-,-,-,-,-
THAP3,HGNC:20855,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1917126,-,-,-,-,23.191.094.619.666,-171.504.469.329.065,n,-,-,-,-,-,-
THAP4,HGNC:23187,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1914276,-,-,-,-,0,788.146.695.124.305,n,-,-,-,-,-,-
THAP5,HGNC:23188,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,319.109.461.966.605,-42.747.631.682.073,n,-,-,-,-,-,-
THAP6,HGNC:23189,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,556.586.270.871.985,-5.390.744.510.371,n,-,-,-,-,-,-
THAP7,HGNC:23190,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1916259,viable,-,-,-,213.358.070.500.928,-132.448.113.711.956,n,-,-,-,-,-,-
THAP8,HGNC:23191,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,927.643.784.786.642,259.544.632.856.997,n,-,-,-,-,-,-
THAP9,HGNC:23192,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,-221.167.519.380.887,n,-,-,-,-,-,-
THAP10,HGNC:23193,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,235.911.201.096.657,n,-,-,-,-,-,-
THAP12,HGNC:9440,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1920231,lethal,"preweaning lethality, complete penetrance",-,-,347.866.419.294.991,-422.594.266.913.628,n,-,-,-,-,-,-
TLX1,HGNC:5056,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:98769,-,-,-,-,0,556.073.131.038.729,n,-,-,-,-,-,-
TRRAP,HGNC:12347,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2153272,lethal,"preweaning lethality, complete penetrance",increased mean corpuscular hemoglobin|abnormal behavior|abnormal cornea morphology|increased circulating magnesium level|increased mean corpuscular volume,-,998.144.712.430.427,-153.169.924.567.709,y,omim_disease,"DEAFNESS, AUTOSOMAL DOMINANT 75|DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM",dd,Autism and Syndromic Intellectual Disability,strong,monoallelic_autosomal
YEATS4,HGNC:24859,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1927224,-,-,-,-,88.682.745.825.603,-777.952.857.666.964,y,-,-,-,-,-,-
ZFHX2,HGNC:20152,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2686934,-,abnormal vertebral arch morphology|hyperactivity|abnormal epididymis morphology|decreased thigmotaxis|decreased anxiety-related response,-,-,185.528.756.957.328,-838.329.697.790.337,n,omim_disease,MARSILI SYNDROME,-,-,-,-
ZFHX4,HGNC:30939,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:2137668,lethal,"preweaning lethality, complete penetrance",decreased exploration in new environment|decreased hematocrit,-,742.115.027.829.314,-811.127.565.443.528,n,-,-,dd,ZFHX4-related developmental disorder (monoallelic),definitive,monoallelic_autosomal
ZFP1,HGNC:23328,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99154,-,-,-,-,0,634.642.513.860.244,n,-,-,-,-,-,-
ZFP2,HGNC:26138,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99167,-,-,-,-,0,144.144.311.006.172,n,-,-,-,-,-,-
ZFP3,HGNC:12861,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99177,-,-,-,-,927.643.784.786.642,-44.305.243.095.284,n,-,-,-,-,-,-
ZFP14,HGNC:29312,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99160,viable,increased heart weight|convulsive seizures,-,-,0,602.525.984.001.804,n,-,-,-,-,-,-
ZFP28,HGNC:17801,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99175,-,-,-,-,0,-129.661.271.757.268,n,-,-,-,-,-,-
ZFP30,HGNC:29555,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99178,subviable,"preweaning lethality, incomplete penetrance",-,-,0,165.410.888.579.776,n,-,-,-,-,-,-
ZFP37,HGNC:12863,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99181,-,-,-,-,0,966.807.838.046.646,n,-,-,-,-,-,-
ZFP41,HGNC:26786,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99186,-,-,-,-,204.081.632.653.061,-169.671.663.258.266,n,-,-,-,-,-,-
ZFP62,HGNC:23241,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:99662,-,-,-,-,0,894.135.645.506.175,n,-,-,-,-,-,-
ZFP64,HGNC:15940,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107342,-,-,-,-,927.643.784.786.642,620.241.127.522.862,n,-,-,-,-,-,-
ZFP69,HGNC:24708,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:107794,viable,decreased circulating iron level|increased startle reflex,-,-,825.602.968.460.111,-272.532.046.129.381,n,-,-,-,-,-,-
ZFP69B,HGNC:28053,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,278.293.135.435.993,-504.889.045.648.412,n,-,-,-,-,-,-
ZFP82,HGNC:28682,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1890753,-,-,-,-,0,784.555.486.063.704,n,-,-,-,-,-,-
ZFP90,HGNC:23329,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:104786,-,-,-,-,0,192.642.276.868.039,n,-,-,-,-,-,-
ZFP91,HGNC:14983,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:104854,lethal,"edema|abnormal skin coloration|pallor|preweaning lethality, complete penetrance|abnormal embryo size",increased startle reflex|cataract|enlarged lymph nodes|decreased body length,-,111.317.254.174.397,-150.662.627.670.659,n,-,-,-,-,-,-
ZFP92,HGNC:12865,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:108094,viable,-,-,decreased bone mineral content|increased total body fat amount|decreased lean body mass,0,355.025.872.391.574,n,-,-,-,-,-,-
ZIM2,HGNC:12875,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,-187.215.050.046.702,n,-,-,-,-,-,-
ZIM3,HGNC:16366,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,-,-,-,-,-,-,0,102.424.386.314.486,n,-,-,-,-,-,-
ZNHIT1,HGNC:21688,approved_symbol,gene_with_protein_product,-,-,-,UCSF,-,-,y,MGI:1917353,lethal,"embryonic lethality prior to organogenesis|preweaning lethality, complete penetrance",decreased grip strength|increased circulating phosphate level,-,284.786.641.929.499,-408.358.878.213.332,n,-,-,-,-,-,-
CENPBD1,HGNC:28272,previous_symbol,pseudogene,-,-,-,UCSF,-,-,-,-,-,-,-,-,NA,NA,-,-,-,-,-,-,-